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CHAPTER 1 
Introduction 
 
Gene Expression Control 
Living organisms comprise an amalgam of molecular interactions, each 
component contributing to the complexity of life. Some of the most basic, yet essential 
processes and components of life hinge on nucleic acids and proteins. Indeed, the 
central dogma of biology is based on interactions between nucleic acids (DNA and 
RNA) and proteins. Decades have been spent studying these processes producing 
great insights into both simple and complex organisms.  
Past research on DNA allows speculation that a conserved and basic role of 
nucleic acids is to encode information. DNA is comprised of nucleotides strung together 
in sequences forming a code to direct functions much like how computer codes can be 
used to direct actions. In the cell, the nucleotide sequence of DNA in genes is used for 
protein synthesis. In this process, cellular machinery reads the DNA sequence code and 
produces a transcript, or copy of the sequence, in the form of RNA. The transcript can 
then be modified, transported, and read by machinery responsible for producing 
proteins. Through this process, proteins are made according to the distinct information 
encoded in each gene. Additionally, by controlling the amount of transcript available of a 
gene, the cell can increase or reduce the levels of any particular protein.  
The amount of RNA produced from a gene is referred to as gene expression and 
varies from gene to gene. In order to perform both simple and complex processes, the 
cell controls the amount and timing of specific protein production. A major way of doing 
this is by controlling the levels of gene expression which is essential for a myriad of 
biological processes including proliferation, differentiation, and just plain cell survival. 
How the cell controls gene expression is a basic and fundamental question in biology 
with no one particular answer. An impressive range of mechanisms have been explored 
in this regard; however, the more that is understood of this process, the more the 
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depths of our ignorance are known. This leaves a vast and exciting frontier of 
exploration into such a fundamental aspect of biology. 
Controlling the expression of genes is a complex task which can involve 
communication between two or more regions of DNA, between DNA and proteins, and 
between proteins interacting with each other. Regions of DNA which are involved in 
controlling gene expression are often referred to as regulatory regions. These are 
sections of DNA which interact with proteins to influence transcription. Proteins, known 
as transcription factors (TFs), are targeted to and bind to regulatory regions and from 
there are able to control the expression of a gene. Some ways in which proteins binding 
to regulatory regions can control gene expression are discussed below. 
In order to obtain expression of a gene, protein machinery responsible for 
transcription must be recruited to that site. Research into this machinery has revealed 
that RNA POLYMERASE II (Pol II) is an enzyme responsible for transcribing most 
protein coding genes1. By modulating Pol II binding and/or activity, specific transcription 
factors can enhance or inhibit transcription2. This is often seen by changes in gene 
expression upon mutation of a transcription factor. In eukaryotes, transcription factors 
can have combinatorial effects in that multiple proteins, or protein complexes, at one 
site are required to modulate expression. Furthermore, transcription factors influence 
each other; for example, a protein binding by itself may cause increases in transcription, 
but when other proteins bind it may repress transcription. These variations in 
transcription factor activity depend on many factors including the local nuclear 
environment of the DNA and the type of regulatory region present as well as regulatory 
regions nearby. 
One type of regulatory region, called a promoter, often occurs near the 
transcriptional start site (TSS) of genes. Core promoters, most often found directly at 
the TSS, are regions bound by transcription factors necessary for recruiting and 
activating Pol II1,3. By controlling TF binding to this region, the cell is able to control 
gene expression3,4. Also near the TSS, proteins can bind and may cause Pol II to pause 
or stall, providing another way to control expression5. Pausing polymerase is thought to 
allow hair-trigger transcription by keeping polymerase and other components ready at 
the site of synthesis. Similar to, and in addition to the core promoter, are proximal 
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promoters where transcription factors often bind4. This region represents an even 
greater dynamic influence on gene expression where specific transcription factor 
interactions at proximal and core promoters can alter transcription at a range of levels. 
Transcription factors influencing gene expression in this way are often called activators 
or repressors because they can either cause increases or decreases to gene 
expression depending on the type of protein, the DNA region targeted, and the 
conditions in the cell.  
While promoters and regions near transcriptional start sites are important regions 
of regulatory DNA, other regions play a significant role in influencing gene expression. 
These regions, known as enhancers, are also bound by transcription factors which can 
interact with transcriptional machinery at promoters4,6. While promoters are generally 
directly upstream of protein coding genes, enhancers can be quite distant or 
downstream of genes, or even on separate chromosomes6. The mechanism by which 
enhancers exert long range control of transcription is an exciting and relatively new field 
and will be discussed in detail later in this chapter. Enhancer / promoter activity can vary 
by tissue type and can respond to environmental stimuli4, allowing specific and precise 
control of gene expression under various conditions. The term enhancer suggests that 
TF binding to these elements positively controls, or enhances, transcription; however, 
silencers are also distant regulatory elements where TFs can bind, but ones which have 
a repressive effect on transcription4. Silencers are often difficult to delineate from 
enhancers as they both are TF binding sites and the expression output can depend on 
cellular conditions, thus enhancer is often used as a general term for distant regulatory 
regions and will be used as such in this text. In either case, distant regions of DNA and 
their associated proteins are able to dynamically control the expression of genes. 
In addition to enhancers, insulators are also regions of DNA which are bound by 
proteins and control gene expression. Insulator proteins are thought to function mainly 
by influencing enhancer-promoter interactions7,8. This function can take the form of 
blocking enhancers from influencing a nearby promoter and / or can cause long-range 
enhancer – promoter interactions8,9. Insulator proteins have also been found to be 
involved in the three dimensional nuclear organization of DNA10 and these proteins in 
particular will be discussed further on. The role of insulators as regulatory regions for 
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genes is gaining increasing attention and their relationship to enhancers and promoters 
seems to be of vast importance6,8. 
Genes and regulatory regions comprise important aspects of transcriptional 
control, but other regions of DNA can also be transcribed. Some of these regions can 
cause drastic changes to genes by even altering the genetic sequence itself. 
Transposable elements (transposons) are DNA sequences which have the ability to 
move, or “jump”, to other areas of DNA11,12. Movement of transposons can occur 
through transcription followed by reverse transcription of these regions to make DNA 
copies which can be inserted into the genome (nuclear DNA content)12. Other types of 
transposons use a method involving DNA excision followed by insertion elsewhere in 
the genome12. In either case insertion of DNA sequence can cause problems for gene 
expression. If insertion occurs inside the gene’s transcribed region, the sequence is 
disrupted and the correct protein will not be formed11. Insertion into regulatory regions 
can also cause problems by disrupting protein recognition sites and thereby alter how 
gene expression is controlled11,13. 
Transposons are present in abundance in the human genome taking up an 
estimated 45% of the human DNA content which is more than thirty times that of protein 
coding genes14. In some organisms (i.e. maize), transposons are even estimated to take 
up approximately 85% of the total DNA content (genome)14. Such a large amount of 
potentially harmful DNA sequence is tightly controlled by mechanisms which inhibit 
protein binding and transcription specifically at these regions12. If transposon movement 
is left unchecked, insertion into gene sequence can disrupt genes or regulatory regions 
and can lead to disease or cell death15. Mechanistic understanding of transposon 
movement and inhibition has allowed insights into several diseases like cancer and has 
generated new tools in bioengineering15,16.  
Although transposons pose potential threats, advantages to the cell in keeping 
these elements present have been proposed. Features and mechanisms controlling 
transposons are also used by the cell in viral defense or in repairing DNA12. These 
elements may also be a way in which organisms can rapidly increase mutagenesis and 
thus may allow the species to adapt to stress12,15. By activation of transposons, 
organisms can randomly alter their genetic sequence, increasing mutagenesis, and thus 
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increasing the likely hood of an advantageous mutation in a population. Transposons 
can also jump imperfectly and carry other genomic (DNA) sequences with them, 
allowing the copying or reshuffling of useful DNA sequences12. Additionally, 
transposons themselves have been proposed to work similar to enhancers, in that 
transcription factors target these regions and can control expression of protein coding 
genes11,17. Very little is known about the regulatory activity of transposons as these are 
most often maintained in a repressed state by the cell; however, repression of 
transposons may also contribute to gene expression. If a silenced transposon is close 
enough to a gene or to other regulatory regions, the mechanism silencing the 
transposon may also control gene expression12. 
Although reports suggest that about 1.5% of the human genome is used as 
genes for protein synthesis18, it is unknown how much of the genome is devoted to 
potential transcription or transcriptional control. It is known, however, that non-coding 
regions (regions not directly containing information for protein synthesis) are essential to 
the cell. For example, by controlling TF binding to enhancers, organisms allow 
activation or repression in an environmental or tissue specific manner4. In addition, 
transposons are loci which can affect gene expression, are abundant in the genome, 
and can be transcribed11,13. In addition to all of these genomic features described, an 
increasing amount of evidence indicates that non-coding RNA transcription is prevalent 
throughout the genome. Non-coding RNA comes from transcription of loci which do not 
encode protein, but the RNA molecules themselves are used for a variety of functions. 
Roles of non-coding RNA in controlling gene expression and transposons will be 
discussed further in this work19–21.  
Overall, genomes are complex organizations providing dynamic and responsive 
gene expression control. Understanding mechanisms which influence regulatory 
regions, and thereby subsequent gene expression, will be valuable in understanding the 
basics of life and will naturally provide insights into organismal development and 
disease. 
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Chromatin 
The environment in which regulatory regions are located is an important way that 
genes expression can be controlled1,22. One way of influencing this environment is by 
controlling chromatin, which is composed of DNA and associated proteins and is utilized 
by eukaryotes to package genetic information. Organisms generally have large amounts 
of DNA in each cell. Stretched linearly, the DNA from one human cell would be 
approximately two meters long, all of which must fit into a ~5-10 micrometer nucleus23. 
For further perspective, the total amount of DNA within one human straightened and 
lined end to end could stretch far past the edges of the solar system24. The packed 
organization of DNA in the nucleus is not random and the ability to effectively organize 
and package DNA is essential to complex organisms. Changes to the packaging at 
specific points can affect the accessibility of genes or regulatory regions to transcription 
machinery, which in turn can affect gene expression22. 
One way in which the cell packages DNA is by wrapping short regions (~147 
base pairs [bp]) around core histone proteins to make up nucleosomes25. This core is 
often composed of two of each H2A, H2B, H3, and H4 proteins with an additional 
histone, H1, which binds to DNA not wrapped around the histone core25,26. Tails of 
these histone proteins extrude from the core nucleosome area and have amino acid 
residues which are prone to chemical modification27. The specific placement and / or 
modification of nucleosomes are fundamental contributors to gene expression 
control26,27 and will be explored further in the work presented here. 
Several lines of evidence support a role of nucleosome positioning in gene 
expression control. Promoters for genes with active transcription are often devoid of 
nucleosomes, a trend which indicates that the presence of these units on regulatory 
regions may influence expression26,28,29. Indeed removal of nucleosomes from 
promoters results in increased transcription30. The effects of nucleosomes on gene 
expression are thought to occur by making TF bindings sites inaccessible26,31. Some 
TFs require specific bends or conformation in the DNA in order to bind, thus it is 
possible that nucleosomes may inhibit TFs by altering the conformation of DNA26. 
Specific nucleosome positioning is also important at other regulatory regions such as 
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enhancers and insulators, and is thought to influence transcription factor binding at 
these sites26,32.  
Additionally, nucleosome occupancy in a given population or at different times 
can vary at individual loci26,30,33. Some nucleosomes can appear to be stable and 
precise, while others regions have more limited or dynamic binding, and others appear 
sloppy without a distinct target in the cellular population26. Nucleosome positioning can 
also change as part of normal cellular processes or in response to environmental 
conditions26,30. This can take the form of insertion or eviction, or by sliding nucleosomes 
to nearby regions26. Changes in nucleosome positioning correspond to changes to gene 
expression and mutants for nucleosome remodeler enzymes can cause dramatic 
phenotypic effects, illustrating the importance of nucleosome remodeling for proper 
development34. 
While nucleosomes at regulatory regions can control gene expression, so can 
well placed nucleosomes often found immediately downstream of the transcriptional 
start site5,26. This nucleosome may control expression by causing polymerase to pause 
or stall5. TFs such as SPT4 and SPT5 (Supressor of Ty insertion 4 / 5) (see Appendix A 
Table 1.1) work as elongation factors to overcome polymerase pausing5,35. This may 
occur through displacement of nucleosomes during polymerase pausing, followed by 
repositioning after transcription has passed through5,35. This is an example of the 
multifaceted relationship between chromatin and transcription factors; chromatin can 
affect TF binding and TF binding can affect chromatin. 
The relationship between chromatin and transcription factors takes on even 
further depth by modification of nucleosome components which stick out from the core, 
called histone tails. Extensive evidence supports the idea that changes to histone 
modifications can influence gene expression27,36,37. This is thought to occur by altering 
the accessibility of DNA through compaction (into heterochromatin) or by decompaction 
/ release (into euchromatin)27. Histone modifications may also work directly as protein 
binding sites, and changing the modification can create or eliminate recognition sites for 
transcription factors27. 
A myriad of histone modifications at dozens of residues have been characterized 
which have varying effects on gene expression27. General rules for histone 
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modifications have been proposed, such that acetylation of H3 (H3Ac) and methylation 
of H3 lysine 4 (H3K4me) often define euchromatin or active transcription, while 
methylation of H3 lysine 9 (H3K9me) often characterizes heterochromatin or inactive 
transcription27,36,38. These are only a few of the known histone modifications and 
interplay between others must also be considered. Additionally, variable effects to gene 
expression between organisms or within the same organism at different genomic 
locations occur and histone modifications must often be viewed as part of a bigger 
picture39,40. These variable effects are likely dependent on the interplay between the 
type of modification present and the specific TF recruited / inhibited. 
Modification of chromatin by nucleosome positioning and histone modification 
have a large role in gene expression control, but another feature of chromatin which can 
affect gene expression is DNA methylation at cytosines41,42. In mammals, DNA 
methylation mainly occurs in the context of CG dinucleotide sequences 41. 
Unmethylated CG islands often occur on regulatory regions associated with active 
transcription, and methylation of these regions is associated with transcriptional 
repression41,43. It is also suggested that more widespread methylation occurs in stem 
cells and that dynamic DNA methylation of regulatory regions is important for tissue 
differentiation and embryogenesis43. In particular, methylation of cytosines in other 
contexts such as CHG or CHH (H = A, C, or T) are thought to occur more frequently in 
embryonic stem cells to help control transcription44.  
CG and CHG methylation are symmetric sequences in that there are cytosines 
on both DNA strands which are generally methylated together41; thus after DNA 
replication, one strand in each copy retains the methylation information (Figure 1.1). 
Maintenance methyltransferases (DNMT1 [DNA METHYLTRANSFERASE 1] in humans 
and MET1 [METHYLTRANSFERASE 1] or CMT3 [CHROMOMETHYLASE 3] in plants 
– see Appendix A Table 1.1) can use single stranded methylation marks in CG or CHG 
sequence contexts to place methylation on the opposite strand41. In fact DNMT1 has 
been shown to associate with the replication machinery and relies on the protein 
UHRF1 for targeting45. UHRF1 recognizes hemimethylated DNA and H3K9me2 for 
targeting and can flip out methylated cytosines which are likely passed to maintenance 
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methyltransferases46,47.  It is likely that this flip-out mechanism allows recognition of un-
methylated cytosines on the opposite strand46,47. 
In contrast to CG or CHG methylation, CHH sites are asymmetric in nature and 
after replication of CHH methylated sites only one copy of the DNA retains the 
methylation (Figure 1.1). In this sequence context the second copy must undergo de 
novo methylation after each round of replication. Even in CG and CHG methylation de 
novo methyltransferases are necessary for the original placement of these marks41; thus 
studying de novo methylation is an effective means to study pathways responsible for 
placing methylation marks regardless of sequence context.  
In plants CHH methylation sites occur much more frequently than mammals and 
are commonly used to study an important pathway for de novo methylation called 
Transcriptional Gene Silencing (TGS)41,48. Studies of this pathway show that targeting of 
de novo DNA methylation to specific loci can alter gene expression34,49. Others have 
shown evidence that misregulation of DNA methylation is involved in cancer and many 
other diseases50. Research also supports an essential role for DNA methylation in 
transposon silencing41,51.  
DNA methylation, like histone modification and nucleosome positioning, could 
exert its function by directly inhibiting transcription factor binding or by recruitment of 
methyl binding proteins. The interplay between DNA methylation and histone 
modifications is strong, such that alterations in DNA methylation can change histone 
modifications and thus affect the accessibility of chromatin52. The inverse is also true, 
where histone modifications can alter the placement of DNA methylation and thereby 
influence transcription factor binding52. It is apparent that both are closely entwined as 
chromatin modulators of the DNA environment. 
Chromatin modifications in the form of DNA methylation, histone modifications, 
and nucleosome positioning are important for gene expression control; however, the 
three dimensional spatial organization of chromatin can also play a role in controlling 
genes. It is often tempting to think of DNA as linear, and even when adding 
nucleosomes to the picture we think of beads on a string. That string, however, is more 
like a tangled ball of yarn. DNA is packed into the nucleus and can loop around to 
linearly distant regions or even to other chromosomes8,53,54. The three dimensional 
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organization of DNA has a function; it allows linearly distant regions of chromatin to 
come into close proximity and influence each other6,54–56. Recent advances in 
technology involving chromosome conformation capture and high throughput 
sequencing have rapidly deepened our understanding of chromosome conformation 
and allow detection of linearly distant enhancer – promoter interactions57. Although 
studying the three-dimensional genome is a relatively new field, general principles of 
nuclear organization have emerged. Data shows the clustering of regions with similar 
chromatin features including centromeres, telomeres, and inactive regions into distinct 
domains, as well as long range interactions between more active regions54,58.  
Chromatin organization also includes the clumping of large genomic sections into 
Topologically Associated Domains (TADs)54,59. These are defined as regions with 
topological similarities which interact at high frequency. These TADs generally consist 
of regions having similar histone modifications and have borders at active chromatin 
marks60. Little is known of their function, but it seems that TADs may play a vital role 
since they have been found in many organisms and are relatively static throughout the 
cell cycle, quickly reforming after mitosis53. However, TADs have not been discovered in 
organisms such as yeast or plants, but this may be due to differences in the 
developmental stage used or in other experimental conditions61,62. 
The organization of chromatin into specific domains is mediated by insulator 
proteins10. These proteins bind preferentially to nucleosome free regions and form 
complexes which bring long distance sections of chromatin into close proximity7,10. 
Insulator proteins cluster at TAD boundaries which may be one way in which these are 
defined, however insulators can also be found throughout the domain60. Several 
insulator proteins have been found in mammals as well as in flies (Drosophila 
melanogaster) with CTCF being the most well known60,63,64. CTCF and other known 
insulators are not found in yeast or plants, which may also explain a lack of evidence 
supporting TAD formation in these systems. However, the lack of TADs does not mean 
that chromatin is not organized specifically. Long distance chromosome looping exists 
in both of these systems and several other proteins might display insulator 
activity61,62,65.  
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In addition to organization of chromatin into TADs, chromatin looping mediated 
by insulators allows for enhancer-promoter interactions6,9. Insulators were traditionally 
thought to “insulate” particular genes from the effects of a nearby enhancer. This is 
generally thought to be at least partially caused by specific chromosome looping to a 
different gene. As mentioned, these interactions can occur at a diverse range of linear 
distances and even between different chromosomes6,54,55; however, the mechanisms for 
precise pairing between specific promoters and enhancers remains a mystery. 
Additionally, it is thought that chromatin modifications influence these interactions, a 
subject about which relatively little is known but which merits further exploration22,55. It 
has been shown that silenced genes and chromatin with repressive marks are much 
less likely to participate in chromosome looping54,58. Similarly promoters with active 
chromatin marks are more likely to form loops than ones with inactive marks54,58. This 
suggests that mechanisms affecting local chromatin landscapes may also affect 
chromosome looping thereby contributing to gene expression control. 
One intriguing idea is that transcription machinery is localized at specific points 
within the nucleus, and that DNA is brought to these sites66. As part of this model of 
transcription factories, active enhancers cluster together and are available for RNA 
Polymerase binding. Evidence for this exists as labeling of nascent RNA forms distinct 
spots within the nucleus67. Other researchers used polymerase fixed in place to show 
that DNA can be moved through the Polymerase68. This model is still under debate and 
others have shown the inverse: that fixing DNA in place causes polymerase to move69. 
It is unsure which is happening in vivo and either mechanism is possible, while an 
alternate scenario could occur where neither is fixed in location and both types of 
molecules move to associate. In any case, chromatin looping can occur and may affect 
transcription. 
The effects of chromatin modifications and looping on the transcription of genes 
and transposons are fast growing fields of study. There are several mechanisms 
affecting chromatin modification, some of which are highlighted here. Nucleosome 
remodelers such as SWI/SNF proteins may slide, place, or evict nucleosomes which in 
turn may block or release potential transcription factor binding sites. Histone 
acetyltransferases and methyltransferases may alter modifications to histone tails, and 
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thus again affect accessibility to chromatin. Similarly, DNA methyltransferases can 
affect accessibility and thus recruitment or inhibition of proteins. The actual three 
dimensional arrangement of DNA can allow long distant regions of chromatin to interact 
and affect gene expression by enhancer-promoter pairing. Each of these aspects of 
chromatin may influence another, creating complex feedback systems between 
features. An additional aspect of chromatin which can control gene expression is non-
coding RNA (ncRNA). Pathways involving ncRNA are involved in gene activation, post-
transcriptional silencing, and in altering chromatin modifications for transcriptional 
silencing70.  
 
Non-Coding RNA 
As mentioned, cells contain a huge amount of information in the form of DNA 
packed into the nucleus, but approximately 98.5% of this information does not encode 
protein18. The functional role of much of this DNA content remains unknown; however, 
increasing evidence indicates that non-coding regions of chromatin are extremely 
important. Although transcription of DNA encoding proteins occurs at very few sites in 
the genome, many other regions are transcribed into non-coding RNA (ncRNA)56. While 
it is unknown how much of the genome is transcribed to form ncRNA, numbers of 
discovered ncRNAs are constantly increasing, to the extent that low levels of 
transcription may occur throughout the entire genome71. These ncRNAs affect gene 
expression in a variety of ways and have been shown to be involved in the RNA splicing 
machinery, translation machinery, post-transcriptional silencing pathways, 
transcriptional regulation, and in chromatin modification70. Although several classes of 
ncRNA exist, the ones relevant to this work are generally classified as small RNA 
(sRNA) and long non-coding RNA (lncRNA). 
Much of what is known of sRNA mechanisms suggests that they play a large role 
in silencing gene expression. One class of sRNA, termed microRNA (miRNA), 
participates in post-transcriptional silencing72. miRNA is generated from hairpin RNA 
formed by base-pairing with itself73,74. This hairpin form is exported out of the nucleus 
and recognized as double-stranded RNA for cleavage by DICER protein into 21 
nucleotide (nt) fragments73. The 21 nt products are miRNAs which load onto an 
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ARGONAUTE (AGO) protein as single stranded fragments.  The sequence specificity of 
the miRNA is able to then guide AGO to mRNA targets with similar sequences72. Once 
bound, AGO and associated small RNAs can silence transcripts in a few ways. If the 
miRNA sequence perfectly base pairs a region of mRNA, AGO can then directly cleave 
the transcript72. However if a few nucleotides do not match up with the mRNA, binding is 
still achieved, but in lieu of cleavage by AGO, this process causes rapid degradation of 
the transcript, and / or blocking of the translational machinery on this mRNA72. In this 
way, mRNA levels are controlled post-transcriptionally in the cytoplasm to regulate gene 
expression, a pathway also referred to as Post Transcriptional Gene Silencing.  
Another class of small RNA is piwi-interacting RNAs (piRNAs) which are found 
mainly in the germ line and are important in gonad formation74. piRNAs are slightly 
longer, approximating 25-33 nucleotides in length and differ from miRNAs in that they 
do not require DICER for processing and that they are loaded onto PIWI proteins which 
are part of the AGO family74. This class of sRNA mainly targets transcribed transposons 
for cleavage, the fragments of which can be processed into additional piRNAs74. 
Another function of piRNAs is to target de novo DNA methylation to transposons in 
order to silence transcription, thus exhibiting a role in chromatin modification74. 
A third class of small RNA is small interfering RNA (siRNA) processed from 
double-stranded RNA (dsRNA) which can act in a broad range of tissue type and are 
found in most organisms74. These are loaded onto AGO proteins and can work similarly 
to miRNA in Post Transcriptional Gene Silencing72. Depending on the biogenesis and 
processing of double stranded RNA these siRNA-AGO complexes can instead target 
chromatin where they direct DNA methylation and chromatin modifications in a process 
known as Transcriptional Gene Silencing (TGS) or RNA-directed DNA Methylation 
(RdDM)41,74. Traditionally, siRNAs affecting chromatin were mainly thought to target and 
silence transposons, but work from several groups have shown that they also target 
regulatory regions of DNA (chapter 2) 49,75,76. 
In addition to small RNA, long non-coding RNA (lncRNA) can affect gene 
expression70. These are loosely defined as transcripts which form no known protein 
product. Some lncRNAs are known to act at enhancers and are important for enhancing 
transcription of genes77,78. This may be through the recruitment of TFs to enhancers / 
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promoters, by causing conformational changes in TFs, or by acting as competitors for 
repressor binding so that DNA regulatory regions are not targeted70. Activating lncRNAs 
such as these are generally found in active chromatin and are implicated as important 
features of chromosome looping79. 
 Perhaps a more prominent role of lncRNA lies in transcriptional silencing. One 
widely known lncRNA, termed HOTAIR, guides repressive chromatin modifications to 
target loci and acts as a scaffold to help proteins associate with chromatin and influence 
expression of genes70,80. Another well known lncRNA, Xist, is essential for dosage 
compensation of the X chromosome81. Xist accumulates along the X chromosome 
marked for inactivation, where it acts as a scaffold for chromatin modifiers to place 
repressive marks81. These lncRNAs illustrate general principles of lncRNA in which they 
act as a scaffold for proteins to guide chromatin modification and thus represent ways in 
which cells may target repressive chromatin marks to specific regions. 
 
The Transcriptional Gene Silencing Pathway 
In most organisms, lncRNAs involved in transcriptional silencing are thought to 
be transcribed by the same polymerase necessary for protein coding genes, 
Polymerase II (Pol II). This dual function makes genetic studies difficult in many 
organisms, as disruption of Pol II would cause widespread changes in gene expression. 
However, in Arabidopsis thaliana a specialized RNA polymerase, Pol V, is responsible 
for transcribing much of the lncRNA in the cell82,83. Pol V recently diverged from Pol II 
and these complexes share several subunits, however a few subunits are specific for 
lncRNA production by Pol V; most notably the largest subunit, NRPE183. This allows 
knockout of Pol V (nrpe1 mutant) without disruption of the Pol II protein coding 
transcriptional machinery.  
In Arabidopsis, the nrpe1 mutant displays no visible phenotype except under 
specific conditions, indicating the maintained functionality of Pol II83. However, knockout 
of Pol V results in activation of a number of transposons as seen by increased Pol II 
transcription at these loci82 and the minor visible phenotype in Arabidopsis is thought to 
be due to the low transposon content of the genome. Indeed in Maize mutations of this 
pathway show more severe phenotypes51.  
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Very little is known of how Pol V is recruited to chromatin since no discernible 
core promoter or motif regions have been found.  However, proteins such as RDM1 
(RNA-DIRECTED DNA METHYLATION 1), DMS3 (DEFECTIVE IN MERISTEM 
SILENCING 3), and DRD1 (DEFECTIVE IN RNA-DIRECTED DNA METHYLATION 1) 
form complexes which are necessary for Pol V to bind chromatin (see Appendix A Table 
1.1)51,84. Additionally, there is some indication that chromatin modifications can play a 
role in Pol V recruitment to chromatin. Mutation in a maintenance DNA 
methyltransferase causes loss of de novo DNA methylation85. It is also suggested that 
the DNA methylation binding proteins, SUVH2 (SU[VAR] 3-9 HOMOLOG 2) and SUVH9 
(SU[VAR] 3-9 HOMOLOG 9), are necessary for proper Pol V chromatin binding 86. This 
represents an example in which chromatin structure may affect not only transcription of 
genes, but also transcription of lncRNA.  
In addition to Pol V, Arabidopsis has another specialized RNA polymerase, Pol 
IV which is involved in creating siRNA48. Pol IV shares several subunits with Pol II and 
Pol V, but the largest subunit, NRPD1, is distinct, of which knockout lines are used in 
genetic studies83. Transcription by this polymerase also contributes to TGS in a different 
role; lncRNA produced by Pol IV is processed into siRNA48,83. Most of the siRNA in the 
nucleus is thought to be derived from Pol IV transcripts, although some can depend on 
Pol V76. Feedback between the two pathways can also influence siRNA levels, to an 
effect that much of the Pol V dependent siRNA may also depend on Pol IV76.  
Pol IV is closely associated with RNA DEPENDENT RNA POLYMERASE 2 
(RDR2) which uses Pol IV transcripts as a template to make double stranded RNA 
(dsRNA) (Figure 1.2)82,87. It is thought that this happens very quickly and that RDR2 
forms a complex with Pol IV so that dsRNA may be synthesized directly as the locus is 
transcribed87.  
Very little is known of how Pol IV and RDR2 are targeted, but some evidence 
suggests that it is dependent on SAWADEE HOMEODOMAIN HOMOLOGUE 1 
(SHH1)88. SHH1 contains lysine binding pockets which may recognize histone tail 
modifications88. These pockets recognize methylated H3K9 and unmethylated H3K4, 
the combination of which is a mark of heterochromatin88. In this way SHH1 may bind 
already present chromatin marks and recruit Pol IV for siRNA production. 
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Once Pol IV has transcribed and double stranded RNA is produced, the RNA is 
then processed by a DICER-LIKE (DCL) protein into 24 nucleotide (nt) siRNA (Figure 
1.2)51. In Arabidopsis there are four different DCL proteins involved in small RNA 
biogenesis89. While some overlap between pathways occurs, DCL3 generally produces 
24 nt siRNA and is the DCL mainly responsible for processing Pol IV / RDR2 produced 
dsRNA for TGS (DCL2 and DCL4 also contribute significantly to the pool of siRNA and 
may have some redundancy with DCL3)51,89.  
An important next step in small RNA biogenesis is methylation on the 3’ end by 
HEN1 (HUA ENHANCER 1)90, but the purpose of methylating small RNA remains 
mysterious. The processed and finalized small RNA products are part of a pool of 
sequences which direct components of TGS to their targets in a sequence specific 
manner.  
As previously discussed, small RNAs can direct silencing by binding to AGO or 
AGO-like proteins41,51,72. In the plant TGS pathway, siRNAs are loaded onto AGO4 
which is then targeted to chromatin with sequences matching the small RNA51. 
However, this targeting of AGO4 seems to be dependent on both siRNA and Pol V 
transcription (Figure 1.2)49. It is likely that siRNA targets AGO4 to loci by base pairing 
with lncRNA produced by Pol V. An alternative also exists where base pairing of siRNA 
to DNA occurs at the region transcribed and opened by Pol V. In any case, the 
sequence specificity is likely important for AGO4 targeting to diverse loci in a precise 
manner.  
Evidence also indicates that AGO4 binds to reiterated WG/GW motifs located on 
the Pol V C-terminal domain (CTD)91. These motifs are found on the NRPE1 subunit 
and may help AGO4 distinguish between various polymerases91. By making AGO4 
dependent on Pol V and on siRNA, a dual check system is in place. In this scenario two 
conditions must be met for AGO4 to recognize a locus for silencing: 1. siRNA matching 
the sequence must be present; 2. Pol V must also be present. This would help hone the 
precision of silencing and eliminate unwanted silencing of other regions matched by 
siRNA or transcribed by Pol V.  
Another component of the TGS pathway, SPT5L (also known as KTF1) 
(SUPRESSOR OF TY INSERTION 5-LIKE / KOW DOMAIN CONTAINING 
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TRANSCRIPTION FACTOR 1), contains WG/GW motifs and is thought to interact with 
AGO492. Like AGO4, SPT5L associates with Pol V transcripts and is dependent on Pol 
V to bind chromatin (Figure 1.2)38,92. SPT5L is structurally similar to the transcription 
elongation factor SPT5, which is part of a nucleosome remodeling complex and is 
thought to help guide Pol II through nucleosome bound DNA35. However, unlike SPT5, 
SPT5L binds chromatin dependent on Pol V and is thought to have little effect on 
lncRNA transcription38. The specific roles of AGO4 and SPT5L in TGS were previously 
unknown, but are investigated in chapters 4 and 5. 
INVOLVED IN DE NOVO 2 (IDN2) also binds to Pol V transcripts and is 
important for TGS (Figure 1.2)34,93,94. There are several IDN or IDN-like proteins which 
are thought to be able to form complexes with IDN2 or to act redundantly in this 
pathway95. It was shown that IDN2 interacts with SWI3B (SWITCH3B) a member of the 
SWI/SNF family of nucleosome remodelers34. This interaction and the roles these 
proteins play in the TGS pathway are discussed in chapter 3 and provide novel insights 
into nucleosome positioning. 
The TGS pathway, otherwise known as RNA-directed DNA Methylation (RdDM), 
results in modification to chromatin, one form of which is the placement of DNA 
methylation41. DNA methylation is targeted through the coordinated action of TGS / 
RdDM pathway components to allow a de novo DNA methyltransferase to bind, called 
DOMAINS REARRANGED METHYLTRANSFERASE 2 (DRM2) (Figure 1.2)41. DRM2 is 
a homolog of the mammalian de novo DNA methyltransferase and is thought to function 
similarly. Evidence suggests that DRM2 binds to both lncRNA and DNA, where it places 
cytosines methylation94. As stated earlier, in Arabidopsis this is usually studied in the 
context of CHH methylation; these marks must be placed after each round of replication 
and thus represent de novo DNA methylation (Figure 1.1). 
 Genome-wide maps of DNA methylation have revealed that although an 
abundance of CHH methylation occurs near centromeres (where transposons are 
abundant), much of the TGS dependent methylation occurs in pericentromeric regions 
and chromosome arms (in more gene dense regions)75,76,85. Presence of CHH 
methylation on chromosome arms near genes is intriguing and could suggest a role in 
controlling expression of protein coding genes. 
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 In addition to DNA methylation and nucleosome positioning, TGS is responsible 
for directing histone modification at specific loci. This generally includes removal of 
active marks such as H3 acetylation and addition of repressive marks such as 
H3K9me241,51. These effects usually are present in conjunction with DNA methylation 
and a great amount of feedback between them may occur51.  Despite this feedback, 
these modifications represent another way in which the TGS / RdDM pathway targets 
discrete loci for silencing by alterations to chromatin. 
 
Functional Roles of Transcriptional Gene Silencing 
 Traditionally, the role of TGS / RdDM is thought to lie in transposon silencing. 
Transposons in many organisms, including humans, are more abundant than genes 
throughout the genome, and, as discussed, can pose a threat to genomic stability14. 
Much of the transposon content in the genome is centered in centromeric regions where 
silencing is maintained49. However, evolutionarily “young” transposons (those which 
have recently moved) are present throughout the genome. RdDM components were 
found to be enriched on these transposons and mutations in the RdDM pathway result 
in loss of repressive chromatin marks and transposon activation49,75.  
 In addition to transposon silencing, this work shows that RdDM also  targets 
regulatory regions and functions in controlling the expression of protein coding genes49 
(Chapter 2). Due to the presence of RdDM components on regulatory regions, and due 
to the great impact this pathway has on chromatin, the RdDM pathway may influence 
long range chromosome interactions. Findings from genome wide chromosome looping 
data are discussed in chapter 6. Here I examine looping in the context of RdDM to study 
if the effects this pathway has on gene expression may be explained by an ability to 
influence enhancer – promoter interactions. 
 RdDM’s control of gene expression may represent a dynamic way in which 
chromatin responds to environmental stimuli. Genes controlled by RdDM often encode 
proteins involved in stress response pathways and evidence shows involvement in heat 
tolerance, pathogen defense, and DNA repair96–98. I propose that under stressful 
conditions, RdDM components are turned off which not only allows the upregulation of 
stress response genes, but also increases mutagenesis from transposon activation. 
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This may allow the cell to not only respond to the change in environment but also may 
provide means for adaptation. 
 A unifying current underlies the diverse functions of TGS / RdDM in that 
chromatin is controlled in order to manipulate genomic features. Whether these features 
are transposable elements or protein coding genes, TGS / RdDM can modify chromatin 
in order to control expression. 
 
Overview of Dissertation 
The work presented here focuses on how the TGS / RdDM pathway can exert 
control of transcription in Arabidopsis thaliana. I seek to understand the relationship 
between central components of TGS / RdDM (SPT5L and AGO4) in order to better 
understand each of their specific roles. I investigate various ways in which TGS / RdDM 
components are involved in chromatin modification, including nucleosome positioning. 
The main purpose of chromatin modifications placed by TGS / RdDM was thought to be 
in silencing transposons , but although transposons are found in abundance near the 
centromere, they can also be found throughout the genome where regulatory regions 
occur. By using genome wide maps of AGO4 binding sites, I investigate a possible role 
in gene expression control through modification of regulatory regions.  Due to the 
myriad of chromatin modifications and the role in controlling gene expression, I also 
examine whether TGS / RdDM is able to influence enhancer – promoter interactions in 
the form of chromosome looping.  
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Figure 1.1 DNA methylation in different contexts 
Cytosines can be found in three different sequence contexts: CG (green), CHG 
(blue), or CHH (red) (H= A, T, or C). Once DNA methylation is established CG and 
CHG methylation can be maintained based on the symmetry of the sequence. CHH 
methylation is asymmetric and thus requires de novo methylation after each round of 
replication. 
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Figure 1.2 Model of Transcriptional Gene Silencing (TGS) in Arabidopsis 
thaliana 
Transcriptional Gene Silencing (TGS) has many components whose roles have been 
discovered. Pol IV (purple) produces transcripts which are made double-stranded by 
RDR2 (gold). Double stranded RNA is then cleaved by DCL3 (pale blue) into 24 nt 
siRNA. Pol V (light blue) produces long non coding RNA (lncRNA) which acts as a 
scaffold for several proteins. AGO4 (pale green) binds siRNA and lncRNA and may 
interact directly with Pol V. SPT5L (orange) is also dependent on Pol V and binds 
chromatin independent of AGO4. IDN2 (beige) forms homodimers and binds lncRNA 
dependent on AGO4. IDN2 interacts with SWI3B (pale orange), a chromatin 
remodeling enzyme which positions nucleosomes at these loci. Many of these factors 
such as AGO4 and SPT5L are also important for de novo DNA methylation placed by 
DRM2 (yellow).  
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CHAPTER 2 
RNA Polymerase V Targets Transcriptional Silencing Components to Promoters 
of Protein-Coding Genes 
 
The contents of this chapter were published and featured on the cover of The Plant 
Journal in 2012. This work was done in partnership with collaborators (Brian Gregory) 
from the University of Pennsylvania. Gudrun Böhmdorfer performed work shown in 
Figure 2.3G-I. Davinder Sandhu constructed libraries and handled the initial data 
processing. Qi Zheng performed work shown in Figure 2.1G, Figure 2.2A,C,D, Figure 
2.3A-C, Figure 2.4A-D, Figure 2.5, Figure 2.8, Figure 2.9B, Figure 2.10, Figure 2.11A, 
Figure 2.12A,B, and Figure 2.13. I generated samples for sequencing and performed all 
other experiments and data analysis shown in this chapter. 
 
Abstract 
Transcriptional gene silencing controls transposons and other repetitive elements 
through RNA-directed DNA methylation (RdDM) and heterochromatin formation. A key 
component of the Arabidopsis RdDM pathway is ARGONAUTE4 (AGO4), which 
associates with siRNAs to mediate DNA methylation. Here, we show that AGO4 
preferentially targets transposable elements embedded within promoters of protein-
coding genes. We find that this pattern of AGO4 binding cannot be simply explained by 
the sequences of AGO4-bound siRNAs, but instead AGO4 binding to specific gene 
promoters is also mediated by long non-coding RNAs (lncRNAs) produced by RNA 
Polymerase V. lncRNA-mediated AGO4 binding to gene promoters directs asymmetric 
DNA methylation to these genomic regions and is involved in regulating the expression 
of targeted genes. Finally, AGO4-binding overlaps sites of DNA methylation affected by 
biotic stress response. Based on these findings, we propose that targets of AGO4-
directed RdDM are regulatory units responsible for controlling gene expression under 
specific environmental conditions.  
28 
 
Introduction 
Transcriptional gene silencing is mediated by repressive chromatin modifications 
directed to transposable elements and other repetitive sequences to prevent their 
expression, which if uncontrolled could result in detrimental effects to the cell. In 
eukaryotic organisms, the primary factors driving the functional mechanism of silencing 
are the conserved Argonaute proteins 1. In Arabidopsis thaliana, the RNA-mediated 
transcriptional gene silencing pathway (also known as RNA-mediated DNA methylation; 
RdDM) is mediated by ARGONAUTE4 (AGO4) 2. Specific genomic localization of AGO4 
has been hypothesized to require the joint activity of two classes of non-coding RNAs. 
The first is small interfering RNAs (siRNAs), which are produced by the activities of 
RNA Polymerase IV (Pol IV), RNA-DEPENDENT RNA POLYMERASE 2 (RDR2) and 
DICER-LIKE 3 (DCL3) 3. siRNAs bind AGO4 and provide sequence-specificity 4 through 
direct base-pairing interactions with complementary loci. The other class of non-coding 
RNAs involved in targeting AGO4 to specific genomic loci is likely long non-coding RNA 
(lncRNA) produced by a plant-specific RNA Polymerase V (Pol V) 5 with some 
involvement of RNA Polymerase II 6. Pol V-produced lncRNAs have been proposed to 
act as binding scaffolds for AGO4-siRNA complexes 7,8. Upon binding to chromatin, 
AGO4 is believed to work with at least one more RNA-associated protein (SPT5L/KTF1) 
9, guide de novo DNA methyltransferase DRM2 and thereby mediate DNA methylation 
primarily in CHH contexts 10.  
Little is known about the genome-wide distribution of AGO4 or other RdDM 
components or the mechanisms that direct them to specific loci. It is also unknown to 
what extent the RdDM pathway controls expression of protein-coding genes involved in 
specific biological processes. To answer these questions we characterized the genome-
wide distribution of AGO4 binding to chromatin. We found that AGO4 preferentially 
targets promoters of protein-coding genes. This specific binding pattern cannot be 
explained by the sequences of AGO4-associated small RNAs and seems to be primarily 
mediated by Pol V-produced lncRNAs. AGO4 binding to gene promoters mediates CHH 
methylation and in some cases affects expression levels of genes controlled by these 
promoters. Moreover, AGO4 binding overlaps DNA methylation affected by biotic stress 
response. This combination of results leads to the intriguing hypothesis that AGO4 
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binding sites are regulatory units controlling gene expression under specific 
environmental conditions. 
 
Results 
AGO4 has no preference towards TE-rich pericentromeric regions 
As the first step towards explaining the mechanism by which AGO4 directs 
RdDM-mediated silencing to specific loci, we assayed the genome-wide distribution of 
AGO4 binding targets using chromatin immunoprecipitation with an anti-AGO4 
polyclonal antibody followed by high-throughput sequencing (ChIP-seq). Using a 
combinatorial comparison approach, where ChIP-seq samples from Col-0 wild type 
were compared to those from ago4 mutant as well as to input sample controls, we 
identified 820 AGO4 binding regions (referred to also as peaks; Figs. 2.1A – C and 2.7). 
We used ChIP followed by real-time PCR (ChIP-qPCR) to validate 24 AGO4 binding 
regions. Binding was confirmed at all 11 tested regions ranked in top 20% by the peak 
calling algorithm (Figs. 2.1D and 2.7B), all 3 tested regions ranked in the middle 60% 
(Figs. 2.1E and 2.7D) and 10 out of 13 tested regions ranked in bottom 20% (Figs. 2.1F 
and 2.7F). Additionally, most previously known AGO4 targets 7,9 displayed evidence of 
strong AGO4 binding in our ChIP-seq, however only IGN25 met the stringent criteria to 
be included on the list of significant AGO4 chromatin binding sites. In total, these results 
indicate that our analysis has a high stringency with low proportion of false positives 
even among the lowest ranking AGO4 binding sites. 
The Arabidopsis RNA-mediated transcriptional gene silencing pathway targets 
mostly transposable elements and other repetitive sequences 3. Because most TEs in 
the Arabidopsis genome cluster within pericentromeric regions 11, silencing components 
may also be expected to be enriched around the centromeres. To test whether the 
genome-wide AGO4 chromatin binding data confirm this prediction, we mapped AGO4 
peaks onto the five nuclear chromosomes of Arabidopsis. Surprisingly, we found AGO4 
peaks to be distributed evenly across all five chromosomes and their density to be 
comparable in both TE-rich pericentromeric regions as well as gene-rich chromosome 
arms (Figs. 2.1G and 2.8). Therefore, genome-wide identification of significant AGO4 
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binding sites indicates that this protein is not preferentially targeted to large 
heterochromatic and repetitive genomic domains. 
AGO4 binds TEs within gene promoters 
Widespread AGO4 binding within gene-rich chromosome arms often overlapped 
protein coding genes (Figs. 2.1G and 2.8), suggesting that AGO4 binding may be 
enriched on genes. To test this possibility, we classified AGO4 peaks based on overlaps 
with annotated genomic features. AGO4 was not enriched on the transcribed regions of 
protein-coding genes (Fig. 2.2A), instead we observed a significant enrichment on gene 
promoters defined as 1 kb regions upstream of transcription start sites (p < 0.001; Fig. 
2.2A) with 64% of all AGO4 peaks mapping to promoters of protein-coding genes. This 
pattern was confirmed by profiling ChIP-seq signal around transcription start sites, 
which revealed preferential AGO4 binding in the approximate region between -500 and -
200 upstream of target gene transcription start sites (TSSs) (Fig. 2.2B). Moreover, 
AGO4 peaks were also depleted in nucleosomes (Fig. 2.9A-B), the absence of 
nucleosomes being a characteristic feature of gene promoters 12. These results 
demonstrate that AGO4 is preferentially binding promoters of protein-coding genes. 
AGO4 binding was also enriched on transposable elements and tandem repeats 
(p -> 0; Fig. 2.2A). This enrichment was significant on most Class I and Class II 
transposable elements (Fig. 2.2C). Interestingly, AGO4 binding was significantly 
depleted on En-Spm DNA transposons as well as Copia long terminal repeat (LTR) 
retrotransposons (Fig. 2.2C), both of which are enriched within coding sequences of 
protein-coding genes 13. AGO4 binding was also depleted on Gypsy LTR 
retrotransposons (Fig. 2.2C). These results reveal that AGO4 has a preference towards 
specific families of transposable elements in the Arabidopsis genome. 
Further analysis of AGO4 binding to gene promoters revealed that out of 528 
AGO4 binding regions identified within gene promoters, 362 (69%) overlapped 
transposable elements (Fig. 2.2D). In contrast, in a comparable set of random control 
regions 436 mapped to gene promoters and only 163 (37%) of them overlapped 
transposable elements (Fig. 2.2E, p < 7x10-22), indicating that AGO4 binding to gene 
promoters does not reflect preferential insertions of TEs into promoter regions. These 
results demonstrate that AGO4 binding shows a significant preference for both gene 
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promoters and transposable elements. Together, our findings reveal that AGO4 
preferentially binds transposons embedded within promoters of protein-coding genes. 
AGO4 binding pattern is mediated by lncRNA 
Sequence specificity of AGO4 binding to chromatin has been proposed to be 
directed by the sequences of incorporated 24 nt siRNAs 4. To test whether 24nt siRNAs 
have a function in directing AGO4 to TEs within promoters of protein coding genes, we 
mapped AGO4-bound siRNAs 14 to AGO4 peaks. We found that AGO4-associated 24 nt 
siRNAs are enriched on AGO4 peaks (Fig. 2.3A). As controls, similar analyses with 
AGO1-bound 24 nt siRNAs 14 demonstrated only minimal enrichment, and 21 nt siRNAs 
bound by either AGO protein revealed negligible enrichment on AGO4 peaks (Fig. 
2.3A). Consistent with these findings, we observed that the total population of 24 nt but 
not 21 nt siRNAs, which are implicated in posttranscriptional silencing 1, was enriched 
on AGO4 peaks (Fig. 2.10A). Furthermore, only 10% of AGO4 peaks were found to 
have little or no association with AGO4-bound siRNAs. These results suggest that 
AGO4 binding to chromatin is correlated with the presence of 24nt siRNAs, which likely 
have a function in guiding AGO4 to specific genomic loci.  
To further test whether the sequences of siRNAs are able to explain the specific 
pattern of AGO4 binding to chromatin, we mapped AGO4-associated 24 nt siRNAs onto 
the five nuclear chromosomes of Arabidopsis. Surprisingly, we found these siRNAs to 
be strongly enriched within TE-rich pericentromeric regions and much less abundant 
within gene-rich chromosome arms (Figs. 2.3B and 2.10B). Therefore, AGO4-
associated siRNAs are not solely responsible for targeting AGO4 to its DNA interaction 
sites. This is consistent with the model where 24 nt siRNAs are necessary but not 
sufficient for mediating AGO4 binding to specific loci. 
Another factor previously implicated in AGO4 binding to specific genomic loci is 
transcription by Pol V, which has been proposed to provide lncRNA scaffolds for AGO4 
binding to chromatin 7. To test if Pol V is required for genome-wide targeting of AGO4, 
we performed ChIP-seq using anti-AGO4 antibody on nrpe1 mutant plants, which are 
deficient for the largest subunit of Pol V. By comparing the ChIP-seq datasets from 
nrpe1 mutant plants to Col-0 wild type and ago4 we tested if AGO4 binding to specific 
loci requires Pol V. Surprisingly, we identified only 7 (0.85%) Pol V-independent AGO4 
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peaks and 41 (4.96%) binding sites that demonstrated intermediate levels of AGO4 
binding in nrpe1 mutant plants (Fig. 2.3C). We also analyzed Pol V-dependence by 
comparing normalized read counts of AGO4 binding sites in Col-0 wild type to the nrpe1 
mutant, which confirmed that the vast majority of sites have ChIP signal strongly 
reduced in the nrpe1 mutant (Fig. 2.11A). These results indicate that Pol V is generally 
required for AGO4 binding to chromatin. The small fraction of Pol V-independent peaks 
or differences in AGO4 chromatin interaction strength may reflect a minor Pol V-
independent mechanism of AGO4 binding or alternatively that this type of targeting is 
not actually biologically significant. Importance of Pol V for AGO4 binding to chromatin 
was further supported by our ChIP-qPCR validation, which demonstrated that AGO4 
binding to all validated loci is dependent on Pol V (Figs. 2.1D – F and 2.7B, D, and F). 
Furthermore, all 11 tested high ranking loci, 3 middle ranking loci, and 9 low ranking loci 
show detectable Pol V binding by ChIP-qPCR with anti-NRPE1 antibody (Figs. 2.3D – F 
and 2.11B – D). Importantly, hitherto undetected AGO4 binding sites showed evidence 
of Pol V-dependent transcription (Figs. 2.3G – I), indicating that Pol V produces lncRNA 
at these loci. 
In total, these results demonstrate that Pol V is required for AGO4 binding to 
most if not all of its target loci. Furthermore, our observations of 1) a strong preference 
for gene promoter binding by AGO4, 2) the lack of concordance between AGO4 
interaction sites and siRNA sequences bound by this protein, and 3) Pol V transcription 
within AGO4 promoter bound regions, suggest that lncRNAs produced by Pol V are also 
a critical factor in mediating the interaction of AGO4 with promoters of specific protein-
coding genes. 
lncRNA-mediated AGO4 binding controls gene activity 
Our observation of lncRNA-mediated AGO4 binding to promoters of protein-
coding genes suggests that non-coding transcription and AGO4 binding may control the 
expression levels of the targeted genes by mediating DNA methylation. To test this 
possibility, we first examined whether AGO4 binding was correlated with DNA 
methylation 15. AGO4 peaks were significantly enriched (p -> 0) in CHH methylation 
relative to the genome-wide level and also demonstrated a less pronounced enrichment 
in CG and CHG methylation (Fig. 2.4A). A similar pattern of DNA methylation coincident 
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with AGO4 binding regions was also present in ros1 dml2 dml3 triple mutant plants that 
are deficient in three DNA demethylases 15 (Fig. 2.12A). Significant enrichment in CHH 
methylation within AGO4-bound regions was also present in met1, a mutant of the 
major CG methyltransferase of Arabidopsis 15 (Fig. 2.12B). However, in drm1 drm2 
cmt3 triple mutant plants 15 CHH methylation of AGO4-bound sites was strongly 
reduced relative to Col-0 wild type (Fig. 2.4B), suggesting that this methylation is 
established by the de novo methyltransferase DRM2, although involvement of CMT3 
cannot be excluded. We also found that DNA methylation within AGO4 binding sites 
was most prominent on transposable elements embedded within promoters of protein-
coding genes (Fig. 2.4C). Additionally, CHH methylation within AGO4 peaks was 
significantly reduced (p -> 0) in the nrpe1 mutant relative to wild type 16 (Fig. 2.4D). 
Together, these results demonstrate that AGO4 binding is correlated primarily with CHH 
methylation and predicts that AGO4 recruitment to specific genomic loci, including TEs 
in gene promoters, likely mediates their CHH methylation. 
To test this prediction, we probed DNA methylation levels on 26 AGO4-bound 
promoter regions in Col-0 wild type as well as ago4 and nrpe1 mutants. Digestion with 
methylation-sensitive restriction endonucleases followed by PCR revealed that tested 
AGO4-bound promoter regions contain CHH methylation, which was strongly reduced in 
both nrpe1 and ago4 mutants (Figs. 2.4E and 2.12C). Taken together, these results 
indicate that lncRNA-mediated AGO4 binding in gene promoters is directing CHH 
methylation, and suggest this might control transcription of those genes. 
To test whether lncRNA-mediated AGO4 binding within gene promoters affects 
expression of proximal genes, we screened 41 genes with AGO4 peaks in their 
promoter regions for significant expression changes in nrpe1 and ago4 mutants. Real-
time RT-PCR identified three genes upregulated in nrpe1 and ago4 mutants and two 
downregulated in nrpe1 and ago4 mutants (Figs. 2.4F – J). These results demonstrate 
that expression of at least a subset of AGO4-bound genes is affected by AGO4 and Pol 
V under standard growth conditions, revealing that lncRNA-mediated AGO4 binding 
within gene promoters is capable of affecting gene expression. One of the genes where 
RNA accumulation was reduced in nrpe1 and ago4 mutants under standard growth 
conditions is ROS1 (AT2G36490; Fig. 2.4I), which encodes a DNA demethylase, which 
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has previously been shown to be positively regulated by CG DNA methylation 17. This 
suggests the presence of a compensatory mechanism, where a reduction in CG 
methylation or RNA-directed CHH methylation results in reduction of DNA demethylase 
production to prevent excessive loss of DNA methylation. In total, these results 
demonstrate that AGO4 binding within promoter regions is capable of controlling the 
expression of targeted genes. 
AGO4 binding is correlated with DNA methylation affected by biotic stress 
responses 
Our observation that only five out of 41 tested AGO4-associated genes are 
affected in ago4 and nrpe1 mutants is consistent with the lack of morphological 
phenotypes associated with Arabidopsis ago4 and nrpe1 mutant plants grown under 
optimal conditions 2,18,19. To test if AGO4 target genes may be controlled in response to 
stress, we performed Gene Ontology (GO) analysis, which revealed significant 
enrichment of genes responsive to biotic and abiotic stimuli (Fig. 2.5A). To test if DNA 
methylation levels at AGO4 binding sites may be affected by stress we calculated the 
average changes in DNA methylation levels at differentially methylated regions (DMRs) 
identified in plants subjected to biotic stressors 20. Differential methylation was 
significantly enriched on AGO4 binding sites relative to the genome overall (Fig. 2.5B). 
In fact, stress-responsive differential CHH methylation was 8-fold more pronounced on 
AGO4 binding sites than on genome overall (p -> 0). This was much higher than the 
3.5-fold enrichment of total CHH methylation on AGO4 binding sites (Fig. 2.4A). These 
results suggest that enrichment of stress-induced differential methylation on AGO4 
interaction regions is not merely a byproduct of overall higher levels of DNA methylation 
in these genomic sites. This was further confirmed by the observation that AGO4 
binding sites significantly overlapped salicylic acid-induced CHH DMRs compared to 
1000 random genomic permutations and vice versa (Figs. 2.13A and 2.13B; p < 0.001 
for both comparisons). These results demonstrate that a significant fraction of AGO4 
binding sites contains DNA methylation that can be dynamically regulated during the 
plant’s response to biotic stresses. Taken together, these findings suggest that changes 
in DNA methylation patterns at AGO4 target genes are a part of a natural gene 
regulatory mechanism during plant biotic stress responses. 
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Discussion 
Argonaute proteins have been shown to recognize the sequences of specific 
target RNAs and genomic loci using incorporated small RNAs 4. Our findings are 
consistent with 24 nt siRNAs being required for AGO4 binding to chromatin, but also 
demonstrate that they are not sufficient. Instead, lncRNAs produced by Pol V mediate 
the specific binding of AGO4 to its genomic targets, many of which are transposons 
embedded within the promoters of protein-coding genes. Intriguingly, these results 
suggest that widespread AGO4-bound transposons within gene promoters may be 
controlling elements as proposed by Barbara McClintock 21, and identify Pol V-produced 
lncRNAs as the primary determinant of their status as regulatory modules.   
Once the overlapping action of 24 nt siRNAs and lncRNAs guides AGO4 to 
specific genomic regions, chromatin modifying enzymes are recruited and repressive 
DNA and histone modifications are established. These modifications in turn affect gene 
expression. A possible mechanism by which RdDM controls gene expression is by 
affecting the binding of transcription factors or other DNA-binding proteins to cis-
elements within promoters (Fig. 2.6). This possibility is consistent with our data showing 
both up- and down-regulation of AGO4-controlled genes in ago4 mutant plants 
reflecting either repressive or activating transcription factors being affected by DNA 
methylation, respectively. It is however also possible that AGO4 binding and RdDM may 
affect the spreading of chromatin modifications 22 or RNA processing. In addition to 
serving as switchable regulatory elements controlled by DNA methylation status, AGO4-
targeted transposable elements may also insert into novel locations providing an 
additional level of transcription regulation relative to the pre-insertion promoter 
sequence. Our model predicts that pericentromeric silenced genomic regions which are 
not bound by AGO4 but give rise to siRNAs, are not transcribed by Pol V. Instead they 
are likely targeted by a different transcriptional silencing pathway. 
Our work provides direct evidence of preferential binding of an RdDM component 
to promoters of protein coding genes. It is consistent with immunostaining data showing 
the presence of AGO4 outside of chromocenters 23,24, with the preferential upregulation 
of euchromatic genes in drm1 drm2 cmt3 triple mutant 25, and with the presence of 
some well characterized RdDM targets in euchromatin 26,27. Targeting of AGO4 towards 
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promoters of protein-coding genes also reveals an additional level of gene expression 
control, likely conserved between plants and animals 22,28. It is interesting that only 
minimal morphological phenotypes are observed in Arabidopsis RdDM mutant plants 
grown under standard conditions 2,18, which suggests that this mechanism may be more 
prevalent in organisms with higher transposon content, like maize where disruption of 
RdDM results in more dramatic phenotypes 29,30. This mechanism may also have much 
greater impact in plants like tomato, where the majority of 24nt siRNAs map to gene-rich 
chromosomal regions 31. AGO4-mediated control of gene expression may also work in 
certain developmental stages as suggested in early embryonic development 32,33 or 
provide a common response to environmental stimuli 34–36 (Fig. 2.5).  
A potential involvement of RdDM-targeted TEs in response to environmental 
stimuli is supported by our observations that AGO4 binding sites significantly overlap 
genomic regions, where biotic stresses have been demonstrated to affect DNA 
methylation levels 20 (Fig. 2.5B). Thus, our findings likely provide an explanation for 
earlier reports showing the involvement of AGO4 and Pol V in pathogen responses 36,37. 
We propose that pathogen infection affects siRNA production and/or Pol V transcription, 
which in turn causes changes in promoter DNA methylation and affects gene 
expression levels. In conclusion, our findings establish further exploration of the 
regulatory functions of AGO4 and the entire RdDM pathway in normal plant 
development and stress responses as an important goal for future research. 
 
Materials and Methods 
Plant material 
Arabidopsis thaliana nrpe1 (nrpd1b-11) and ago4 (ago4-1 2) introgressed into the Col-0 
background) were described previously 7,38. Plants were cultivated at 22 ˚C under long 
day conditions (16 h day, 8 h night). 
RNA Analysis 
For assays of mRNA accumulation, total RNA was extracted from 2-3 week old plants 
using RNeasy Plant Mini Kit (Qiagen) and three biological replicates were amplified 
using SuperScript III Platinum SYBR Green One-Step qRT-PCR Kit (Invitrogen) in an 
Applied Biosystems 7500 real time PCR machine. For assays of Pol V transcript 
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accumulation, total RNA was extracted from 2-3 week old plants using RNeasy Plant 
Mini Kit (Qiagen) and assayed as described 5, except that random primers were used 
and cDNA was amplified in a BioRad CFX Connect real time PCR machine. Two 
independent biological repeats were performed. 
DNA Methylation Analysis 
Genomic DNA was extracted from above-ground tissue of 2-week-old plants using 
DNeasy Plant Mini Kit (Qiagen). 100 ng of genomic DNA was digested with 10 units of 
AluI, DdeI, or Sau3AI restriction enzymes (NEB) for 20 min. After heat-inactivation of 
the enzyme, DNA was amplified using 0.75 units Platinum Taq (Invitrogen).  
Antibodies 
Affinity-purified rabbit polyclonal anti-AGO4 and anti-NRPE1 antibodies were described 
previously 7,39. 
Chromatin Immunoprecipitation 
ChIP was performed as described 9 with slight modifications. A detailed protocol is 
provided in the Appendix B. 
ChIP-seq library preparation and sequencing 
All ChIP-seq and input libraries were prepared according to the Illumina ChIP-seq 
library preparation protocol, and subjected to sequencing on a Genome Analyzer IIx as 
per manufacturer's instructions (Illumina, La Jolla, CA).  
Sequence processing 
Raw reads were pre-processed and mapped to the Arabidopsis genome using a 
pipeline as previously described 40 with slight modifications. Specifically, we used the 
Bowtie program 41 instead of the original cross_match aligner. All valid alignments were 
reported so as to tolerate non-uniquely mapping reads, since AGO4 is thought to target 
heterochromatin and repetitive elements in Arabidopsis. A detailed procedure is 
provided in the Appendix B. 
AGO4 binding site identification 
AGO4-bound peaks (AGO4 binding regions) were called using the CSAR R package 42. 
To do this, all mapped reads were extended up to 250 nt and merged from both strands. 
Then, peaks were required to reach a significant fold-enrichment between test and 
control with an FDR < 0.05. To identify high-quality peaks with minimum false positives, 
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5 sets of peaks were called either between ChIP and input samples ("traditional calls") 
or between Col-0 and ago4 or nrpe1 mutants (“direct-comparison”) as our basis for 
defining substantial peaks. Then Pol V-dependent and Pol V-independent peaks were 
determined by “peak-arithmetic” manipulations, which reliably identify peaks enriched 
for both ChIP vs. input and wild-type vs. mutant comparisons. See Appendix B for 
descriptions of these manipulations. 
An additional filtering step was also implemented to exclude peaks with a potential 
ecotype bias, because the ago4 mutant plants used in this study were originally 
identified 2 in the Landsberg (Ler-1) ecotype of Arabidopsis and subsequently back-
crossed to Col-0 plants three successive times. To do this, any peak that either 1) 
cannot be mapped to the Ler-1 draft genome (Ler-1 unmappable) or 2) can be better 
mapped to the Ler-1 draft genome (Ler-1 better mapped) were discarded from further 
analysis. 
To distinguish the AGO4 peaks that are completely dependent from those that are 
partially dependent on Pol V activity, we determined if the clone-abundance of AGO4 
binding sites is comparable (less than 2 fold difference) between nrpe1 ChIP and ago4 
ChIP samples (Pol V-dependent) or not (Pol V partially dependent). The vast majority of 
Pol V-dependent peaks were completely dependent, and therefore we didn’t separate 
these peaks in further analyses. 
AGO4 binding site classification 
To classify and annotate AGO4 peaks, their genomic coordinates were compared to 
various classes of known genetic elements annotated by TAIR (TAIR9 release) on the 
Arabidopsis genome, including protein-coding genes (exons and introns), rRNAs, 
tRNAs, miRNAs, snoRNAs, snRNAs, ncRNAs, pseudogenes, and transposable 
elements (TEs). To supplement this analysis, additional repetitive elements were 
defined using the RepeatMasker program (http://www.repeatmasker.org/). We also 
defined gene promoters as the regions 1 kb upstream from the transcription start sites 
(TSS) of protein-coding genes. As a negative control, 1000 sets of random peaks (NC-
peaks) were sampled from the genome, classified, and annotated similarly, and the p-
values of enrichment or depletion in specific categories were estimated using a 
bootstrapping method based on these NC-peaks. To comprehensively characterize the 
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classes and families of transposable elements in AGO4 peaks, we used the 
RepeatMasker identified TEs and their corresponding annotation information.  
To characterize small RNA profiles near AGO4 peaks, published small RNA-IP and total 
small RNA datasets 14 for both AGO4 and AGO1 from Arabidopsis seedlings were used 
for our analysis; the smRNA-IP or total smRNA reads were searched within the AGO4 
peaks as well as their flanking regions (2 kb up- and downstream). 
To characterize the cytosine methylation (mC) in AGO4 peaks, we used the published 
single nucleotide mC datasets datasets including genome-wide mC profiles from Col-0, 
met1, ddc and rdd mutant plants 15 kindly provided by Dr. Ryan Lister. The mC sites 
were searched within all AGO4 peaks as well as NC-peaks, and the mC density was 
calculated and compared between AGO4 peaks and NC-peaks for CG, CHG and CHH 
methylation or as a whole. The mC density was also directly compared between Col-0 
and nrpe1 mutant plants using recently published mC datasets 16. 
To characterize AGO4 binding profiles around TSSs, the log fold change profile of 
ChIP-seq reads between Col-0 and ago4 samples was generated using the CEAS 
program 43 relative to positions in the TSS of all protein-coding genes. Similarly, to 
characterize the nucleosome profile around AGO4 peaks, we used published MNase-
seq datasets 12 and calculated the log fold change of MNase-seq reads between Col-0 
and ago4 samples using the CEAS program 43 relative to positions in the TSS. We also 
called the well-positioned nucleosomes as previously described 44, and determined the 
nucleosome density profiles for all or promoter overlapping AGO4 peaks. 
GO analysis 
To identify significantly enriched biological processes for the genes corresponding to 
AGO4 bound promoters, the gene IDs of these loci were analyzed using the GOEAST 
online analysis tool 45 with an FDR < 0.05. 
Accession number and genome-browser link 
All six ChIP-seq library datasets were deposited into NCBI GEO under the accession 
GSE35381. The AnnoJ genome-browser for all of the ChIP-seq libraries as well as 
external datasets (smRNAs and DNA methylation) presented in this paper is publicly 
available at: http://gregorylab.bio.upenn.edu/annoj_atAGO4/. 
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Figure 2.1 Identification of AGO4-bound loci 
A – C) Graphical representation of sample AGO4-bound loci identified using ChIP-seq. 
The genome browser screenshots show from top genome annotation, ChIP-seq 
sequencing reads from Col-0 wild type, nrpe1 and ago4 strains, CHH DNA methylation 
and total small RNA reads. More loci are shown in Fig. 2.7. 
D – F) ChIP-real time PCR validation of AGO4 binding to chromatin on AGO4 peaks 
identified using ChIP-seq in Col-0 wild type, nrpe1 and ago4 mutants. Bars represent  
A) 
 
B) 
 
C) 
 
D) 
 
E) 
 
F) 
 
G) 
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averages from three independent amplifications. Error bars represent standard 
deviations. More loci are shown in Fig. 2.7. 
G) AGO4 binding shows no preference towards transposon-rich pericentromeric 
regions. The top graph shows the distribution of AGO4 peaks along the length of 
chromosome 5 vs. peak length in nucleotides (nts). The corresponding category for 
each colored dot can be found in the legend. The lower graph provides the density of 
genes (red line and y-axis label) and transposable elements (blue line and y-axis label) 
along the length of chromosome 5. 
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Figure 2.2 AGO4 is enriched on transposable elements within promoters of 
protein-coding genes 
A) AGO4 binding is significantly enriched at promoters, transposable elements, and 
tandem repeats, but deficient in gene bodies. Classification of all AGO4 (black bars) or 
a set of randomly generated (grey bars) peaks. TE and TR are transposable elements 
and tandem repeats, respectively. *, **, and *** denote p-values < .05, < .001, and  
0, respectively. 
B) AGO4 binding is enriched on regions upstream of transcription start sites. Profile of 
AGO4 binding around transcription start sites of all annotated Arabidopsis genes 
showing proportion of ChIP-seq reads in Col-0 wild type to the ago4 mutant plants. 
rpm – reads per million. 
C) AGO4 binding sites are significantly enriched in DNA transposons, but are devoid 
of LTR transposable elements. Classification of specific transposable element levels in 
AGO4 (black bars) or a set of randomly generated (grey bars) peaks. Transposable 
elements are as specified on the x-axis. *, **, and *** denote p-values < .05, < .001, 
and  0, respectively. 
D – E) AGO4 preferentially binds transposable elements within gene promoters. D) 
Venn diagram showing AGO4 peaks mapping to regions 1kb upstream of transcription 
start sites, transposable elements and both. E) Venn diagram showing random 
genomic regions 1kb upstream of transcription start sites, transposable elements and 
both. 
 
A) 
 
B) 
 
C) 
 
D) 
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Figure 2.3 AGO4 binding specificity towards TEs in gene promoters is mediated 
by lncRNA 
A) AGO4 binding sites have a significant overlap with AGO4-bound 24 nt but not 21 nt 
smRNAs. The plot demonstrates the levels of previously identified 24 nt and 21 nt 
AGO4- (red lines as indicated) and AGO1-bound (blue lines as indicated) smRNAs. 
The solid black line at the top of the graph indicates the average AGO4 peak size. The 
dashed black line denotes the position of AGO4 peak summits. 
B) Density of AGO4-bound 24 nt siRNAs along the length of chromosome 5. RPKM – 
reads per kilobase per million. 
C) AGO4 binding is dependent on Pol V. Proportions of AGO4 binding sites identified 
as fully Pol V-dependent, partially Pol V-dependent and Pol V-independent are shown. 
D – F) ChIP-real time PCR showing Pol V binding to AGO4 peaks. Bars represent 
averages from three independent amplifications. Error bars represent standard  
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deviations. More loci are shown in Figs. 2.11B – D. 
G – I) Pol V-dependent transcripts are present on AGO4 binding sites. Graphs show 
ncRNA accumulation assayed using real-time RT-PCR in Col-0 wild type, nrpe1 and 
ago4 mutant plants normalized to Actin as a control. Bars represent averages from 
three independent amplifications. Error bars represent standard deviations. 
 
48 
 
Figure 2.4 AGO4 binding mediates DNA methylation and controls gene activity 
A) AGO4 binding sites are enriched in DNA methylation, especially at CHH sites. The 
graph shows the average levels of CG (green portion of bars), CHG (red portion of 
bars), and CHH (purple portion of bars) per kilobase (kb) of the Arabidopsis genome 
overall (left bar) or within AGO4 peaks (right bar). Methylation data is previously 
published for Col-0 wild-type plants. *** denotes p-value  0. 
B) CHH methylation enrichment of AGO4 binding sites requires non-CG DNA 
methyltransferases. The graph shows the average levels of CG (green portion of 
bars), CHG (red portion of bars), and CHH (purple portion of bars) per kilobase (kb) of 
the Arabidopsis genome overall (left bar) or within AGO4 peaks (right bar). Methylation 
data is previously published for drm1 drm2 cmt3 triple mutant plants. 
C) DNA methylation within AGO4 binding sites is significantly higher on transposable  
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elements embedded within gene promoters. The graph shows the average levels of 
CG (green portion of bars), CHG (red portion of bars), and CHH (purple portion of 
bars) per kilobase (kb) of all promoter-associated AGO4 binding sites (left bar) or 
within TEs embedded in promoter-associated AGO4 binding sites (right bar). 
Methylation data is previously published for Col-0 wild-type plants. *** denotes p-value 
 0.  
D) CHH methylation within AGO4 binding sites is dependent on Pol V. The graph 
shows the average levels of CG (green portion of bars), CHG (red portion of bars), and 
CHH (purple portion of bars) per kilobase (kb) of AGO4 binding sites in nrpe1 mutant 
(right bar) and Col-0 wild type derived from a corresponding dataset (left bar). 
Methylation data is previously published (Wierzbicki et al., 2012). *** denotes p-value 
 0. 
E) AGO4 and Pol V are required for CHH DNA methylation on AGO4 binding sites. 
DNA methylation analysis using AluI DNA methylation-sensitive restriction 
endonuclease. Digested genomic DNA was amplified using PCR. A sequence lacking 
AluI sites (IGN5) was used as a loading control. More loci are shown in Fig. 2.12C. 
F – J) AGO4 affects the expression levels of certain protein-coding genes whose 
promoters are binding sites. Graphs show mRNA accumulation assayed using real-
time RT-PCR in Col-0 wild type, nrpe1 and ago4 mutant plants normalized to Actin as 
a control. Bars represent averages from three biological replicates. Error bars 
represent standard deviations.  
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Figure 2.5 AGO4 binding is enriched on genes affected by stress 
A) AGO4 promoter binding may regulate genes encoding proteins in stress, 
environmental, and hormone responses. The 11 most significantly enriched biological 
processes (and corresponding p-value) for all the genes whose promoters are bound 
by AGO4. 
B) Biotic stress-mediated differential DNA methylation is enriched on AGO4 binding 
sites. The graph shows the average levels of CG (green portion of bars), CHG (red 
portion of bars), and CHH (purple portion of bars) per kilobase (kb) of the Arabidopsis 
genome overall (left bar), within all AGO4 peaks (middle bar) or within promoter-
associated AGO4 peaks (right bar). Methylation data is previously published  (Dowen 
et al., 2012). *** denotes p-value  0. 
 
A) 
 
B) 
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Figure 2.6 A model for AGO4 function on gene promoters  
Pol V produces long non-coding RNA which is a scaffold for AGO4-siRNA binding. 
AGO4 recruits DRM2 de novo DNA methyltransferase. CHH methylation affects 
transcription factor binding within gene promoters which in turn positively or negatively 
affects Pol II transcription and gene expression. 
 
52 
 
 
Figure 2.7 Identification of AGO4-bound loci (supplementary to Figure 2.1) 
A, C, E) Graphical representation of AGO4-bound loci identified using ChIP-seq. A) 
Actin control and loci with the score of AGO4 binding ranking in the top 20%. C) Loci 
with the score of AGO4 binding ranking in the middle 60%. E) Loci with the score of 
AGO4 binding ranking in the bottom 20%. The genome browser screenshots show from 
top genome annotation, ChIP-seq sequencing reads from Col-0 wild type, nrpe1 and 
ago4 strains, CHH DNA methylation and total small RNA reads  
B, D, F) ChIP-real time PCR validation of Pol V-dependent AGO4 binding to chromatin 
on AGO4 peaks identified using ChIP-seq. B) Actin control and loci with the score of 
AGO4 binding ranking in the top 20%. D) Loci with the score of AGO4 binding ranking in 
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the middle 60%. F) Loci with the score of AGO4 binding ranking in the bottom 20%. 
Bars represent averages from three independent amplifications. Error bars represent 
standard deviations. 
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Figure 2.8 AGO4 binding shows no preference towards transposon-rich 
pericentromeric regions (supplementary to Figure 2.2) 
The graphs show the distribution of AGO4 peaks along the length of the five nuclear 
chromosomes of Arabidopsis (as indicated in the Figure). The corresponding category 
for each colored dot can be found in the legend. The lower graphs for each 
chromosome provide the density of genes (red line and y-axis label) and transposable 
elements (blue line and y-axis label). 
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Figure 2.9 The summit of AGO4 peaks is devoid of nucleosomes (supplementary 
to Figure 2.2) 
The average number of mononucleosome-sequencing reads (A) and nucleosomes (B) 
is plotted over the average length of all (red line) or only promoter-localized (blue line) 
AGO4 peaks. 
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Figure 2.10 Pattern of AGO4 binding cannot be explained by AGO4-bound siRNAs 
(supplementary to Figure 2.3) 
A) AGO4 binding sites have a significant overlap with previously identified 24 nt but not 
21 nt smRNAs. The plot demonstrates the levels of previously identified 24 nt (solid 
green line) and 21 nt (dashed green line) smRNAs. The solid black line at the top of the 
graph indicates the average AGO4 peak size. The dashed black line denotes the 
position of AGO4 peak summits. 
B) Density of AGO4-bound 24 nt siRNAs along the length of the five nuclear 
chromosomes of Arabidopsis thaliana. 
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Figure 2.11 AGO4 binding specificity towards TEs in gene promoters is mediated 
by Pol V-produced lncRNAs (supplementary to Figure 2.3) 
A) AGO4 binding is dependent on Pol V. A scatterplot showing the log-odds of 
normalized ChIP-seq reads per million (RPM) values for Col-0 wild type (x-axis) and 
nrpe1 (y-axis) versus ago4 mutant plants. The dashed line indicates the value at which 
AGO4 binding can be described as Pol V partially dependent. The red, green, and blue 
dots indicate AGO4 peaks that are completely, partially, and not dependent on Pol V, 
respectively. 
B-D) ChIP-real time PCR showing Pol V binding to AGO4 peaks. B) Actin control and 
loci with the score of AGO4 binding ranking in the top 20%. C) Loci with the score of 
AGO4 binding ranking in the middle 60%. D) Loci with the score of AGO4 binding 
ranking in the bottom 20%. Bars represent averages from three independent 
amplifications. Error bars represent standard deviations.  
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Figure 2.12 AGO4 binding mediates DNA methylation (supplementary to Figure 
2.4) 
A-B) AGO4 binding sites are enriched in DNA methylation, especially at CHH sites. The 
graphs show the average levels of CG (green portion of bars), CHG (red portion of 
bars), and CHH (purple portion of bars) per kilobase (kb) of the Arabidopsis genome 
overall (left bar) or within AGO4 peaks (right bar). Methylation data is previously 
published (Lister et al., 2008) for ros1 dml2 dml3 (A) and met1 (B) mutant plants. *** 
denotes p-value  0. 
C) AGO4 and Pol V are required for CHH DNA methylation on AGO4 binding sites. 
DNA methylation analysis using AluI, Sau3AI, HaeIII and DdeI DNA methylation-
sensitive restriction endonucleases. Digested genomic DNA was amplified using PCR. 
Sequence lacking Sau3AI and DdeI sites (AT2G36490) or HaeIII (AT2G27860) were 
used as loading controls. More loci and a control for AluI are shown in Fig. 2.4E. 
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Figure 2.13 AGO4 binding overlaps genomic regions containing stress-induced 
differential CHH methylation (supplementary to Figure 2.5) 
A) Percentages of AGO4 peaks overlapping differentially methylated regions (DMRs) 
identified upon treatment with biotic stress. Average overlaps of AGO4 peaks with 1000 
random genomic regions are shown as controls (light grey bars). All enrichments are 
statistically significant (p < 0.001). 
B) Percentages of differentially methylated regions (DMRs) identified upon treatment 
with biotic stress overlapping AGO4 peaks. Average overlaps of DMRs with 1000 
random genomic regions are shown as controls (light grey bars). All enrichments are 
statistically significant (p < 0.001). 
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CHAPTER 3 
A SWI/SNF Nucleosome Remodeling Complex Acts in Non-Coding RNA-Mediated 
Transcriptional Silencing 
 
The contents of this chapter were published in Molecular Cell in 2013. Gudrun 
Böhmdorfer performed work shown in Figure 3.1A,B, Figure 3.4D-H, Figure 3.8A, and 
Figure 3.11 E-I. Yongyou Zhu performed work shown in Figure 3.1C-F, Figure 3.2, 
Figure 3.3A-E, Figure 3.4A-C, Figure 3.6, Figure 3.8 B-F, Figure 3.9A-D, Figure 3.10A-
E, and Figure 3.11 A-D,K. Andrzej Wierzbicki performed experiment in Figure 3.12 A. I 
performed all other experiments and data analysis shown in this chapter. 
 
Abstract 
RNA-mediated transcriptional silencing prevents deleterious effects of 
transposon activity and controls the expression of protein-coding genes. It involves long 
non-coding RNAs (lncRNAs). In Arabidopsis thaliana some of those lncRNAs are 
produced by a specialized RNA Polymerase V (Pol V). The mechanism by which 
lncRNAs affect chromatin structure and mRNA production remains mostly unknown. 
Here we identify the SWI/SNF ATP-dependent nucleosome remodeling complex as a 
component of the RNA-mediated transcriptional silencing pathway. We found that 
SWI3B, an essential subunit of the SWI/SNF complex, physically interacts with a 
lncRNA-binding protein, IDN2. SWI/SNF subunits contribute to lncRNA-mediated 
transcriptional silencing. Moreover, Pol V mediates stabilization of nucleosomes on 
silenced regions. We propose that Pol V-produced lncRNAs mediate transcriptional 
silencing by guiding the SWI/SNF complex and establishing positioned nucleosomes on 
specific genomic loci. We further propose that guiding ATP-dependent chromatin 
remodeling complexes may be a more general function of lncRNAs. 
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Introduction 
Transposable elements and other classes of repetitive genomic elements are 
controlled by RNA-mediated transcriptional silencing 1, in plants also known as RNA-
dependent DNA methylation (RdDM) 2. This process not only prevents deleterious 
activities of transposons but is also believed to regulate the expression of protein-coding 
genes 3,4. 
RNA-mediated transcriptional silencing pathway involves two independent 
classes of non-coding RNA: small interfering RNA (siRNA) and long non-coding RNA 
(lncRNA) 2. In Arabidopsis thaliana siRNA is produced by the activities of RNA 
Polymerase IV (Pol IV), RNA-DEPENDENT RNA POLYMERASE 2 (RDR2) and 
DICER-LIKE 3 (DCL3). It then incorporates into the ARGONAUTE4 (AGO4) protein and 
gives it specificity towards genomic loci with the same sequence as siRNA 2. Despite 
being necessary for AGO4 to bind chromatin and mediate repressive chromatin 
modifications, siRNA is not sufficient for those events. Another required component is 
lncRNA produced by RNA Polymerases II and V (Pol II and Pol V, respectively), which 
is necessary for siRNA to recognize its genomic target loci 5–7.  
Pol V is a DNA-dependent RNA polymerase with subunit composition similar to 
Pol II 8,9. Pol V-produced lncRNAs originating from silencing targets have been shown 
to be required for AGO4 association with chromatin, CHH DNA methylation and 
transcriptional silencing 4,6,10. These RNAs are believed to work as scaffolds for the 
assembly of silencing complexes, which establish DNA methylation and repressive 
histone modifications 5,11. They have also been proposed to be the primary factors 
guiding repressive chromatin modifications to gene regulatory regions 4,12. The 
mechanism connecting lncRNAs to the activities of chromatin modifying enzymes is not 
well understood and only two lncRNA-binding proteins have been identified so far: 
AGO4 and SUPPRESSOR OF TY INSERTION 5 – LIKE (SPT5L). 
SPT5L is a homolog of the SPT5 Pol II elongation factor 8,13,14. It binds chromatin 
at silenced loci independently of AGO4 and has been proposed to work together with 
AGO4 in the recruitment of chromatin modifying enzymes 15. lncRNAs were also 
hypothesized to interact with IDN2, an RNA-binding protein required for RNA-mediated 
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transcriptional silencing, which has been shown to bind double-stranded RNA in vitro 16–
19. However, the in vivo function of IDN2 remains mysterious. 
Besides DNA methylation and posttranslational histone modifications, chromatin 
status may also be affected by active nucleosome positioning by ATP-dependent 
chromatin remodeling complexes, which control DNA accessibility by positioning, 
moving or exchanging nucleosomes 20,21. Although active nucleosome remodeling has 
been shown to control nucleosome positioning and affect transcription throughout 
genomes 22, it remains unknown if nucleosomes are controlled by the transcriptional 
silencing pathways. One of the families of ATP-dependent chromatin remodeling 
complexes is known as SWI/SNF 21. In Arabidopsis thaliana SWI/SNF complexes are 
known to contain at least five core subunits, including an Snf2-family ATPase and two 
SWI3 proteins 23,24. 
In this work we discovered a hitherto unidentified component of the RNA-
mediated transcriptional silencing pathway. Looking for lncRNA-associated proteins we 
identified SWI3B, a subunit of the SWI/SNF ATP-dependent chromatin remodeling 
complex. SWI3B interacts with Pol V-produced lncRNAs indirectly with IDN2 dimers 
serving as adaptors. SWI3B is required for RNA-mediated transcriptional silencing as 
indicated by derepression of several known silenced loci and a significant overlap of 
genes misregulated in mutants defective in lncRNA production or SWI3B activity. 
Defects in silencing were also observed in mutants of other SWI/SNF subunits 
indicating that this process involves the whole ATP-dependent chromatin remodeling 
complex. Consistently, elimination of Pol V-produced lncRNAs resulted in widespread 
changes in nucleosomes positioning on silencing targets. Moreover, DNA methylation 
levels were partially reduced in the swi3b mutant. These results support a model, where 
lncRNA recruits IDN2 dimers, which interact with the SWI/SNF complex by its SWI3B 
subunit. The SWI/SNF complex positions nucleosomes, which affect Pol II transcription 
by facilitating DNA methylation and/or restricting protein access to DNA. 
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Results 
Pol V-produced lncRNAs associate with IDN2 
To test if IDN2 physically interacts with Pol V-produced lncRNAs we performed 
RNA immunoprecipitation (RNA IP) with affinity-purified anti-IDN2 antibody and assayed 
the obtained samples using real time RT-PCR with primers specific for Pol V transcripts 
identified by Pol V ChIP-seq 15,25. IDN2 pulled down RNA from Col-0 wild type plants at 
much higher levels than from the idn2-1 mutant (Figures 3.1A-B and 3.8A). RNA 
recovery was also strongly reduced in nrpe1, a mutant defective in the largest subunit of 
Pol V and unable to produce lncRNA 6, which suggests that pulled down RNAs are Pol 
V-produced lncRNAs. Western blot demonstrated that the anti-IDN2 antibody was 
specific and that IDN2 stability was not affected in the nrpe1 mutant (Figure 3.8B). This 
demonstrates that IDN2 interacts at least with a subset of Pol V-produced lncRNAs. The 
idn2-1 mutant has a substitution followed by an eight aminoacid deletion in its XS 
domain, which adopts an RNA recognition motif fold and interacts with RNA 16,19,26. In 
contrast to the knock-out T-DNA mutant allele idn2-2, idn2-1 line still accumulates IDN2, 
although at a lower level than wild type (Figure 3.8B). Because the idn2-1 mutant is 
defective in transcriptional silencing 16 and unable to bind lncRNA (Figure 3.1A-B) this 
suggests that interaction of IDN2 with lncRNA may be important for its function in 
RdDM. 
IDN2 interacts with SWI3B 
Having established that IDN2 physically interacts with lncRNA we used a yeast 
two hybrid screen with IDN2 as a bait to identify proteins that might be indirectly 
associated with lncRNA. Among positive clones we found several corresponding to 
SWI3B, a subunit of the SWI/SNF ATP-dependent chromatin remodeling complex 23 
(Figure 3.1C). To validate this finding we used a targeted yeast two hybrid test, which 
confirmed that IDN2 interacts with full length SWI3B but not with other SWI3 homologs 
(SWI3A, SWI3C or SWI3D; Fig 3.1D). This interaction was then confirmed in vivo by 
reciprocal co-immunoprecipitations of FLAG- and GFP-tagged IDN2 and SWI3B 
transiently overexpressed in tobacco leaves (Figure 3.1E and Figure 3.8C) and by co-
immunoprecipitation of SWI3B-GFP and IDN2-FLAG driven by their respective native 
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promoters in stable Arabidopsis transformants (Figure 3.1F). This interaction was lost in 
IDN2 truncations eliminating predicted coiled-coil regions (Figure 3.8D) but not in a 
deletion mutant in the RNA-binding XS domain (Figure 3.8E-F) 16, suggesting that IDN2 
binds SWI3B using its coiled-coil domain. Together, these results indicate that SWI3B 
physically interacts with IDN2 and therefore SWI3B might be involved in lncRNA-
mediated transcriptional silencing. 
IDN2 dimerization is required for silencing but not for interaction with SWI3B 
To check if recently reported IDN2 dimerization 19,26 (Figure 3.2A) plays a role in 
the interaction with SWI3B we identified a region within the IDN2 coiled-coil domain 
responsible for homodimerization (Figure 3.2B). We created the IDN2 M8 mutant with 
eight point mutations introduced within this region (Figure 3.2C) to disrupt 
homodimerization by specific interactions of the coiled-coil domain. The IDN2 M8 
mutant was unable to dimerize in the yeast two hybrid assay (Figure 3.9A) and in vivo 
co-immunoprecipitation in tobacco leaves (Figure 3.2D). We tested DNA methylation 
levels in idn2-2 knock out mutants transformed with wild-type IDN2 and IDN2 M8 by 
digesting genomic DNA with methylation-sensitive restriction endonucleases followed 
by PCR. DNA methylation levels on silencing targets AtSN1, IGN5 and MEA-ISR were 
reduced in the idn2-2 knock out mutant (Figure 3.2E, Figure 3.9B). Transformation of 
the idn2-2 mutant with wild type IDN2 restored DNA methylation to wild-type levels, 
however IDN2 M8 was unable to restore DNA methylation (Figure 3.2E, Figure 3.9B). 
This indicates that dimerization of IDN2 is required for the biological function of IDN2 in 
the transcriptional gene silencing pathway. We further tested if IDN2 dimerization was 
disrupted by deletion in the XS domain present in the idn2-1 mutant. Yeast two hybrid 
and co-immunoprecipitation in tobacco leaves revealed that deletion in the XS domain 
did not affect IDN2 dimerization (Figure 3.9C-D), suggesting that the XS domain is not 
needed for IDN2 dimerization. Together with our observation that deletion in the XS 
domain does not disrupt IDN2 interaction with SWI3B (Figure 3.8E-F), this suggests that 
deletion within the XS domain only disrupts IDN2 binding to RNA. This provides 
additional support for interaction with lncRNA being important for IDN2 function in 
RdDM. We further tested if dimerization of IDN2 is required for its interaction with 
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SWI3B. Yeast two hybrid assay revealed that IDN2 M8 was still able to interact with 
SWI3B (Figure 3.2F). Although we cannot exclude that the M8 mutation affects other 
aspects of IDN2 function, these results suggest that IDN2 dimerization is required for 
RdDM but not for the interaction of IDN2 with SWI3B. 
SWI3B contributes to transcriptional silencing 
To test if SWI3B is involved in RNA-mediated transcriptional silencing we 
assayed accumulation of RNA produced from silencing targets in a swi3b mutant. 
Because homozygous knock-out mutants of SWI3B are embryo lethal 23, we used 
plants heterozygous for the swi3b-2 mutation (swi3b/+), which have been shown to 
have the expression level of SWI3B reduced to about 50% and display phenotypes 
attributed to SWI3B deficiency 27 (Figure 3.10A). Real time RT-PCR revealed that two 
transposon-originating transcripts within the solo LTR region, a well characterized target 
of RNA-mediated transcriptional silencing 6,28, were derepressed in the swi3b/+ mutant 
as well as in the idn2 and nrpe1 mutants (Figure 3.3A-B). Derepression of solo LTR was 
more pronounced in nrpe1 mutant than in swi3b/+ and idn2 mutants, which is consistent 
with partial reduction of SWI3B in the swi3b/+ line 27 (Figure 3.10A) and with IDN2 
having several potentially redundant homologs 16,19. Similar partial reactivation of RdDM 
targets in the swi3b/+ mutant was observed on several other RdDM targets (Figures 
3.3C-E and 3.10B-D). These results show that SWI3B contributes to RNA-mediated 
transcriptional silencing of at least a subset of silencing targets. 
SWI3B controls expression of genes affected by silencing  
Interaction of SWI3B with lncRNA-binding protein IDN2 and requirement of 
SWI3B for transcriptional silencing suggest a functional relationship between lncRNA 
and SWI3B. To test this possibility we used a genome-wide approach to identify genes 
whose expression is affected in the swi3b/+, nrpe1 and idn2-1 mutants. RNA-seq from 
three biological repeats revealed that out of 280 genes significantly upregulated in the 
nrpe1 mutant, 137 (49%) were also upregulated in the swi3b/+ line (Figures 3.3F and 
3.10G). This is significantly more than 1.8% expected by chance (p -> 0, chi-square 
test). Similarly, out of 343 genes significantly upregulated in the idn2-1 mutant, 122 
(36%) were also upregulated in the swi3b/+ line (Figures 3.3F and 3.10G). This is 
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significantly more than 1.7% expected by chance (p -> 0, chi-square test). Importantly, 
55 genes were upregulated in all three mutants (Figure 3.3F), which is significantly 
more than less than one gene expected by chance (p -> 0, chi-square test). A slightly 
smaller, although still highly significant overlap was observed among genes 
downregulated in nrpe1, idn2 and swi3b/+ mutants (Figure 3.10F). In contrast, genes 
upregulated in one genotype and downregulated in another genotype were found at 
rates not significantly higher than expected by chance (Figure 3.10G). These results 
suggest that Pol V, IDN2 and SWI3B affect overlapping groups of genes. Although it is 
unknown which of those genes are direct targets of Pol V, IDN2 and SWI3B, these 
results are consistent with SWI3B being involved in the same gene regulatory pathway 
as Pol V and IDN2. Together with IDN2-lncRNA interaction, IDN2-SWI3B interaction 
and derepression of silencing targets in the swi3b/+ mutant, these data demonstrate 
that SWI3B is involved in the RNA-mediated transcriptional silencing pathway. 
SWI/SNF complex contributes to transcriptional silencing 
SWI3B is a subunit of a putative SWI/SNF ATP-dependent chromatin remodeling 
complex 23. Therefore, the involvement of SWI3B in RNA-mediated transcriptional 
silencing suggests that the SWI/SNF complex may be involved in this process. To test 
this possibility, we assayed transcriptional silencing in mutants defective in several 
known components of the SWI/SNF complexes, including four SWI3 proteins 23,29 and 
two Snf2-family ATPases SPLAYED (SYD) 30 and BRAHMA (BRM) 24,31. Solo LTR was 
significantly derepressed in the swi3b/+, swi3d and syd mutants (Figure 3.4A), which 
shows that this locus is controlled by a SWI/SNF complex including SWI3B, SWI3D and 
SYD. Another silencing target At2TE78930 was derepressed in swi3b/+, swi3c and brm 
mutants (Figure 3.4B) indicating that this locus is also controlled by a SWI/SNF 
complex, however the subunit composition of the complex acting on At2TE78930 is 
different than on solo LTR. Other tested loci also displayed locus-specific contributions 
of specific SWI/SNF subunits for transcriptional silencing (Figures 3.4C and 3.11A-C). 
These results indicate that SWI3B is not the only subunit of SWI/SNF required for 
transcriptional silencing. They further suggest that the SWI/SNF complex as a whole 
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contributes to RNA-mediated transcriptional silencing, but subunit contributions may be 
locus-specific. 
SWI/SNF functions downstream of lncRNA production 
The physical interaction of a SWI/SNF subunit with lncRNA-binding protein IDN2 
suggests that SWI/SNF functions downstream of Pol V and might be recruited by Pol V 
and IDN2 to specific targets in the genome in a similar fashion as AGO4 10 and SPT5L 
15. Alternatively, SWI/SNF could work with the RDD complex 32 and mediate Pol V 
binding to chromatin and/or Pol V transcription 6,10,33. To distinguish between these 
possibilities we assayed the accumulation of known Pol V transcripts 6,15,25 in idn2 and 
swi3b/+ mutants. Because of low abundance, these transcripts were not detectable in 
our RNA-seq datasets and could only be assayed using targeted RT-PCR. We found 
levels of all tested Pol V transcripts to be unchanged in both idn2 and swi3b/+ mutants 
(Figure 3.4E-H and 3.11F-I). This shows that IDN2 and SWI/SNF work either in parallel 
to Pol V transcription or downstream of Pol V-produced lncRNA. This was further 
confirmed by chromatin immunoprecipitation (ChIP) with anti-SWI3B antibody, which 
indicated that at least on the tested loci SWI3B binding to chromatin was reduced in the 
nrpe1 mutant (Figure 3.11J). Together with the IDN2-SWI3B interaction and the 
requirement of SWI/SNF for silencing these results suggest that Pol V-produced 
lncRNAs guide the SWI/SNF complex to specific genomic loci with IDN2 being an 
intermediate adaptor protein. 
Pol V affects nucleosome positioning  
Because SWI/SNF is a putative ATP-dependent chromatin remodeling complex, 
if it is guided to chromatin by lncRNA, it is expected to affect nucleosome positioning in 
an lncRNA-dependent manner. To test this prediction we digested nuclei from Col-0 
wild type and nrpe1 mutant plants with micrococcal nuclease (MNase), which 
specifically cuts genomic DNA not protected by nucleosomes 34 (Figure 3.12A). We 
sequenced mononucleosomal DNA and identified 2544 nucleosomes which were 
significantly weaker in nrpe1 than Col-0 wild type (“Pol V-stabilized”) and 2362 
nucleosomes which were significantly stronger in nrpe1 than Col-0 wild type (“Pol V-
destabilized”). We further narrowed down the list of differential nucleosomes by 
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performing two biological repeats of ChIP-seq with anti-H3 antibody in Col-0 wild type 
and nrpe1 mutant, although limited resolution of ChIP affects the ability to detect 
differential nucleosomes located in close proximity to well stabilized unaffected 
nucleosomes. This stringent approach yielded 108 Pol V-stabilized and 655 Pol V-
destabilized high confidence nucleosomes. We validated several identified 
nucleosomes (Figure 3.12B) using a locus-specific assay, where MNase-digested 
chromatin is subject to anti-H3 ChIP followed by real time PCR (Figure 3.5A). These 
nucleosomes were also destabilized in the idn2-1 mutant (Figure 3.5A), which is 
consistent with IDN2 being and adaptor protein connecting Pol V-produced lncRNA to 
SWI/SNF. A subset of assayed nucleosomes was also affected in a knock-out brm 
mutant (Figure 3.5A), which further suggests that at least a fraction of lncRNA-mediated 
nucleosome positioning is mediated by the SWI/SNF complex. Together, these data 
allow speculation that Pol V-produced lncRNAs mediate nucleosome positioning by 
guiding the SWI/SNF complex to specific genomic loci with IDN2 being an intermediate 
adaptor protein. 
Pol V mediates nucleosome stabilization on silencing targets 
Nucleosomes have been shown to be generally correlated with DNA methylation 
35. To test if Pol V may contribute to this phenomenon, we compared published DNA 
methylation data 12 to the nucleosomes affected by Pol V. We found that in Col-0 wild 
type, Pol V-stabilized nucleosomes were significantly enriched in CHH methylation 
when compared to nucleosomes with no significant changes in nrpe1 (p < 10-9; t-test; 
Figures 3.5B and 3.12C). Pol V-stabilized nucleosomes were also significantly, yet to a 
lesser extent enriched in CHG methylation (p < 10-4; t-test; Figures 3.5C and 3.12D). 
We further compared DNA methylation on nucleosomes in Col-0 wild type to the nrpe1 
mutant. We found that DNA methylation on Pol V-stabilized nucleosomes was reduced 
in the nrpe1 mutant to levels comparable to observed on nucleosomes unaffected in 
nrpe1 or throughout the entire genome (Figure 3.5B-D). Observed reduction in DNA 
methylation was especially apparent in CHH (p < 10-9; t-test) and CHG (p < 0.002; t-
test) contexts. This indicates that Pol V-stabilized nucleosomes overlap Pol V-mediated 
DNA methylation. In contrast, Pol V-destabilized nucleosomes showed no enrichment in 
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wild type DNA methylation compared to nucleosomes unaffected in nrpe1 or to the 
entire genome (Figures 3.5B-D and 3.12C-E). In the nrpe1 mutant DNA methylation on 
Pol V-destabilized nucleosomes was slightly increased (CHH p < 0.002; CHG p < 0.03; 
CG p < 0.002; t-test), which reflects similar effects on nucleosomes unaffected in nrpe1 
or throughout the entire genome 25 (Figure 3.5B-D). These findings indicate that Pol V-
stabilized but not Pol V-destabilized nucleosomes are preferentially present on regions 
of Pol V-dependent DNA methylation. This is consistent with Pol V-produced lncRNAs 
mediating both DNA methylation and nucleosome positioning. 
To further test if Pol V-stabilized nucleosomes overlap direct Pol V targets, we 
used a published Pol V ChIP-seq dataset 25 to calculate enrichment of Pol V binding on 
the three categories of nucleosomes. We found that Pol V-stabilized nucleosomes were 
enriched in Pol V binding compared to Pol V-destabilized nucleosomes or nucleosomes 
unaffected in nrpe1 (Figure 3.5E). Pol V binding and Pol V-dependent CHH methylation 
are also clearly visible on validated Pol V-stabilized nucleosomes (Figure 3.12B). These 
results show that Pol V-stabilized nucleosomes are present on Pol V targets. This 
suggests that, in addition to facilitating DNA methylation, Pol V mediates nucleosome 
positioning and further supports the model that Pol V-produced lncRNAs control 
nucleosome positioning on silencing targets. 
Pol V-stabilized nucleosomes were also enriched on gene promoters and 
depleted on transcribed sequences (Figure 3.12F) suggesting that nucleosome 
remodeling may be involved in the control of gene expression. To test this possibility we 
overlapped the long list of differential nucleosomes generated using only MNase-seq 
with genes affected in swi3b/+, nrpe1 and idn2-1 mutants. Pol V-stabilized nucleosomes 
were slightly, yet significantly enriched on genes upregulated or downregulated in all 
three mutants compared to corresponding permutations of genes (Figure 3.5F). 
Consistently, when we mapped nucleosomes affected in the nrpe1 mutant to 
chromosomes, Pol V-stabilized nucleosomes were present throughout gene-rich 
chromosome arms (Figure 3.12G).  In contrast, Pol V-destabilized nucleosomes 
displayed a preference towards pericentromeric regions (Figure 3.12G), which is 
consistent with redistribution of silencing towards pericentromeric regions in the nrpe1 
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mutant 25. This shows that Pol V-stabilized nucleosomes can be correlated with Pol V- 
and SWI/SNF-controlled genes. This is further consistent with lncRNA-guided 
nucleosome positioning being an important factor in transcriptional silencing. 
SWI/SNF contributes to DNA methylation 
Correlation between Pol V-stabilized nucleosomes and Pol V-mediated DNA 
methylation may be explained by both nucleosome stabilization and DNA methylation 
being independently guided by lncRNA to the same genomic regions. Alternatively, 
preexisting DNA methylation may promote nucleosome stabilization or nucleosomes 
may be preferred targets for DNA methyltransferases. We tested these possibilities by 
assaying positioning of selected Pol V-stabilized nucleosomes in drm2, a mutant in de 
novo DNA methyltransferase. Five of the tested nucleosomes were destabilized in the 
drm2 mutant, while one nucleosome was not affected (Figure 3.5A). This is consistent 
with DNA methylation promoting nucleosome positioning but only on a subset of loci. To 
test if nucleosome positioning affects DNA methylation we assayed DNA methylation on 
silenced loci in the swi3b/+ mutant. Solo LTR, siR02 and At2TE78930 all had CHH 
methylation levels reduced to around 50% in swi3b/+ (Figure 3.6A-C). Less pronounced 
reduction was observed at IGN6, IGN22 and LTRCO3 (Figure 3.6D-F). This suggests 
that nucleosome positioning affects DNA methylation possibly by well positioned 
nucleosomes being preferential targets for DNA methyltransferases, however indirect 
effects cannot be excluded. Together, these results are consistent with a model where 
transcriptional silencing is established by Pol V-produced lncRNA guiding both 
positioned nucleosomes and DNA methylation, while maintenance of silencing is 
additionally facilitated by a mutual feedback loop between well positioned nucleosomes 
and DNA methylation. 
 
Discussion 
Our results uncover an additional pathway connecting Pol V-produced lncRNA to 
the establishment of silent chromatin status. The initial step in this pathway is the 
association of lncRNA with IDN2 (Figure 3.1A), a process which may involve an entire 
IDN2-containing complex composed of an IDN2 dimer (Figure 3.2A) and two IDN2-
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related proteins 18,19,26. IDN2 has been shown in vitro to bind double-stranded RNA 
using its XS domain 16,19,26, therefore IDN2 may bind lncRNA-siRNA duplexes or hairpin 
regions within lncRNA. It also implies that the IDN2-lncRNA association may be directed 
either by AGO4-siRNA complexes or IDN2 may bind lncRNA without the requirement 
for siRNA in a manner similar to SPT5L 15. 
The next step in this pathway is the physical interaction between IDN2 and 
SWI3B, a subunit of the ATP-dependent chromatin remodeling complex (Figure 3.1C-
F). Consistently, transcriptional silencing was partially lost on several known loci in the 
swi3b/+ mutant (Figure 3.3A-E). Although it remains possible that IDN2-lncRNA 
complexes are distinct from the ones formed by IDN2 and SWI/SNF, our transcriptome 
analysis shows a significant overlap between genes affected by the nrpe1 mutant, idn2-
1 mutant, where IDN2 is unable to interact with lncRNA and the swi3b/+ mutant (Figure 
3.3F). This is consistent with lncRNA, IDN2 and SWI/SNF working together and 
suggests that the silencing signal is transmitted from Pol V-produced lncRNA to SWI3B 
by IDN2 (Figure 3.7).  
Defects in transcriptional silencing observed in plant lines defective for the other 
tested subunits of the SWI/SNF complex (Figures 3.4A-C) suggest that the involvement 
of SWI3B in transcriptional silencing reflects the involvement of the entire SWI/SNF 
complex. Interestingly, however, subunit composition of the SWI/SNF complex seems to 
be locus specific (Figures 3.4A-C). This is consistent with the subunit variants being 
responsible for functional diversification of the SWI/SNF complexes 21,23,36. High level of 
functional diversification of the Arabidopsis SWI/SNF complexes is further supported by 
the observation that mutants in SWI/SNF subunits have additional phenotypes, which 
are likely not associated with RNA-mediated transcriptional silencing 23,36–39. This 
indicates that SWI/SNF complexes also have other biological functions beyond RNA-
mediated transcriptional silencing. 
The following step in this pathway is nucleosome positioning, as demonstrated 
by the changes in nucleosome patterns in the nrpe1 mutant. Our findings are consistent 
with a model (Figure 3.7), where these effects are mediated by the ATP-dependent 
chromatin remodeling activity of SWI/SNF, however alternative mechanisms cannot be 
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excluded at this moment. Pol V-produced lncRNA does not seem to be involved in the 
establishment of conserved nucleosome patterns 35 on most protein-coding genes. 
Instead, it specifically mediates stabilization of nucleosomes on sequences enriched in 
Pol V-dependent non-CG DNA methylation (Figure 3.5B-D), a hallmark of RNA-
mediated transcriptional silencing 32. This is consistent with previously observed 
genome-wide correlation between positioned nucleosomes and DNA methylation in all 
sequence contexts 35. The Pol V-stabilized nucleosomes were also significantly 
enriched on genes upregulated in the nrpe1, idn2-1 and swi3b/+ mutants (Figure 3.5F), 
indicating that these nucleosomes may affect Pol II transcription of at least a subset of 
silencing targets. 
The final step of the pathway is repression of Pol II transcription on silenced 
regions, demonstrated by reduction of transcriptional silencing in nrpe1, idn2 and 
swi3b/+ mutants (Figure 3.3A-E). Locus-specific destabilization of nucleosomes in the 
drm2 mutant and partial reduction of DNA methylation in the swi3b/+ mutant (Figures 
3.5A and 3.6A-F) support a model, where transcriptional silencing is established by Pol 
V-produced lncRNA guiding both positioned nucleosomes and DNA methylation. On the 
other hand maintenance of silencing is mediated by continuous action of lncRNA further 
reinforced by a mutual feedback loop between well positioned nucleosomes and DNA 
methylation. Pol II is then repressed by DNA methylation of cis-regulatory regions 
and/or well positioned nucleosomes directly affecting the ability of transcriptional 
machinery to bind DNA.  
Our data show the role of nucleosome positioning in the final steps of the RNA-
mediated transcriptional silencing pathway. It is however possible that active changes in 
nucleosome occupancy are also critical at other steps of the pathway and in other 
silencing pathways. Production of siRNA and Pol V-produced lncRNA has been shown 
to require two distinct putative chromatin remodelers CLASSY1 and DRD1 6,40–42. 
Additionally, maintenance of DNA methylation requires the DDM1 protein, which has 
been shown to have a nucleosome remodeling activity in vitro 43,44. This indicates that 
nucleosome remodeling may play a multitude of roles in transcriptional silencing. 
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Generally, Involvement of lncRNAs is a common theme in transcriptional regulation in 
various groups of organisms 45 and guiding protein factors to specific genomic loci is a 
function of lncRNA in several regulatory processes, including RNA-mediated 
transcriptional silencing 46. It is therefore possible that the recruitment of ATP-
dependent chromatin remodeling complexes and nucleosome positioning may be a 
general and conserved feature of lncRNA. 
Overall, our results are consistent with a model where lncRNAs produced by Pol 
V affect gene expression by mediating nucleosome positioning (Figure 3.7). Nascent 
Pol V transcripts physically interact with IDN2 dimers, which then recruit the SWI/SNF 
ATP-dependent chromatin remodeling complex by the physical interaction with SWI3B. 
SWI/SNF positions nucleosomes, which affect transcription machinery. Additionally, 
maintenance of silencing is reinforced by a feedback loop between DNA methylation 
and nucleosome positioning.  
 
Materials and Methods 
Plant lines 
Arabidopsis thaliana nrpe1 (nrpd1b-11) mutant was described previously 47. 
swi3a-1 (SALK_035320), swi3c-2 (Koncz_3737) and swi3d-2 (Koncz_14259) were 
kindly provided by Tomasz Sarnowski 23. swi3b-2 23 (GABI_302G08), syd-4 
(SALK_149549) and brm-4 48 (WiscDsLox 436E9) were obtained from ABRC. idn2-1 16 
was kindly provided by Steve Jacobsen. idn2-2 (FLAG_550B05) was obtained from 
INRA. 
Protein-protein interaction assays 
Protein-protein interactions were assayed using yeast two hybrid as well as co-
immunoprecipitation of proteins expressed in tobacco leaves or in Arabidopsis 49. 
Details are provided in the Appendix C. 
Site-directed mutagenesis 
Entry plasmids containing full length genomic IDN2 or cDNA clones were used to 
introduce deletions or mutations in IDN2 using the Quickchange Site-Directed 
Mutagenesis Kit (Stratagene). 
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RNA-immunoprecipitation (RNA IP) 
RNA IP was performed as described 6 except that IP was performed with 40 µl of 
Dynabeads protein A, an anti-IDN2 antibody at 4°C over-night and analyzed by real-
time RT-PCR. Amplified cDNA was generated with the Ovation RNA-Seq System V2 
(Nugen) according to the manufacturer’s protocol. Rabbit polyclonal anti-IDN2 antibody 
was raised against an N-terminal portion of the IDN2 protein (aa 4-201) expressed in 
bacteria and affinity purified. 
Chromatin-immunoprecipitation (ChIP) 
ChIP-seq was performed as described 4. Library generation and Illumina 
sequencing were performed by the University of Michigan Sequencing Core. ChIP-real 
time PCR protocol was based on 6 with an additional Micrococcal Nuclease (MNase) 
digestion prior to IP. We used anti-histone H3 antibody (ab1791, Abcam) or affinity-
purified rabbit polyclonal anti-SWI3B antibody raised against a C-terminal portion of the 
SWI3B protein (aa 248-469). Details are provided in the Appendix C. 
MNase-seq 
Nuclei were extracted from two weeks old Arabidopsis seedlings as described 6 
and digested with Micrococcal Nuclease (MNase; NEB). Mononucleosomal DNA was 
gel-purified and used for library generation and Illumina sequencing. Details are 
provided in the Appendix C. 
Bioinformatic analysis 
RNA-seq reads from three independent biological repeats were aligned and 
processed to the Arabidopsis TAIR10 genome using the BOWTIE suite (BOWTIE, 
TOPHAT, and CUFFLINKS) 50. Overlaps between sets of differentially expressed genes 
were determined based on gene ID while expected values were derived by the formula: 
set1 (set2/total genes); p values were generated from these values using chi-square 
test.  
MNase-seq and ChIP-seq reads were aligned using BOWTIE default settings 
and nucleosomes were called using MNase-seq data as described 51. Nucleosome lists 
were generated in Col-0 as well as in nrpe1 and the lists from both genotypes were 
combined. Reads corresponding to nucleosomes were counted in both genotypes, 
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quantile normalization was applied and the highest 5% nucleosomes according to read 
depth were removed. The remaining nucleosomes were classified as either decreased 
in nrpe1 (Pol V-stabilized) or increased in nrpe1 (Pol V-destabilized) via a combination 
of 2 fold change cutoff and Poisson significance of p<0.001; unchanged nucleosomes 
were classified as having less than 1.5 fold difference between genotypes. 
Nucleosomes were further filtered using enrichment scores from H3 ChIP-seq with a 
Poisson significance of p<0.05. Published DNA methylation data 12 were overlapped 
with the nucleosome list and methylation profiles were generated in 10bp windows with 
a 5bp sliding window for smoothing. Published Pol V ChIP-seq data 25 was similarly 
overlapped with nucleosomes and profiles were generated with Sitepro from the CEAS 
suite 52. Overlaps with differential transcripts were performed using 1000 permutated 
gene sets to obtain expected numbers and p values. 
Accession Numbers 
Next generation sequencing data reported in this manuscript have been 
deposited in GEO (Accession number GSE38464). 
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Figure 3.1 IDN2 interacts with lncRNA and SWI3B 
A-B) IDN2 interacts with Pol V-produced lncRNA. RNA immunoprecipitation was 
performed using anti-IDN2 antibody in Col-0 wild type, nrpe1 mutant and idn2-1 
mutant with a deletion in the RNA-binding XS domain. Recovered RNA was digested 
with DNase I and assayed using real time RT-PCR A) or reverse transcribed and 
amplified followed by real time PCR B). ACTIN2 signal serves as a loading control. 
Graphs show averages normalized to wild type and SD from four (A) or two (B) 
biological repeats. Input, no antibody and no RT controls as well as RNA IP results 
normalized to wild type inputs are shown in Figure 3.8A.  
C) Domain structure of SWI3B and SWI3B clones identified using the yeast two-hybrid 
screen with IDN2 as a bait. 
D) IDN2 interacts with SWI3B but not with its homologs SWI3A, SWI3C or SWI3D. 
Interaction of full length SWI3A, SWI3B, SWI3C and SWI3D with IDN2 was tested 
using yeast two-hybrid. A series of three 10x dilutions is shown. Yeast growth on a 
plate with His is shown as a loading control.  
E) IDN2 interacts with SWI3B in tobacco. GFP-tagged SWI3B was co-expressed in 
tobacco leaves with FLAG-tagged IDN2. After immunoprecipitation with anti-GFP 
antibody the sample was analyzed using western blot with anti-FLAG antibody. Plants 
expressing only single construct were used as controls. Total protein extracts (inputs) 
were assayed using western blot to demonstrate comparable protein expression 
levels. Asterisk indicates a non-specific band. Reciprocal co-immunoprecipitation is 
shown in Figure 3.8C. 
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F) IDN2 interacts with SWI3B in Arabidopsis. GFP tagged SWI3B and FLAG-tagged 
IDN2 under the control of their respective native promoters were transformed into 
Arabidopsis. Obtained transgenic lines were crossed and analyzed using co-
immunoprecipitation with anti-GFP antibody and western blot with anti-FLAG antibody. 
Asterisks indicate non-specific bands. 
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Figure 3.2 IDN2 homodimerization is required for silencing but not for the 
interaction with SWI3B 
A) IDN2 dimerizes. GFP- and FLAG-tagged IDN2 were coexpressed in tobacco 
leaves. After immunoprecipitation with anti-GFP antibody the sample was analyzed 
using western blot with anti-FLAG antibody.  
B) Subdomain B within coiled-coil region of IDN2 is responsible for IDN2 dimerization. 
Four coiled-coil sub-domains were identified within IDN2 using Parcoil2 and 
corresponding deletion mutants were tested using yeast two hybrid for interaction with 
wild type IDN2.  
C) Point mutants within subdomain B of the coiled-coil region of IDN2. Point mutants 
were designed to contain three (triple) or eight (octuple, M8) aminoacids within 
registers A and D of the coiled-coil alpha helix changed to arginines or glycines to 
disrupt interactions mediated by the coiled-coil with minimal impact on the alpha-helix 
of the coiled-coil domain. 
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D) Dimerization is lost in IDN2 with a mutated coiled-coil domain. GFP-tagged wild 
type IDN2 was coexpressed in tobacco leaves with FLAG-tagged IDN2 M8. After 
immunoprecipitation with anti-GFP antibody the sample was analyzed using western 
blot with anti-FLAG antibody. FLAG-tagged wild type IDN2 was used as a control. 
Total protein extracts (inputs) were assayed using western blot to demonstrate 
comparable protein expression levels. Asterisk indicates a non-specific band. 
E) IDN2 dimerization is required for DNA methylation. idn2-2 knock out mutant 
Arabidopsis plants were transformed with wild type IDN2 and IDN2 M8. Flowers of 
obtained transgenic plants were assayed for changes in DNA methylation by digesting 
with DNA methylation-sensitive restriction endonucleases (HaeIII for AtSN1 and IGN5, 
Sau3AI for MEA-ISR) followed by PCR. Sequences with no restriction sites were used 
as controls (ACTIN2 for HaeIII and JA35/JA36 for Sau3AI). More independent 
transgenic lines are shown in Figure 3.9B. 
F) IDN2 dimerization is not required for interaction with SWI3B. IDN2 M8 mutant within 
the subdomain B of the coiled-coil region was tested for interaction with SWI3B using 
yeast two hybrid.  
 
85 
 
Figure 3.3 SWI3B contributes to RNA-mediated transcriptional silencing 
A-E) Silencing targets are derepressed in the swi3b/+ mutant. RNA accumulation in 
flowers from solo LTR (A-B), At1TE51360 (C), At2TE78930 (D) and At3TE47400 (E) 
were assayed using real time RT-PCR in idn2-2 mutant compared to Ws wild type and 
in swi3b/+ and nrpe1 mutants compared to Col-0 wild type. Graphs show averages 
normalized to ACTIN2 and SD from three biological repeats. More loci are shown in 
Figure 3.10B-E. 
F) SWI3B controls the expression levels of a significant subset of Pol V and IDN2 
targets. Venn diagram showing genes identified using RNA-seq to be upregulated in 
nrpe1, idn2-1 and/or swi3b/+ mutants. RNA-seq was performed in three independent 
biological repeats in seedlings. * denotes statistically significant enrichment of overlaps 
(see text and Figure 3.10G for details). 
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Figure 3.4 RNA-mediated transcriptional silencing involves the SWI/SNF 
complex, which works downstream of lncRNA production 
A-C) Silencing targets are derepressed in mutants defective in SWI/SNF subunits. 
RNA accumulation in flowers from solo LTR (A), At2TE78930 (B) or At1TE51360 (C) 
was assayed using real time RT-PCR in swi3a/+, swi3b/+, swi3c, swi3d, syd and brm 
mutants compared to Col-0 wild type. Graphs show averages normalized to ACTIN2 
and SD from three biological repeats, normalized to Col-0 wild type. 
D-H) IDN2 and SWI3B are not required for lncRNA production. Pol V-produced 
lncRNAs IGN29 (E), IGN5 (F), IGN22 (G) and IGN27 (H) were assayed in seedlings 
using real time RT-PCR in idn2-1 and swi3b/+ mutants compared to Col-0 wild type. 
nrpe1 mutant was used as a negative control. To check for potential DNA 
contaminations no RT control was performed on ACTIN2 (Figure 3.11E) and 
additionally no RNA controls were performed for all primer pairs tested. ACTIN2 (D) is 
a loading control. More loci are shown in Figures 3.11F-I. 
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Figure 3.5 Pol V mediates nucleosome positioning 
A) Validation of Pol V-stabilized nucleosomes. Nucleosomes identified using genome-
wide assays (Figure 3.12B) were assayed in seedlings and in case of brm in mature 
leaves with MNase digestion followed by H3 ChIP and real time PCR. ChIP signal 
values were normalized to ACTIN2 and to wild type. HSP70 is a negative control. Bars 
show averages and SD from three independent biological repeats. 
B-D) Nucleosomes stabilized by Pol V are enriched in Pol V-dependent DNA 
methylation. Published genome-wide DNA methylation datasets from Col-0 wild type 
and nrpe1 mutant were used to calculate average DNA methylation levels on 
nucleosomes identified using MNase-seq and H3 ChIP-seq. Pol V-stabilized and Pol 
V-destabilized nucleosomes were compared to nucleosomes  
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unaffected in nrpe1 and to the entire genome (genome overall). DNA methylation 
levels were independently calculated in CHH (B), CHG (C) and CG (D) contexts. 
Asterisks indicate significant enrichment (see text). 
E) Pol V-stabilized nucleosomes are enriched in Pol V binding. Published Pol V ChIP-
seq dataset was used to calculate profiles of Pol V binding around the centers of 
nucleosomes identified using MNase-seq and H3 ChIP-seq, which are Pol V-
stabilized, Pol V-destabilized or unaffected in nrpe1. 
F) Pol V-stabilized nucleosomes are enriched on genes upregulated or downregulated 
in nrpe1 and swi3b/+ mutants. Nucleosomes identified using MNase-seq as Pol V-
stabilized were overlapped with genes identified using RNA-seq as upregulated or 
downregulated in nrpe1 or swi3b. Permutations of gene sets were overlapped in 
parallel to calculate enrichment. Asterisks indicate significant enrichment (p<0.02). 
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Figure 3.6 SWI/SNF is required for wild type levels of CHH methylation 
A-F) DNA methylation was assayed in flowers using digestion with methylation 
sensitive restriction endonucleases followed by real time PCR amplification of solo 
LTR (A), siR02 (B), At2TE78930 (C), IGN6 (D), IGN22 (E) and LTRCO3 (F). Graphs 
show average DNA methylation levels normalized to ACTIN2 and to wild type. Error 
bars are SD from three biological repeats.  
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Figure 3.7 A model of the involvement of nucleosome positioning in lncRNA-
mediated transcriptional silencing 
siRNA is produced by the activities of Pol IV, RDR2 and DCL3 to give AGO4 
sequence-specificity. Pol V produces lncRNAs, which are bound by IDN2 dimers. 
IDN2 recruits the SWI/SNF ATP-dependent chromatin remodeling complex by physical 
interaction with SWI3B. The SWI/SNF complex positions nucleosomes. Positioned 
nucleosomes silence transcription directly or by facilitating DNA methylation by the de 
novo methyltransferase, DRM2. Maintenance of silencing is reinforced by a positive 
feedback between DNA methylation and nucleosome positioning. 
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Figure 3.8. IDN2 interacts with SWI3B (supplementary to Figure 3.1) 
A) IDN2 interacts with Pol V-produced lncRNA. Input, no antibody and no RT controls 
as well as RNA IP results shown in Figure 3.1A were normalized to wild type input. No 
RT control was performed using ACTIN2 primers. Bars show averages normalized to 
wild type and standard deviations from four biological repeats. 
B) IDN2 protein levels. Equal amounts of total protein extracts from idn2 mutants, nrpe1 
mutant and corresponding wild type controls were assayed using western blot with 
affinity purified rabbit polyclonal anti-IDN2 antibody. 
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C) IDN2 interacts with SWI3B in tobacco. FLAG-tagged SWI3B was coexpressed in 
tobacco leaves with GFP-tagged IDN2. After immunoprecipitation with anti-GFP 
antibody the sample was analyzed using western blot with anti-FLAG antibody. Plants 
expressing only single construct were used as controls. Total protein extracts (inputs) 
were assayed using western blot to demonstrate comparable protein expression levels. 
Asterisks indicate non-specific bands. Reciprocal co-immunoprecipitation is shown in 
Figure 3.1E. 
D) IDN2 interacts with SWI3B using its coiled-coil domain. Truncated IDN2 was 
assayed for interactions with SWI3B using yeast two hybrid. A series of three 10x 
dilutions is shown. Yeast growth on a plate with His is shown as a loading control. 
E) The XS domain within IDN2 is not required for interaction with SWI3B in yeast two 
hybrid assay. A deletion mutant in the XS domain of IDN2 corresponding to the idn2-1 
mutant was tested for interaction with SWI3B using yeast two hybrid. A series of three 
10x dilutions is shown. Yeast growth on a plate with His is shown as a loading control. 
F) The XS domain within IDN2 is not required for interaction with SWI3B in tobacco 
leaves. A FLAG-tagged deletion mutant in the XS domain of IDN2 corresponding to the 
idn2-1 mutant was coexpressed with GFP-tagged SWI3B in tobacco leaves. After 
immunoprecipitation with anti-GFP antibody the sample was analyzed using western 
blot with anti-FLAG antibody.
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Figure 3.9 Characterization of IDN2 dimerization domain and its functional 
significance (supplementary to Figure 3.2) 
A) Octuple mutations in subdomain B of the coiled-coil region disrupt IDN2 dimerization. 
Interaction of wild type IDN2, IDN2 with subdomain B deleted, IDN2 with octuple 
mutations (M8) and IDN2 with triple mutations were assayed for interaction with wild 
type IDN2 using yeast two-hybrid. A series of three 10x dilutions is shown. Yeast growth 
on a plate with His is shown as a loading control. 
B) IDN2 dimerization is required for its function – additional independent transgenic 
lines extending the result shown in Figure 3.2E. idn2-2 knock out mutant Arabidopsis 
plants were transformed with wild type IDN2 or IDN2 M8. Obtained transgenic plants 
were assayed for changes in DNA methylation by digesting with DNA methylation-
sensitive restriction endonucleases (HaeIII for AtSN1 and IGN5, Sau3AI for MEA-ISR) 
followed by PCR. Transformation of the idn2-2 knock out mutant with wild type IDN2 
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restored DNA methylation to wild type levels at all tested loci. IDN2 M8 was unable to 
restore DNA methylation at any of the tested loci. Sequences with no restriction sites 
were used as controls (ACTIN2 for HaeIII and JA35/JA36 for Sau3AI).  
C) The XS domain of IDN2 is not required for dimerization in yeast two hybrid. A 
mutated IDN2 corresponding to the idn2-1 mutant was tested for interaction with wild 
type IDN2 using yeast two hybrid. A series of three 10x dilutions is shown. Yeast growth 
on a plate with His is shown as a loading control. 
D) The XS domain of IDN2 is not required for dimerization in tobacco leaves. A FLAG-
tagged deletion mutant in the XS domain of IDN2 corresponding to the idn2-1 mutant 53 
was coexpressed with GFP-tagged wild type IDN2 in tobacco leaves. After 
immunoprecipitation with anti-GFP antibody the sample was analyzed using western 
blot with anti-FLAG antibody. 
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Figure 3.10 SWI3B contributes to RNA-mediated transcriptional silencing 
(supplementary to Figure 3.3) 
A) SWI3B expression is reduced in the swi3b/+ line. RNA accumulation of SWI3B was 
assayed using real time RT-PCR in swi3b/+ mutant compared to Col-0 wild type. 
Graphs show averages and standard deviations from three biological repeats. 
B-E) Silencing targets are derepressed in swi3b/+ mutant. RNA accumulation from 
At1TE58825, At4TE27915 and At3TE51910 was assayed using real time RT-PCR in 
idn2-2 mutant compared to Ws wild type and in swi3b/+ and nrpe1 mutants compared to 
Col-0 wild type. UBQ10 was tested as a control (E). Graphs show averages normalized 
to ACTIN2 and wild type and standard deviations from three biological repeats. 
F) SWI3B controls the expression levels of a significant subset of Pol V and IDN2 
targets. Venn diagram showing genes identified using RNA-seq to be downregulated in 
nrpe1, idn2-1 and/or swi3b/+ mutants. RNA-seq was performed in three independent 
biological repeats. * denotes statistically significant enrichment of overlaps (see text and 
Figure 3.10G for details). 
G) Overlaps between genes identified by RNA-seq to be upregulated or downregulated 
in the analyzed mutants. p-values correspond to the observed overlap compared to 
overlap expected by chance and were obtained using chi-square test. 
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Figure 3.11 RNA-mediated transcriptional silencing involves the SWI/SNF 
complex, which works downstream of lncRNA production (supplementary to 
Figure 3.4) 
A-D) Silencing targets are derepressed in mutants defective in SWI/SNF subunits. RNA 
accumulation from At3TE47400 (A), At4TE27915 (B) or At5G27845 (C) was assayed 
using real time RT-PCR in swi3a/+, swi3b/+, swi3c, swi3d, syd and brm mutants 
compared to Col-0 wild type. ROC3 was tested as a control (D). Graphs show averages 
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normalized to ACTIN2 and wild type and standard deviations from three biological 
repeats. 
E-I) IDN2 and SWI3B function downstream of lncRNA production. Pol V-produced 
lncRNAs IGN20 (F), IGN25 (G), IGN26 (H) and IGN28 (I) were assayed using real time 
RT-PCR in idn2-1 and swi3b/+ mutants compared to Col-0 wild type. nrpe1 mutant was 
used as a negative control. To check for potential DNA contaminations no RT control 
was performed on ACTIN2 (E) and additionally no RNA controls were performed for all 
primer pairs tested. Graphs show averages normalized to wild type and standard 
deviations from three biological repeats. 
J) SWI3B binding to chromatin is reduced in the nrpe1 mutant. ChIP with anti-SWI3B 
antibody was performed in Col-0 wild type and nrpe1 mutant. Bars show averages and 
standard deviations from three biological repeats, normalized to inputs and Col-0. 
Western blot showing antibody specificity is in (K). 
(K) Western blot showing specificity of anti-SWI3B antibody. Total proteins from tobacco 
leaves expressing epitope-tagged SWI3B and from Col-0, nrpe1 and swi3b/+ 
Arabidopsis plants were assayed using affinity-purified anti-SWI3B antibody. Asterisks 
indicate non-specific bands detectable only in Arabidopsis extracts.
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Figure 3.12 Pol V mediates nucleosome positioning (supplementary to Figure 3.5) 
A) Micrococcal Nuclease (MNase) digestion of nuclei from Col-0 wild type and nrpe1 
mutant. MNase activity is shown in Kunitz Units. Mononucleosomal DNA was later 
sequenced using Illumina sequencing. 
B) Genome browser screenshots showing regions of Pol V-stabilized nucleosomes 
selected for validation (Figure 3.5A). Shown data include from top: annotation, MNase-
seq in Col-0 wild type and nrpe1 mutant, Pol V ChIP-seq in Col-0 wild type and nrpe1 
mutant, CHH methylation in Col-0 wild type and nrpe1 mutant. 
C-E) Nucleosomes stabilized by Pol V are enriched in Pol V-dependent DNA 
methylation. Profiles of CHH methylation (C), CHG methylation (D) and CG methylation 
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(E) were calculated and plotted on nucleosomes identified using MNase-seq and H3 
ChIP-seq with nucleosome center in the middle of each graph. Nucleosomes unaffected 
in nrpe1 were tested as controls. Published DNA methylation data were used. 
F) Nucleosomes stabilized by Pol V are enriched on gene promoters. Nucleosomes 
identified using MNase-seq were overlapped with gene promoters and transcribed 
regions. 
G) Nucleosomes stabilized by Pol V are distributed throughout the chromosomes but 
nucleosomes destabilized by Pol V are enriched at the centromere. Differential 
nucleosomes identified using MNase-seq were plotted on the chromosome 5 with the 
fold value of the change in nrpe1 mutant compared to Col-0 wild type. Pol V-stabilized 
nucleosomes have negative and Pol V-destabilized nucleosomes have positive 
enrichment values. 
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CHAPTER 4 
Independent Chromatin Binding of ARGONAUTE4 and SPT5L/KTF1 Mediates 
Transcriptional Gene Silencing 
 
The contents of this chapter were published in PLOS Genetics in 2011. Maria Avrutsky 
performed experiments shown in Figure 4.4J. Christopher Sifuentes’ work is shown in 
Figure 4.1K. Ligia Pereira’s work is shown in Figure 4.1J and 4.3J. I performed all other 
experiments shown in this chapter.  
 
 
Abstract 
Eukaryotic genomes contain significant amounts of transposons and repetitive 
DNA elements, which, if transcribed, can be detrimental to the organism. Expression of 
these elements is suppressed by establishment of repressive chromatin modifications. 
In Arabidopsis thaliana, they are silenced by the siRNA-mediated transcriptional gene 
silencing pathway where long non-coding RNAs (lncRNAs) produced by RNA 
Polymerase V (Pol V) guide ARGONAUTE4 (AGO4) to chromatin and attract enzymes 
that establish repressive chromatin modifications. It is unknown how chromatin 
modifying enzymes are recruited to chromatin. We show through chromatin 
immunoprecipitation (ChIP) that SPT5L/KTF1, a silencing factor and a homolog of SPT5 
elongation factors, binds chromatin at loci subject to transcriptional silencing. Chromatin 
binding of SPT5L/KTF1 occurs downstream of RNA Polymerase V, but independently 
from the presence of 24-nt siRNA. We also show that SPT5L/KTF1 and AGO4 are 
recruited to chromatin in parallel and independently of each other. As shown using 
methylation sensitive restriction enzymes, binding of both AGO4 and SPT5L/KTF1 is 
required for DNA methylation and repressive histone modifications of several loci. We 
propose that the coordinate binding of SPT5L and AGO4 creates a platform for direct or 
indirect recruitment of chromatin modifying enzymes. 
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Author Summary 
Transposons and other repetitive elements occupy vast areas of the eukaryotic 
genomes. They pose a threat to genome integrity but at the same time regulate 
expression of many genes and have been proposed to be a major factor contributing to 
genome evolution. One of the processes responsible for controlling activity of 
transposons and other repetitive elements is transcriptional gene silencing. This process 
uses small interfering RNA and long non-coding RNA to recruit enzymes that establish 
repressive chromatin modifications. Several proteins have been identified to be needed 
for siRNA-mediated transcriptional silencing in Arabidopsis thaliana, however for many 
of them their position in the silencing pathway is unknown. One of those proteins is 
SPT5L/KTF1, a homolog of an elongation factor associated with RNA Polymerase II. 
Here we establish the position of SPT5L in the silencing pathway and propose the 
molecular mechanism of its function. This gives further knowledge of the mechanism of 
transcriptional gene silencing and is important to understand how transposons are 
controlled. 
 
Introduction 
Eukaryotic genomes contain significant amounts of transposons and other 
repetitive DNA elements, which usually remain transcriptionally inactive. Efficient 
silencing of transposon transcription is essential for preventing their mobility and for 
maintaining genome integrity 1. Transposon silencing has also been hypothesized to 
regulate expression of genes that contain transposable elements in their promoters and 
to facilitate the evolution of genomes 2.  
Transposons are silenced at both transcriptional and post-transcriptional levels 
by mechanisms that involve small interfering RNAs (siRNAs) 3. These 20-25-nt RNA 
molecules are generated by the RNase III enzyme Dicer and provide sequence 
specificity for effector complexes mediating RNA cleavage and/or the establishment of 
chromatin modifications that silence transcriptional activity 3. In Arabidopsis thaliana, 
single-stranded RNA precursors for siRNA biogenesis are produced by RNA 
Polymerase II (Pol II) or RNA Polymerase IV (Pol IV), while the second strand is 
synthesized by RDR2 (RNA-Dependent RNA Polymerase 2). DCL3 (Dicer-like 3) 
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cleaves double-stranded RNA into siRNAs that are then incorporated into 
ARGONAUTE4 (AGO4) 4,5. This mechanism seems to be similar in maize where 
homologs of RDR2 and Pol IV have been shown to be involved in transcriptional gene 
silencing 6–8. 
Recognition of target loci by AGO4-siRNA complexes requires sequence identity 
between siRNAs and the genomic loci. These loci, however, are often actively 
transcribed, and it is not clear if siRNAs base-pair interact with DNA or nascent RNA 
transcripts 3,9. The latter possibility is well supported in Schizosaccharomyces pombe 
where loci subject to siRNA-mediated transcriptional silencing are actively transcribed 
by RNA Polymerase II 10–12. The central role of nascent transcripts in recognition of 
siRNA targets in S. pombe was observed by the ability of Argonaute proteins to cleave 
RNA. This ability is required for the establishment of repressive chromatin modifications 
13. Moreover, tethering Argonaute and siRNA-containing RITS (RNA-induced initiation of 
transcriptional gene silencing) complex to nascent transcripts is sufficient for the 
initiation of repressive chromatin modifications and transcriptional silencing 14.  
This mechanism may be similar in Arabidopsis where transcriptional silencing 
requires a specialized RNA Polymerase complex known as RNA Polymerase V (Pol V) 
15–17. Pol V produces non-coding transcripts in otherwise silent chromatin, and its 
activity is required for the establishment and maintenance of repressive chromatin 
modifications 18. Pol V-produced non-coding transcripts physically interact with AGO4 
and recruit siRNA-AGO4 complexes to their targets 19. Additionally, transcriptional 
silencing of several loci needs AGO4 slicer activity 20, suggesting that in plants siRNAs 
may recognize their targets by base-pair interactions with Pol V transcripts 19. 
RNA Polymerases and AGO4 are assisted in their functions by several other 
known protein components of the plant silencing system, all of which are required for 
efficient establishment and maintenance of transcriptional silencing 5. One of them is 
SPT5L (Suppressor of Ty insertion 5 - like; also known as SPT5-like or KTF1), a 
homolog of SPT5 Pol II-associated elongation factor. It was shown to contain a domain 
rich in WG/GW repeats that facilitate physical interaction with AGO4 21–23. Because 
SPT5L interacts with RNA but is not required for the accumulation of Pol V-dependent 
transcripts, it was hypothesized to work downstream of Pol V and recruit AGO4 to Pol V-
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transcribed loci 22,24.  
Despite the recent progress in understanding the mechanisms of transcriptional 
gene silencing, it is not known how siRNAs work with Pol V transcripts, AGO4 and other 
proteins to recruit chromatin modifying enzymes to their target loci in chromatin. It is 
unknown how chromatin-bound AGO4 recruits enzymes that establish repressive 
chromatin modifications. It is unknown if other protein components of the silencing 
system help AGO4 recruit chromatin modifying enzymes. It is also unknown in what 
order proteins involved in silencing are recruited to chromatin. Here we try to resolve the 
mechanism of siRNA-mediated recruitment of chromatin modifying enzymes to 
chromatin and the function of SPT5L in this process. We show that SPT5L physically 
interacts with chromatin and that SPT5L works downstream of Pol V but does not 
require 24-nt siRNA. SPT5L and AGO4 are recruited to chromatin in parallel and at least 
partially independently of each other and both are needed for DNA methylation and 
repressive histone modifications at several loci.  We propose that the coordinate binding 
of SPT5L and AGO4 creates a platform for direct or indirect recruitment of chromatin 
modifying enzymes. 
 
Results 
SPT5L interacts with chromatin 
The interaction of SPT5L with AGO4 21,22 suggested that like AGO4 19, SPT5L 
may bind loci targeted by siRNA-mediated transcriptional gene silencing. We first used 
chromatin immunoprecipitation (ChIP) with anti-SPT5L antibody to test if SPT5L binds 
chromatin. Subsequent real-time PCR demonstrated recovery of IGN5 and solo LTR 
DNA from Col-0 wild type at much higher levels than from spt5l mutant which represents 
the background level (Fig. 4.1CD). This shows that SPT5L physically interacts with 
IGN5 and solo LTR loci which are known to be transcribed by Pol V and silenced by the 
siRNA-mediated transcriptional gene silencing pathway 18,19,25,26. There was, however, 
no enrichment on the control Actin 2 and Tubulin 8 (TUB 8) loci (Fig. 4.1AB), which are 
transcribed by Pol II and not occupied by components of the silencing pathway 18,27. 
This suggests that SPT5L is present at the loci undergoing transcriptional silencing and 
that its function in silencing is most likely direct.  
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Interaction of SPT5L with chromatin was also demonstrated at IGN20, IGN22, 
IGN23, IGN25 and IGN26 (Fig. 4.1E-I), which have been identified in a genome-wide 
screen of Pol V occupancy (A. Wierzbicki, R. Lister, B. Gregory, J. Ecker and C. 
Pikaard, unpublished data), suggesting that SPT5L binding may be a general feature of 
Pol V-transcribed loci. 
SPT5L works downstream of Pol V 
SPT5L interacts with chromatin (Fig. 4.1C-I) as well as with AGO4, Pol V 
complex and Pol V transcripts 21–23. SPT5L is also not required for the accumulation of 
Pol V-dependent transcripts at IGN5, IGN6 or AtSN1 22. This suggests that SPT5L 
should work downstream of Pol V. To test this prediction we assayed Pol V binding to 
chromatin by ChIP with antibody against NRPE1, the largest subunit of Pol V. 
Subsequent real-time PCR demonstrated recovery of DNA from Col-0 wild type at much 
higher level than from the nrpe1 mutant at IGN5, solo LTR and AtSN1 loci but not at 
Actin 2 or Tubulin 8 loci (Fig. 4.2A-E) demonstrating that Pol V binds chromatin at IGN5, 
solo LTR and AtSN1 loci. DNA recovery from spt5l mutant was comparable to Col-0 wild 
type (Fig. 4.2A-E) showing that SPT5L is not needed for Pol V binding to chromatin. 
Interestingly, Pol V binding to chromatin was reproducibly increased at solo LTR locus in 
ago4 mutant (Fig. 4.2C), indicating that AGO4 may inhibit Pol V binding to chromatin 
possibly by affecting initiation and/or elongation of Pol V transcription. We conclude that 
SPT5L does not work upstream of Pol V in siRNA-mediated transcriptional gene 
silencing pathway.  
Because both Pol V and SPT5L are required for DNA methylation at several 
silenced loci 21–23, SPT5L may be functionally dependent on Pol V and/or Pol V 
transcription. To test this possibility we performed western blot with anti-SPT5L antibody 
in nrpe1 mutant background. Accumulation of SPT5L was strongly reduced in the nrpe1 
mutant (Fig. 4.1J). To test if nrpe1 mutation affects accumulation of SPT5L mRNA or 
SPT5L protein stability, we assayed SPT5L RNA using real time RT-PCR. Accumulation 
of SPT5L RNA was not reduced in the nrpe1 mutant (Fig. 4.1K) indicating that Pol V is 
needed for SPT5L protein stability. This behavior of SPT5L in nrpe1 mutant is 
reminiscent of reduced AGO4 protein stability in mutants that reduce siRNA production 
28. Interestingly, we observed a slight increase in SPT5L RNA level in the nrpe1 mutant 
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which may be explained by the presence of an AtMU10 transposon in SPT5L coding 
region. Overall, these results suggest that SPT5L is functionally dependent on Pol V.  
We further tested the functional relationship between Pol V and SPT5L by 
performing ChIP with anti-SPT5L antibody in nrpe1 mutant background. Consistent with 
the reduced stability of SPT5L in nrpe1 (Fig. 4.1J), DNA recovery from Pol V-transcribed 
loci was reduced to the level observed in the spt5l mutant (Fig. 4.1C-I). This result may 
be explained by the overall reduction in the amount of SPT5L. However, a similar 
reduction in the SPT5L protein accumulation in rdr2 mutant (Fig. 4.1J) did not affect 
SPT5L binding to chromatin (see below). This suggests that nrpe1 may affect the ChIP 
signal not only by destabilizing SPT5L, but also by affecting its ability to bind chromatin. 
Because SPT5L does not work upstream of Pol V and is functionally dependent on Pol 
V, we conclude that SPT5L works downstream of Pol V and/or Pol V transcription and 
may be recruited to chromatin by Pol V. 
SPT5L binds chromatin independently of AGO4 
The recruitment of SPT5L to chromatin by Pol V (Fig. 4.1, Fig. 4.2) is consistent 
with the interaction of SPT5L with Pol V transcripts and AGO4 21,22. There are at least 
two explanations of SPT5L function in the establishment of siRNA-mediated 
transcriptional gene silencing. SPT5L may be recruited by Pol V and then help recruit 
AGO4-siRNA complexes. Alternatively, AGO4-siRNA may recognize target loci and then 
recruit SPT5L which further recruits chromatin modifying enzymes. To test the latter 
possibility we performed ChIP with αSPT5L antibody in the ago4 mutant. DNA recovery 
of all tested Pol V-transcribed loci was comparable from Col-0 wild type and the ago4 
mutant (Fig. 4.1C-I). This shows that binding of SPT5L to chromatin was not affected in 
the ago4 mutant, and suggests that SPT5L is not recruited to its target loci by AGO4-
siRNA complexes. We conclude that SPT5L does not work downstream of AGO4 in the 
siRNA-mediated transcriptional gene silencing pathway. 
AGO4 binds chromatin partially independently of SPT5L 
Having concluded that SPT5L does not work downstream of AGO4, we tested 
the alternative hypothesis that SPT5L may work upstream of AGO4 by binding Pol V 
and/or Pol V transcripts and recruiting AGO4 to chromatin. To test this possibility we 
performed ChIP with anti-AGO4 antibody. As demonstrated by real-time PCR we 
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recovered DNA from wild type plants above the background level observed in the ago4 
mutant at IGN5 and solo LTR (Fig. 4.3CD) as well as at IGN20, IGN22, IGN23, IGN25 
and IGN26 loci (Fig. 4.3E-I). This indicates that AGO4 binds chromatin at all tested Pol 
V-transcribed loci. In the spt5l mutant total accumulation of AGO4 protein was not 
affected (Fig. 4.3J). At all assayed Pol V-transcribed loci AGO4 binding to chromatin in 
the spt5l mutant was reproducibly above the background level observed in the ago4 
mutant indicating that AGO4 is able to bind chromatin in the absence of SPT5L (Fig. 
4.3C-I). Interestingly, we observed that the intensity of AGO4 binding to chromatin is 
slightly reduced in the spt5l mutant at solo LTR, IGN20, IGN22, IGN23, IGN25 and 
IGN26 (Fig. 4.3C-I). This indicates that although SPT5L is not required for AGO4 
recruitment to chromatin, it enhances AGO4 chromatin binding. Alternatively, most loci 
may be occupied by two pools of AGO4. One being SPT5L-dependent and other 
recruited to chromatin independently of SPT5L.  
We conclude that SPT5L is not required for recruitment of a pool of AGO4 to 
specific loci in chromatin and therefore does not work upstream of AGO4 in the siRNA-
mediated transcriptional gene silencing pathway. Since SPT5L also does not work 
downstream of AGO4, they are most likely recruited in parallel and at least partially 
independently of each other.  
SPT5L binds chromatin independently of 24-nt siRNA 
The parallel and independent recruitment of SPT5L and AGO4 to chromatin 
suggests that they are both guided by the interactions with Pol V complex and/or Pol V 
transcripts. To test if SPT5L is also guided by siRNA we used ChIP to assay SPT5L 
binding to chromatin in rdr2, a mutant in an RNA-dependent RNA polymerase 
responsible for production of the majority of 24-nt siRNA 29. The rdr2 mutation reduced 
the stability of SPT5L protein (Fig. 4.1JK) but did not cause reduction in DNA recovery 
of the tested loci after ChIP (Fig. 4.4C-I). This suggests that although RDR2 increases 
the amount of SPT5L protein, the chromatin-bound fraction of SPT5L is not affected by 
the rdr2 mutation. This also suggests the presence of siRNA-dependent pool of SPT5L 
that does not physically interact with assayed Pol V-transcribed loci. 
These results demonstrate that binding of SPT5L to chromatin is not affected in 
the rdr2 mutant and suggest that RDR2-dependent siRNA is not required for SPT5L 
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binding to chromatin. In contrast, RDR2 is necessary for proper establishment of DNA 
methylation at AtSN1, IGN5, IGN25, IGN23, IGN26, solo LTR and IGN22 (Fig. 4.4J); 
demonstrating that all assayed loci are in fact targets of the siRNA-mediated 
transcriptional gene silencing pathway. We conclude that SPT5L is recruited to 
chromatin in a manner independent of 24-nt siRNA.  
Both AGO4 and SPT5L are needed for repressive chromatin modifications 
Parallel and at least partially independent recruitment of SPT5L and AGO4 by Pol 
V suggests that at Pol V-transcribed loci none of them is sufficient for the establishment 
and maintenance of silent chromatin modifications. To further test this possibility we 
assayed several Pol V-transcribed loci for DNA methylation side-by-side in nrpe1, ago4 
and spt5l mutants using DNA methylation-sensitive restriction endonucleases. 
Methylation of cytosines in HaeIII, AluI or AvaII restriction sites blocks the enzymes from 
cutting and allows amplification of the genomic region by PCR. However, unmethylated 
sites are cleaved and PCR amplification fails. All three enzymes recognize asymmetric 
(CHH) methylation at tested loci. Consistently with previous reports, DNA methylation 
was strongly reduced at AtSN1 locus in both ago4 19,24,30 and spt5l mutants 21–23 and at 
IGN5 locus in ago4 mutant 19 (Fig. 4.5A). DNA methylation was also reduced at IGN5 
locus in spt5l mutant and at IGN23, IGN25 and IGN26 loci in both ago4 and spt5l 
mutants (Fig. 4.5AB). Importantly, in all these cases reduction of DNA methylation was 
comparable in ago4 and spt5l mutants (Fig. 4.5AB) suggesting that neither AGO4 nor 
SPT5L is sufficient for the establishment of asymmetric DNA methylation at Pol V-
transcribed loci.  
We also tested the effect of nrpe1, ago4 and spt5l mutations on dimethylation of 
lysine 9 of histone H3 (H3K9me2). At IGN5 and IGN26 loci, H3K9me2 was reduced in 
all three mutants (Fig. 4.5DF) showing that both AGO4 and SPT5L are required not only 
for the establishment and/or maintenance of DNA methylation but also H3K9me2. We 
conclude that at least at a subset of loci SPT5L and AGO4 work together to recruit 
repressive chromatin modifications. We propose that it is the coordinate action of 
SPT5L and AGO4 that directly or indirectly recruits de novo DNA methyltransferase 
DRM2 and H3K9 methyltransferases. 
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SPT5L contributes to repressive chromatin modifications in a locus-specific 
manner 
While AtSN1, IGN5, IGN23, IGN25 and IGN26 loci require both AGO4 and 
SPT5L for repressive chromatin modifications (Fig. 4.5), soloLTR has been shown to be 
methylated independently of SPT5L 21,23. We confirm this result and further show that 
solo LTR and IGN22 which, like other Pol V-transcribed loci, are methylated in a Pol V 
and AGO4-dependent manner (Fig. 4.6A) did not show reduction of DNA methylation on 
AluI or AvaII sites in the spt5l mutant (Fig. 4.6A). This suggests that there is some 
significant locus specificity in SPT5L contributions to DNA methylation. Furthermore, 
H3K9me2 was reduced at both soloLTR and IGN22 in nrpe1 and ago4 mutants but not 
in the spt5l mutant (Fig. 4.6BC). Also acetylation of histone H3 (H3Ac) at solo LTR was 
increased in nrpe1 and ago4 but not in spt5l (Fig. 4.6D). This demonstrates that the 
locus-specific function of SPT5L affects not only DNA methylation but also H3K9me2 
and H3Ac.  
The requirement of SPT5L for repressive chromatin modifications (Fig. 4.5,2.6) 
does not correlate with the extent of partial SPT5L-dependency of AGO4 binding to 
chromatin (Fig. 4.3). It suggests that the pool of AGO4 that is bound to chromatin in an 
SPT5L-dependent manner is not required for silencing. This is consistent with our 
interpretation that AGO4 and SPT5L are recruited to chromatin in parallel and 
independently of each other. 
 
Discussion 
Order of events in siRNA-mediated silencing 
Our findings establish the order of events leading to siRNA-mediated 
establishment of transcriptional silencing. This process is initiated by recognition of 
silencing targets and production of two classes of non-coding RNA. The first class is 
siRNA which is produced from double-stranded RDR2 products by DCL3 and becomes 
incorporated into AGO4 and possibly also AGO6 and AGO9 4,5,24. The second class is 
long non-coding RNA produced by Pol V and/or Pol II 18,26. Pol V transcription is initiated 
independently of siRNA and Pol V transcripts most likely are not precursors for siRNA 
biogenesis 18,31. Pol V recruitment to chromatin and transcription requires the presence 
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of DMS3, DRD1 and RDM1, which either help initiate Pol V transcription or assist 
elongation of Pol V transcripts 18,19,32.  
Pol V transcription is followed by association of two RNA-binding proteins with 
chromatin (Fig. 4.7). First is AGO4 which is recruited to chromatin by Pol V transcripts 
and uses the incorporated siRNA to provide sequence-specificity of silencing 19. The 
second is SPT5L (Fig. 4.1,2.2), which is recruited to chromatin by an unknown 
mechanism, possibly involving interactions between SPT5L and Pol V complex and/or 
with Pol V transcripts 22,23. SPT5L binds chromatin independently of 24-nt siRNA (Fig. 
4.4) and is likely a general factor associated with transcribing Pol V and its transcripts 
21–23. Since SPT5L binds chromatin in the absence of AGO4 (Fig. 4.1), and the 
functional pool of AGO4 is able to bind chromatin in the absence of SPT5L (Fig. 4.3), we 
concluded that they are recruited to chromatin in parallel and independently of each 
other. Both AGO4 and SPT5L are required for the establishment and/or maintenance of 
DNA methylation and repressive histone modifications at the majority of tested loci (Fig. 
4.5). This suggests that both are needed for the recruitment of enzymes establishing 
repressive chromatin modifications. 
Mechanism recruiting chromatin modifying enzymes 
Because AGO4 and SPT5L bind chromatin independently of each other, and, at 
the majority of tested loci both are required for establishment and maintenance of 
silencing, we propose that AGO4 and SPT5L create a binding platform for the 
recruitment of chromatin modifying proteins. One possibility is that both weakly interact 
with a downstream protein but the interaction becomes strong enough to recruit 
chromatin modifying enzymes only when both are present. Alternatively, AGO4 may be 
a sole interacting partner of downstream proteins but SPT5L, which has a C-terminal 
domain rich in WG/GW motifs, interacts with AGO4 and alters its conformation to 
facilitate the recruitment of chromatin modifying enzymes.  
Our results show that there are loci where DNA methylation is established in a 
Pol V, AGO4 and SPT5L-dependent manner (Fig. 4.5A), but these loci have an overall 
low level of H3K9me2 and no change in the histone modifications in tested mutants 
(IGN23 in Fig. 4.5E). It suggests that the de novo DNA methyltransferase DRM2 is likely 
the chromatin modifying enzyme directly recruited by the AGO4-SPT5L platform. It is 
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also possible that DRM2 may be recruited indirectly by another protein that binds the 
AGO4-SPT5L platform. 
Assembly of the silencing complexes 
Binding of AGO4 and SPT5L to chromatin is mediated by multiple protein-protein 
and protein-RNA interactions. These interactions may mediate recruitment of proteins to 
specific genomic regions and/or stabilize binding after recruitment by an independent 
mechanism.  
SPT5L binding to chromatin occurs downstream of Pol V and is most likely 
mediated by protein-RNA interaction between SPT5L and Pol V transcripts 22. Like 
canonical SPT5, SPT5L may also form a heterodimer with SPT4 33. Alternatively, SPT5L 
may be recruited to chromatin by protein-protein interaction with Pol V complex as 
suggested by identification of SPT5L in Pol V holoenzyme 23 and interactions between 
yeast SPT5 as well as bacterial homolog of SPT5, nusG, with RNA polymerases 34,35. It 
is also possible that SPT5L is recruited to chromatin by interacting with both Pol V 
transcripts and Pol V complex. All these mechanisms explain the AGO4-independent 
binding of SPT5L to Pol V-transcribed loci.  
Interaction with Pol V transcripts seems to be the major factor recruiting AGO4-
siRNA to chromatin 19. AGO4 also interacts with WG/GW-rich C-terminal domains of Pol 
V and SPT5L 21,22,36. Because Argonautes contain only one WG/GW binding pocket 37 
these interactions may be employed sequentially. First, they help recruit AGO4 to 
chromatin by interaction with Pol V and then they stabilize the binding of AGO4 to 
chromatin on its target loci by interaction with SPT5L. It is consistent with our 
observation that AGO4 binding to chromatin is slightly reduced in the spt5l mutant (Fig. 
4.3).  
Locus-specific regulation of silencing 
We show that SPT5L contributes to regulation of siRNA-mediated transcriptional 
silencing in a highly locus-specific manner. This is demonstrated by the observation that 
two of the tested loci require Pol V and AGO4 but not SPT5L for establishment and/or 
maintenance of repressive chromatin modifications (Fig. 4.6). It could be explained by 
presence of the canonical SPT5 at a subset of silenced loci. However, both loci are 
occupied by SPT5L in wild type plants (Fig. 4.1) suggesting that SPT5L is in fact 
111 
 
involved in their silencing. Only when SPT5L is mutated, the canonical SPT5 is able to 
compensate the deficiency at these particular loci. Alternatively, it is possible that the 
observed locus-specificity of SPT5L is caused by the presence of both Pol V and Pol II 
at a subset of loci 26. Pol II-bound canonical SPT5 may be able to compensate the lack 
of Pol V-bound SPT5L. The mechanism deciding locus specificity of the SPT5L function 
remains unknown. 
Our results also suggest the presence of two pools of AGO4: SPT5L-dependent 
and SPT5L-independent. Because both pools are detectable at loci that are silenced in 
a SPT5L-independent manner, the SPT5L-dependent pool of AGO4 is likely not 
required for silencing. It may be recruited independently of siRNA by direct interaction 
with SPT5L and may have some other, yet unknown and locus-specific functions. 
 
Materials and Methods 
Plant lines and antibodies 
Arabiodopsis thaliana nrpe1 (nrpd1b-11), dms3-4, and ago4-1 introgressed into 
Col-0 background were described previously 19,38. rdr2-1 mutant was obtained from J. 
Carrington. spt5l-1 (rdm3-3; SALK_001254) mutant line, affinity-purified anti-SPT5L 
(anti-KTF1), affinity-purified anti-Pol V (anti-NRPE1) and affinity-purified anti-AGO4 
antibodies were described previously 19,22,39. Mouse monoclonal anti-H3K9me2 antibody 
(cat. #ab1220) was obtained from Abcam, rabbit polyclonal anti-H3Ac antibody (cat. 
#06-599) was obtained from Millipore. 
Chromatin Immunoprecipitation 
ChIP was performed essentially as described 18,19. Detailed ChIP protocol is 
included in Appendix A. ChIP samples were amplified in triplicate in Applied Biosystems 
7500 real time PCR machine and obtained data were analyzed using comparative CT 
method relative to inputs 40. All ChIP experiments were performed in three independent 
biological replicates. Results from every biological replicate were normalized to Col-0 
wild type and normalized data were used to obtain averages and standard deviations 
that show fold difference between analyzed strains. Normalized data were subsequently 
multiplied by average ChIP signal level of Col-0 wild type. This way data are corrected 
for variability in overall signal strength between independent experiments, the unit is 
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%input and presented data reflect the relative signal strength observed at particular loci. 
Standard deviations for Col-0 wild type are not available because Col-0 wild type was 
used to normalize data. 
DNA and RNA analysis 
For DNA methylation analysis genomic DNA was extracted from above-ground 
tissue of 2-week old plants using DNeasy Plant Mini Kit (Qiagen). 100 ng of genomic 
DNA was digested with 10u of HaeIII, AluI or AvaII restriction enzymes (NEB) for 20 
min. After heat-inactivation of the enzyme DNA was amplified using 0.75u Platinum Taq 
(Invitrogen). 
Total RNA was extracted from 2-week old plants using RNeasy Plant Mini Kit 
(Qiagen) and amplified using SuperScript III Platinum SYBR Green One-Step qRT-PCR 
Kit (Invitrogen) in Applied Biosystems 7500 real time PCR machine.  
Oligonucleotide primers used in this study are shown in a table in Appendix D. 
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Figure 4.1 SPT5L interacts with chromatin in a Pol V-dependent and AGO4 
independent manner 
A-I) ChIP data showing SPT5L binding to chromatin in Col-0 wild type, nrpe1, ago4 
and spt5l mutants at loci transcribed by Pol V and silenced by siRNA-mediated 
transcriptional silencing: solo LTR(C), IGN5 (D), IGN20 (E), IGN22 (F), IGN23 (G), 
IGN25 (H) and IGN26 (I). Two loci transcribed by Pol II are shown as controls: Actin 2 
(A) and Tubulin 8 (B). No antibody controls (white bars) provide background level for 
ChIP samples (black bars). Bars represent mean value of ChIP signals normalized to 
Col-0 wild type. Error bars are standard deviations of three independent biological 
replicates. 
J) Immunoblot detection of SPT5L in whole-cell protein extracts from Col-0 wild type, 
ago4, spt5l, dms3, nrpe1 and rdr2 mutants. Ponceau S staining of the membrane is a 
loading control. Asterisk denotes nonspecific bands. 
K) Real time RT-PCR detection of SPT5L RNA in Col-0 wild type, ago4, spt5l, dms3, 
nrpe1 and rdr2 mutants. Bars represent average SPT5L mRNA accumulation relative 
to Actin 2 from three biological replicates. Error bars represent standard deviation. 
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Figure 4.2 SPT5L and AGO4 are not required for Pol V binding to chromatin  
A-E) Pol V occupancy of Actin 2 (A) and Tubulin 8 (B) control loci, solo LTR (C), IGN5 
(D) and AtSN1 (E) assayed by ChIP in Col-0 wild type, nrpe1, spt5l and ago4. No 
antibody controls (white bars) provide background level for ChIP samples (black bars). 
Bars represent mean value of ChIP signals normalized to Col-0 wild type. Error bars 
are standard deviations of three independent biological replicates. 
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Figure 4.3 AGO4 can bind chromatin independently of SPT5L  
A-I) ChIP data showing AGO4 binding to chromatin in Col-0 wild type, spt5l and ago4 
mutants at Actin 2 (A) and Tubulin 8 (B) control loci, solo LTR (C), IGN5 (D), IGN20 
(E), IGN22 (F), IGN23 (G), IGN25 (H) and IGN26 (I). No antibody controls (white bars) 
provide background level for ChIP samples (black bars). Bars represent mean value of 
ChIP signals normalized to Col-0 wild type. Error bars are standard deviations of three 
independent biological replicates. 
J) Immunoblot detection of AGO4 in whole-cell protein extracts from Col-0 wild type, 
ago4, spt5l, dms3 and nrpe1 mutants using anti-AGO4 antibody. Asterisk denotes a 
nonspecific band. Ponceau S staining of the membrane shown in Fig. 4.1J is a loading 
control. 
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Figure 4.4 SPT5L interacts with chromatin in an siRNA-independent manner  
A-I) ChIP data showing SPT5L binding to chromatin in Col-0 wild type, rdr2 and spt5l 
mutants at loci transcribed by Pol V and silenced by siRNA-mediated transcriptional 
silencing: solo LTR(C), IGN5 (D), IGN20 (E), IGN22 (F), IGN23 (G), IGN25 (H) and 
IGN26 (I). Two loci transcribed by Pol II are shown as controls: Actin 2 (A) and Tubulin 
8 (B). No antibody controls (white bars) provide background level for ChIP samples 
(black bars). Bars represent mean value of ChIP signals normalized to Col-0 wild type. 
Error bars are standard deviations of three independent biological replicates. 
J) DNA methylation analysis of AtSN1, IGN5, IGN23 and IGN25 performed by 
digestion with HaeIII restriction endonuclease, IGN26 and solo LTR performed by 
digestion with AluI restriction endonuclease and IGN22 performed by digestion with 
AvaII restriction endonuclease. Digested genomic DNA was amplified by PCR. 
Sequences lacking HaeIII (Actin 2), AluI (IGN5) or AvaII (Actin 2) were used as loading 
controls. 
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Figure 4.5 Both SPT5L and AGO4 are required for silencing at certain loci  
A) DNA methylation analysis of AtSN1, IGN5, IGN23 and IGN25 performed by 
digestion with HaeIII restriction endonuclease. Digested genomic DNA was amplified 
by PCR. Sequence lacking HaeIII (Actin 2) sites was used as a loading control. 
B) DNA methylation analysis of IGN26 performed by digestion with AluI restriction 
endonuclease. Digested genomic DNA was amplified by PCR. Sequence lacking AluI 
(IGN5) sites was used as a loading control. 
C-F) Analysis of H3K9me2 at actin 2 (C), IGN5 (D), IGN23 (E) and IGN26 (F) loci 
performed by ChIP with anti-H3K9me2 antibody in Col-0 wild type, nrpe1, ago4 and 
spt5l. No antibody controls (white bars) provide background level for ChIP samples 
(black bars). Bars represent mean value of ChIP signals normalized to Col-0 wild type. 
Error bars are standard deviations of three independent biological replicates. 
 
120 
 
Figure 4.6 Locus-specific effects of SPT5L on silencing 
A) DNA methylation analysis of solo LTR performed by digestion with AluI restriction 
endonuclease and IGN22 performed by digestion with AvaII restriction endonuclease. 
Digested genomic DNA was amplified by PCR. Sequences lacking AluI (IGN5) or AvaII 
(Actin 2) sites were used as loading controls. 
B-C) ChIP analysis of H3K9me2 at solo LTR (B) and IGN22 (C) in Col-0 wild type, 
nrpe1, ago4 and spt5l. Corresponding no antibody controls are shown in panels D and 
E. Bars represent mean value of ChIP signals normalized to Col-0 wild type. Error bars 
are standard deviations of three independent biological replicates. 
D-E) ChIP analysis of H3Ac at solo LTR (D) and IGN 22 (E) in Col-0 wild type, nrpe1, 
ago4 and spt5l. No antibody controls (white bars) provide background level for ChIP 
samples (black bars). Bars represent mean value of ChIP signals normalized to Col-0 
wild type. Error bars are standard deviations of three independent biological replicates. 
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Figure 4.7 Model of SPT5L involvement in the recruitment of chromatin 
modifying enzymes 
Pol V produces intergenic non-coding transcripts which are the binding points for 
SPT5L and AGO4-siRNA complex. Both AGO4 and SPT5L may interact with both Pol 
V transcripts and Pol V complex itself. SPT5L and AGO4 are recruited to Pol V 
transcripts in parallel and independently of each other. When both AGO4 and SPT5L 
are present they create a binding platform for direct or indirect recruitment of DRM2 de 
novo DNA methyltransferase and other chromatin modifying enzymes. Establishment 
of chromatin modifications represses Pol II transcription. 
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CHAPTER 5 
Distinct Roles of SPT5L and AGO4 in Transcriptional Gene Silencing 
 
The contents of this chapter will be submitted for publication in the near future. Jan 
Kuciński prepared AGO4 ChIP samples for sequencing. Lilia Bouzit generated profiles 
shown in Figure 5.1A,C,D. Natalie Blackwood performed experiments shown in Figure 
5.9C. I performed all other experiments and data analysis shown in this chapter. 
 
Abstract 
Transcriptional Gene Silencing (TGS) protects genomes from harmful 
transposons and controls gene expression. This is accomplished through chromatin 
modification directed by small RNA and long non-coding RNA (lncRNA) bound proteins. 
In Arabidopsis thaliana, lncRNA is produced by RNA Polymerase V (Pol V) which helps 
guide ARGONAUTE4 (AGO4) to chromatin and directs de novo DNA methylation. Other 
proteins such as SPT5L (Supressor of Ty insertion 5 – Like) and IDN2 (INVOLVED IN 
DE NOVO 2) also interact with lncRNA and are important for TGS. However, the role of 
SPT5L in directing DNA methylation varies at individual loci. We show through genome 
wide maps of SPT5L and AGO4 binding sites (ChIP-seq) that these proteins bind 
chromatin mostly independent of each other, but that feedback through Pol V 
transcription can occur. We also show that SPT5L has a more limited role in directing 
de novo DNA methylation than does AGO4, and that this limited role is similar to that of 
IDN2. Furthermore, by examining genome-wide maps of H3 occupancy, we show that 
both SPT5L and AGO4 help direct nucleosome positioning. We propose that 
coordinated binding of SPT5L and AGO4 creates an additional level of silencing by 
increasing the nucleosomal density at TGS targets. 
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Author Summary 
Transposable elements are regions of DNA which are silenced to decrease the 
potential risks to genomic integrity. This silencing is often in the form of modification 
such as DNA methylation and chromatin compaction. One pathway responsible for 
establishing these modifications is Transcriptional Gene Silencing, otherwise known as 
RNA-directed DNA Methylation. As the name implies, chromatin modification is directed 
by long non-coding RNAs which act as scaffolds for RNA binding proteins to interact 
with chromatin. AGO4 and SPT5L are two such proteins which bind RNA and are 
thought to direct chromatin modifiers. While the role of AGO4 in directing de novo DNA 
methylation is established, the role of SPT5L is unknown. Here we show that while 
AGO4 is more important for DNA methylation, both AGO4 and SPT5L are necessary for 
nucleosome positioning. 
 
Introduction 
The Transcriptional Gene Silencing (TGS) pathway is responsible for silencing 
transposons by directing chromatin modification to discrete loci 1. Central to this 
pathway is long non-coding RNA (lncRNA) which acts as a scaffold for proteins to bind 
chromatin 2,3. While most features of TGS are conserved in eukaryotes 1,4, in 
Arabidopsis thaliana lncRNA is produced by RNA Polymerase V (Pol V) 3, an RNA 
Polymerase separate from Pol II. This distinction allows effective genetic studies in this 
organism.  
TGS, also known as RNA-directed DNA methylation (RdDM), directs chromatin 
modification by both lncRNA and siRNA to which ARGONAUTE (AGO) proteins 
bind1,2,5,6. AGO4 is directed to transposons and gene promoters by the presence of Pol 
V / lncRNA and by siRNA 5,7. These components are then necessary for the de novo 
DNA methyltransferase DOMAINS REARRANGED METHYLTRANSFERASE 2 (DRM2) 
to place DNA methylation 1.  
In addition to DNA methylation, RdDM directs other types of chromatin 
modification, one of which is nucleosome positioning 8. Another protein, INVOLVED IN 
DE NOVO 2 (IDN2), interacts with Pol V transcripts and is thought to guide SWI/SNF 
chromatin remodelers to RdDM targets 8,9. It was found that knockout of Pol V (nrpe1 
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mutant) and thus loss of IDN2 binding, leads to decreases in nucleosome occupancy 8. 
AGO4 is also necessary for nucleosome positioning at several loci, but whether SPT5L 
participates in this function is unknown 8.  
A less well understood component of RdDM is SPT5L (Supressor of Ty insertion 
5 - Like) which is similar to SPT5 a Pol II elongation factor 10.  While it has been 
proposed that SPT5 works to guide stalled Pol II transcription through nucleosomes 11, 
SPT5L on the other hand interacts with lncRNA and is dependent on Pol V to bind 
chromatin 10,12. Also unlike canonical SPT5, SPT5L contains a GW/WG sequence 
repeat domain, also known as an AGO hook, and interacts with AGO4 10. Locus specific 
assays have shown that SPT5L binds chromatin independent of AGO4 and that DNA 
methylation defects occur in the spt5l mutant only at some loci 12. The role of SPT5L in 
RdDM remains mostly unknown as the limited effects to DNA methylation suggest a 
lesser or different role than that of AGO4.  
Here we investigate locus variability of RdDM components and the role of SPT5L 
in RdDM. By using genome-wide binding site data we show that SPT5L and AGO4 bind 
chromatin independent of each other at a majority of loci, but that they can influence 
each other through effects to Pol V transcripts. We further show that AGO4 binding to 
chromatin plays a major role in directing de novo DNA methylation, while SPT5L binding 
does not. We also show that spt5l and idn2 defects in DNA methylation correlate well 
with each other and that both AGO4 and SPT5L are necessary for nucleosome 
positioning. 
 
Results 
Spt5l binding sites reflect RdDM activity 
While it is known that SPT5L and AGO4 are both important components of 
RdDM 1,10,12, their individual roles in this process remain mysterious. Previously, we 
found that mutation of spt5l leads to DNA methylation defects at some RdDM targets, 
but not at others. To investigate this locus variability in SPT5L dependent chromatin 
modification, we first asked whether SPT5L works mainly in RdDM or elsewhere.  
To investigate whether SPT5L is important in RdDM genome wide, we performed 
ChIP-seq using SPT5L antibody in Col-0 wild-type, ago4, and spt5l mutant. We found 
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5011 loci showing significant SPT5L binding (enrichment compared to the spt5l mutant), 
with a false discovery rate (FDR) < 0.001. These loci display prominent peaks in Col-0 
indicating that binding site discovery was accurate (Figure 5.1A). To further verify ChIP-
seq data we tested several loci by ChIP-qPCR with SPT5L antibody in three biological 
replicates,  and found that all tested loci showed enrichment in Col-0 compared to spt5l 
(Figure 5.7A). These loci included sites with low (JR693), middle (soloLTR, JR341), or 
high (JR213)  peak calling scores, as well as a few sites that did not meet our stringent 
enrichment criteria for peak calling but showed at least minor read enrichment (JA19, 
JR587, JR687), illustrating the stringency of our SPT5L peak calls. We also tested 
whether SPT5L binding is dependent on Pol V at these loci and found that at each locus 
tested, SPT5L signal is reduced to background levels in nrpe1 (Figure 5.7A). This is 
consistent with previous findings that SPT5L targets chromatin through interaction with 
POL V transcripts 10,12. 
Due to the similarities between SPT5L and SPT5, we asked whether SPT5L acts 
outside of RdDM 11,13. To test whether detected SPT5L binding sites represent RdDM 
targets or function like SPT5 at Pol II transcripts, we first examined SPT5L binding sites 
in relation to transcriptional start sites (TSS) of protein coding genes. We see 
enrichment of SPT5L directly upstream of genes, matching that which was found for 
AGO4 7 (Figure 5.7B). To further investigate the possibility of SPT5L working at genes 
we examined binding on genes, promoters, and transposons. Protein coding genes 
actually show depletion of detectable SPT5L compared to random peaks (random 
genomic regions; p< .001); however, promoters and transposons show enrichment of 
SPT5L (Figure 5.1B, p<.001). This localization to promoters and transposons is similar 
to what has been shown for both Pol V and AGO4 7,14,15 and further implicates SPT5L’s 
function as part of RdDM.  
To test whether SPT5L bound loci have other components of RdDM, we 
examined previously published Pol V ChIP-seq data 14. Indeed we see Pol V signal 
enrichment present at loci where SPT5L is bound (Figure 5.1C). We also examined 
previously published AGO4 ChIP-seq data 7 and found enrichment of AGO4 signal at 
SPT5L binding sites (Figure 5.1D).  Furthermore, SPT5L binding sites represent 
functionally significant RdDM loci as seen by enrichment of CHH methylation at these 
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loci compared to random genomic regions (Figure 5.1E, p<.001). Due to the presence 
of several hallmarks of RdDM at SPT5L binding sites, we conclude that SPT5L mainly 
functions as part of RdDM. 
SPT5L and AGO4 independent chromatin binding is a genome-wide trend  
SPT5L interacts with AGO4 through a reiterated GW/WG repeat doman and it 
was originally proposed that SPT5L functions as a bridge between AGO4 and DRM2. 
However, we have shown that SPT5L and AGO4 bind chromatin independent of each 
other at individual loci. I is unknown whether these loci represent the majority of RdDM 
targets in the genome. We decided to test whether SPT5L and AGO4 binding chromatin 
independently represents RdDM sites genome-wide.  
In order to explore the relationship between SPT5L and AGO4 we performed 
ChIP-seq with AGO4 antibody in Col-0, spt5l, and ago4 mutant. Using our same set of 
stringent peak calling criteria, we found 3988 significantly enriched AGO4 binding sites 
(FDR < .001). Median profiles around these sites display enrichment of AGO4 in Col-0 
vs ago4 indicating accurate binding site discovery (Figure 5.2A). We also tested several 
loci by ChIP-qPCR with AGO4 antibody, and found that all tested loci showed 
enrichment in Col-0 compared to ago4 (Figure 5.8A). These loci also included ones not 
present in the list of called peaks (JR341, JR587), illustrating the stringent requirements 
of peak calling. These loci were also reduced to background levels in nrpe1 which is 
consistent with previous findings that AGO4 depends on Pol V to bind chromatin (Figure 
5.1D) 5,7.  
To test if detected AGO4 binding sites represent RdDM targets we examined Pol 
V ChIP-seq data 14 at these loci. Pol V ChIP-seq signal is indeed enriched on AGO4 
peaks (Figure 5.2B) as it was on SPT5L peaks (Figure 5.1C) and is consistent with a 
previous genome-wide study of AGO4 7. We then checked whether SPT5L is enriched 
at AGO4 binding sites and see enrichment of SPT5L (Figure 5.2C). To further verify the 
accuracy of this data we also examined AGO4 signal on SPT5L peaks and see strong 
enrichment there (Figure 5.8B). Furthermore, detected AGO4 binding sites display an 
enrichment of CHH methylation (Figure 5.2D, p<.001) consistent with what was 
previously shown 7. From this we conclude that detected AGO4 binding sites represent 
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targets of RdDM, and that Pol V, SPT5L, and AGO4 bind chromatin at the same loci 
consistent with a model where these components work in complex with each other. 
In order to test whether SPT5L binds chromatin independent of AGO4, we 
performed SPT5L ChIP-seq in the ago4 mutant. Overall levels of SPT5L are unaffected 
by ago4 (Figure 5.1A), indicating that at a majority of loci SPT5L does not depend of 
AGO4 to bind chromatin. We also tested whether AGO4 binds chromatin independent 
of SPT5L by performing AGO4 ChIP-seq in the spt5l mutant. Overall levels of AGO4 are 
unaffected by spt5l, indicating that AGO4 does not depend on SPT5L to bind chromatin 
(Figure 5.2A). We conclude that AGO4 and SPT5L binding to chromatin independent of 
each other is indeed a genome-wide phenomenon. 
Pol V transcript availability determines AGO4 and SPT5L binding to chromatin 
While it is true generally that SPT5L and AGO4 bind to chromatin independent of 
each other, variations of RdDM occur. This is seen in variations in feedback between 
chromatin marks, variations in small RNA production, and variations in RdDM 
components necessary for silencing 12,14,16. We decided to ask whether variations in 
SPT5L and AGO4 binding dependencies occur. 
To check whether SPT5L is influenced by ago4 at some loci, we categorized 
SPT5L binding sites into those reduced in the ago4 mutant (ago4/Col-0 < 0 .5), those 
unchanged in ago4 (0.5 < ago4/Col-0 < 2), and those that increase in ago4 (ago4/Col-0 
> 2).  While the majority of SPT5L peaks are independent of AGO4 (63%), some are 
dependent on (21%) or are suppressed by AGO4 (16%) (Figure 5.3A, Figure 5.9A). 
This indicates that while the general trend confirms that SPT5L binds chromatin 
independently of AGO4, locus specific variation can occur. 
To determine if AGO4 is influenced by spt5l we divided AGO4 peaks into those 
reduced, unchanged, or increased in spt5l. While AGO4 mostly binds chromatin 
independent of SPT5L (73%), loci where AGO4 is reduced (9%) or increased (18%) in 
spt5l mutant are present (Figure 5.3B, Figure 5.9B). This indicates that AGO4 is indeed 
influenced by SPT5L at some loci. 
SPT5L and AGO4 mostly bind chromatin independent of each other, but 
dependent on Pol V (Figure 5.1A, Figure 5.1B) 7,12. Furthermore, the signal strength of 
both SPT5L and AGO4 corresponded to that of Pol V (Figure 1C, Figure 2B). We 
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sought to determine whether variations of SPT5L and AGO4 binding to chromatin are 
explained by variations to Pol V transcripts upon which they depend. We first tested 
whether changes to SPT5L binding in the ago4 mutant can be explained by changes to 
Pol V transcripts in the ago4 mutant. Pol V transcripts identified by RT-PCR were tested 
in the ago4 mutant and we found that the ago4 mutant can result in Pol V transcript 
levels to decrease, increase, or remain the same (Figure 5.9C). When comparing the 
effects of ago4 on Pol V transcripts to the effects of ago4 on SPT5L ChIP-seq data we 
see a correlation between changes in SPT5L signal and changes in Pol V transcript 
signal in the ago4 mutant (Figure 5.3C, R2 = .6356). In essence Pol V transcripts that 
decrease in the ago4 mutant correspond to SPT5L signal decreases in ago4. Likewise, 
Pol V transcript increases occur at the same loci where SPT5L signal increases in ago4. 
This is consistent with a model where Pol V transcripts act as scaffolds for SPT5L 
binding to chromatin and can explain the locus specific effects that ago4 has on SPT5L. 
Next we tested whether the spt5l mutant can affect Pol V transcript levels; we 
tested the aforementioned Pol V transcripts and found that spt5l can indeed cause 
changes to transcript levels (Figure 5.9C). We compared these changes in transcript 
levels to the changes in AGO4 binding signal in spt5l and found correlation between 
transcript level changes and AGO4 signal changes (Figure 5.3D – R2 = .5425). Loci with 
increased Pol V transcripts in spt5l corresponded to AGO4 signal increased in spt5l. 
Likewise, decreased Pol V transcripts in spt5l corresponded to AGO4 signal decreased 
in spt5l. We propose that locus specific effects to AGO4 by spt5l can be explained at 
least in part by the effects of spt5l on Pol V transcripts. 
Since variations of chromatin binding of both SPT5L and AGO4 may be 
explained by Pol V transcript levels, we sought to determine whether these effects on 
the two proteins occur at the same loci. We combined both lists of binding sites (AGO4 
and SPT5L) and examined the overlap between SPT5L reduced in ago4 and AGO4 
reduced in spt5l. Although SPT5L sites reduced in ago4 coincided relatively well with 
AGO4 sites reduced in spt5l, they most often coincide with sites where AGO4 is 
unchanged in spt5l (Figure 5.3E, Figure 5.9D).  This is true for all sites tested whether 
examining binding reduction, or binding increases. This indicates that locus variability of 
SPT5L and AGO4 chromatin binding do not occur at the same loci. We propose that the 
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effects exerted by SPT5L and AGO4 on each other likely result from the altered 
availability of Pol V transcripts, but that they affect transcription in different ways. 
Despite these locus specific effects, however, it should be noted that the majority of loci 
reflect a mechanism where SPT5L and AGO4 bind chromatin independent of each 
other. 
SPT5L plays a more limited role than AGO4 in directing DNA methylation 
Although both SPT5L and AGO4 bind at RdDM targets (Figure 1E, Figure 2D), 
the effect of SPT5L on DNA methylation varies at individual loci 12. We sought to 
determine whether the variable role of SPT5L on DNA methylation can be explained by 
variations in chromatin binding.  
Utilizing previously published bisulfite sequencing data 17, we identified regions with Pol 
V dependent CHH methylation (nrpe1 DMRs) and found that the majority of DMRs 
overlapped those of ago4 (Figure 5.4A, Figure 5.10A). In contrast, only about half of 
nrpe1 DMRs were also spt5l DMRs (Figure 5.4A). This confirms that, while AGO4 is 
necessary for DNA methylation at most RdDM targets, SPT5L’s role is more variable.  
We next tested if spt5l causes severe DNA methylation reduction at some loci 
and leaves others completely unchanged. In fact, most nrpe1 DMRs display at least 
some reduction in spt5l, although not nearly as much as in ago4 (Figure 5.4BC, Figure 
5.10BC). The contrast between the effects of ago4 and spt5l on DNA methylation 
indicates that SPT5L’s role in directing DNA methylation is not an “on” or “off” scenario, 
but a gradient of effects.  
The limited role of SPT5L in directing DNA methylation may result from limited 
binding of SPT5L at these sites. To test this possibility we tested if SPT5L binding is 
stronger at nrpe1 DMRs with severely reduced DNA methylation in spt5l than at nrpe1 
DMRs with minor or unchanged methylation in spt5l. Interestingly, SPT5L binding is 
enriched for these sites to the same degree (Figure 5.4D). This suggests that SPT5L 
binding to chromatin is not directly linked to directing de novo DNA methylation. 
Although, AGO4 is necessary at a majority of nrpe1 DMRs, variations in DNA 
methylation defects occur in this mutant also (Figure 5.10A). We tested whether 
variations in methylation dependency on AGO4 can be explained by variations in AGO4 
binding. AGO4 binding signal is seen at nrpe1 DMRs affected in ago4, but not at those 
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unaffected in ago4 (Figure 5.4E). This is in stark contrast to SPT5L where SPT5L 
binding was seen at sites unaffected in spt5l (Figure 5.4D). This suggests that AGO4, 
more than SPT5L, corresponds to directing DNA methylation at a majority of loci. 
We found loci where AGO4 is reduced in spt5l (Figure 5.3C); we also found loci 
where DNA methylation depends heavily on spt5l (Figure 5.4AB, Figure 5.10AB); we 
sought to determine whether spt5l affects DNA methylation by influencing AGO4 
binding to chromatin. We took categorized AGO4 binding sites that are reduced, 
unchanged, or increased in spt5l and tested whether these corresponded to the effects 
of spt5l on CHH methylation. Loci with AGO4 signal reduced in spt5l correspond to 
more severe reductions to DNA methylation in spt5l mutant (Figure 5.4F). This means 
that the most dramatic methylation changes in spt5l are in fact due to reduction in 
AGO4 binding. In contrast AGO4 binding sites that are unchanged or increased in spt5l 
have less severe DNA methylation reductions in spt5l (Figure 5.4F). This suggests that 
spt5l has a limited effect on DNA methylation at most loci, and that locus specific severe 
effects of this mutant may be explained by feedback to AGO4 chromatin binding. 
Overall, we propose that AGO4 is important for directing DNA methylation, and that 
SPT5L plays a more limited role in this aspect. 
Both SPT5L and AGO4 are necessary for RdDM specific nucleosome positioning 
SPT5L’s limited role in directing CHH methylation could possibly indicate that it 
has a distinct role from that of AGO4 in the RdDM pathway. To find components with 
similar effects as spt5l, we checked whether other mutants in the RdDM pathway 
display limited methylation defects. Using a principle component analysis of methylation 
at nrpe1 DMRs we examined the effects of 11 different mutants on CHH methylation. 
Interestingly spt5l, idn2, and the idn2/idnl1/idnl2 triple mutant clustered together 
indicating that these have similar effects on de novo DNA methylation (Figure 5.5A). 
Additionally, while these mutants cluster together, they all were closer to mutants for 
proteins involved in DNA methylation than to Col-0 (WT) demonstrating their role, 
however limited, in directing methylation (Figure 5.5A). This is in contrast to that of ago1 
which is not connected to POLV dependent DNA methylation and has CHH methylation 
most similar to Col-0 wild-type (Figure 5.5A). 
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In order to explore the relationship between SPT5L and IDN2 we further 
examined methylation levels at nrpe1 DMRs. We first compared CHH methylation 
changes in idn2/idnl1/idnl2 and in spt5l and found that the methylation level reductions 
in these mutants correlate well with each other (Figure 5.5B, Pearson Correlation = 
0.758). We next compared the idn2 triple mutant to ago4 and found that CHH 
methylation is generally reduced more in ago4 (Figure 5.5C). This is similar to spt5l and 
ago4 (Figure 5.4BC) in that ago4 has a much larger effect on methylation than spt5l 
(Figure 5.5D). In contrast ago4 and drm1/drm2 show more similar methylation defects 
to each other (Figure 5.11A, Pearson Correlation = 0.43). Overall this suggests that 
AGO4 is mainly responsible for directing DRM2 dependent methylation, and that SPT5L 
and IDN2 may work together or similarly in RdDM. 
Previously we have shown that IDN2 plays an important role in nucleosome 
positioning 8. Since idn2 and spt5l methylation patterns suggest that a connection may 
exist between the two, we tested whether SPT5L is important for nucleosome 
positioning. We performed H3 ChIP-seq on MNase digested chromatin to obtain 
genome-wide nucleosome maps in Col-0, nrpe1, ago4, and spt5l. We then took 
nucleosomes depleted in nrpe1 and examined their occupancy in ago4 and spt5l. 
Interestingly, most nucleosomes reduced in nrpe1 were also reduced in both ago4 and 
spt5l (Figure 5.5E). This indicates that while SPT5L plays a limited role in directing DNA 
methylation, both AGO4 and SPT5L are necessary for nucleosome positioning.  
Due to the strong effects of the ago4 mutant on CHH methylation (Figure 5.4C) 
we checked whether the methylation defects can explain nucleosome dependency. We 
took nucleosomes reduced in nrpe1 and examined changes to DNA methylation in ago4 
and spt5l. Many of these nucleosomes actually displayed no change in DNA 
methylation in either ago4 or spt5l, suggesting that nucleosome positioning functions 
independent of de novo methylation (Figure 5.11B). We further filtered these 
nucleosomes for those that represent nrpe1 DMRs. These nucleosomes display the 
same pattern of DNA methylation changes as total nrpe1 DMRs (Figure 5.5F, Figure 
5.5D). This indicates that AGO4 and SPT5L are important for nucleosome positioning 
independent of their roles in directing de novo DNA methylation. We also compared 
nucleosome changes in ago4 to CHH methylation changes in ago4 and see no 
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correlation (Figure 5.11C). Similarly comparison of nucleosome changes in spt5l to 
CHH methylation changes in spt5l displays no correlation (Figure 5.11D). We propose 
that AGO4 and SPT5L direct nucleosome positioning independent of their functions in 
directing de novo DNA methylation. 
 
Discussion 
Despite the finding that SPT5L is involved in RdDM 10, it was found that the spt5l 
mutant has locus specific effects to DNA methylation and histone modifications 12. Since 
then the exact function of SPT5L in RdDM has been in question. Here we show that 
AGO4 and SPT5L bind chromatin independent of each other, but that one may affect 
the other indirectly by feedback to Pol V transcripts. Furthermore, while it was supposed 
that SPT5L was only important for DNA methylation at some RdDM sites, spt5l causes 
at least minor changes in DNA methylation at nearly all nrpe1 DMRs (Figure 5.4B). This 
methylation pattern is similar to that of idn2 mutants (Figure 5.5D), which have been 
identified as proteins necessary for nucleosome positioning 8. Indeed SPT5L is also 
important for nucleosome positioning to the same degree (if not more than) AGO4 
(Figure 5.5E).  
Therefore, despite the limited effects to DNA methylation in spt5l, we propose a 
model where SPT5L and AGO4 are necessary for directing nucleosome remodeler 
binding or function at RdDM loci (Figure 5.6). In this model SPT5L and AGO4 bind 
chromatin independent of each other, but dependent on Pol V transcripts. AGO4 is then 
responsible for directing de novo DNA methylation and both SPT5L and AGO4 are 
essential to direct nucleosome positioning. 
A role in nucleosome positioning is intriguing due to the similarities between 
SPT5L and the Pol II elongation factor, SPT5 10,11. Canonical SPT5 has been proposed 
to guide Pol II through nucleosomes and reposition the nucleosome after transcription 
has passed 11,13. SPT5L may function at Pol V transcripts similar to SPT5, however it is 
likely that Pol V transcribes mostly independent of spt5l (as seen by limited effects to 
AGO4 binding in spt5l). It is more likely that Pol V transcription occurs before placement 
of nucleosomes and that SPT5L and AGO4 help direct chromatin modifiers to RdDM 
targets.  
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The similarity between SPT5L and SPT5 could also allow for compensation 
between the two. This might explain locus variability of the effects of spt5l on DNA 
methylation in that SPT5 may be able to at least partially compensate for SPT5L. 
However, changes in nucleosome positioning were as dramatic in spt5l as they were in 
ago4 suggesting that full compensation does not occur. Additionally, SPT5L is likely 
specific for RdDM as it was enriched upstream of genes and was conspicuously absent 
inside Pol II genes (Figure 5.1B, Figure 5.7B). In comparison, SPT5 in mouse was also 
shown to bind near genes, however in this system two profile summits are present: one 
directly upstream of the TSS and one slightly downstream or at the TSS 18, suggesting 
that two separate functions of SPT5 may exist in other systems. We propose that, like 
other components of RdDM in Arabidopsis, SPT5L’s function has been specialized for 
RdDM and is separate from that of SPT5.  
Overall, despite the limited role of SPT5L in directing DNA methylation, this 
component of RdDM is still vital for effective chromatin silencing. In conclusion, our 
findings indicate that while AGO4 is necessary for directing de novo DNA methylation, 
SPT5L and AGO4 together help direct nucleosome occupancy at RdDM targets. 
 
Materials and methods 
Plant Material and Antibodies 
nrpe1 (nrpd1b-11), spt5l (rdm3-3), and ago4 [(ago4-1) introgressed into the Col-0 
background] have been described previously 5,10,19. α-SPT5L, α-AGO4, and α-IDN2 
antibodies were also described previously 5,10,20. 
RT-PCR  
Total RNA was isolated from above ground tissue of three week old seedlings 
using the SV total RNA Isolation kit from Promega. After isolation, an additional 
incubation with Turbo DNase was performed as described 21. cDNA synthesis was 
performed using 3µg RNA with random primers (Invitrogen). Mean values relative to 
Col-0 and standard deviations were calculated from three biological replicates. Pol V 
transcripts were identified as loci with signal reduction in nrpe1 and were then tested in 
ago4 and spt5l. ChIP-seq reads covering these regions were counted and plotted 
relative to Col-0. Primers used are included in Appendix E. 
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Chromatin Immunoprecipitation 
3g above ground tissue of three week old seedlings were crosslinked and used in 
ChIP mostly as described 21. In lieu of phenol : chloroform extraction, 
immunoprecipitated samples were purified using the QIAquick PCR Purification Kit from 
Qiagen, after which libraries were prepared using the Diagenode Microplex Library 
Preparation Kit followed by Illumina sequencing. For H3 ChIP-seq, nuclei were 
resuspended in MNase buffer (NEB) after final wash in Honda buffer. Chromatin was 
digested in the presence of 6,000 Gel Units MNase (NEB) at 37°C for ten minutes. 
Nuclei were then broken by sonicating on ice three times for ten seconds each on the 
lowest setting. Immunoprecipitation and sample preparation were then performed as 
described for SPT5L and AGO4.  
Bioinformatics analysis  
Mapping to the TAIR10 genome and peak calling were performed using SOAP2 
and CSAR as previously described 21,23,24. SPT5L peaks found in Col-0 vs spt5l were 
combined with those found in ago4 vs spt5l for downstream analysis. AGO4 peaks 
found in Col-0 vs ago4 were combined with those found in spt5l vs ago4 for 
downstream analysis. Overlap between peaks and genomic features were done using 
TAIR10 annotations. Genome-wide ChIP-seq for Pol V and AGO4, and for bisulfite 
sequencing data used was taken from the NCBI data repository SRP013929 14, 
GSE35381 7, and GSE39901 17 respectively. The ago4 mutant was backcrossed from 
the Landsberg ecotype and could still contain some genomic sequence similarity, thus 
AGO4 peaks matching these regions were filtered as described 7. CHH methylated 
regions were identified using a 2 step process: 1. Regions were identified as having 
more than one methylated base in a CHH context (> 10% methylation score) within 
100bp of each other; 2. Regions less than 50bp in length and with less than 10% 
methylation per 10 bp were filtered to keep only highly methylated regions. DMRs were 
then called as having less than 25% methylation in the mutant vs Col-0. Weighted Venn 
diagrams of peaks and of DMRs were created using the Venneuler package in R 25. 
PCA analysis of nrpe1 DMRs was performed using the prcomp function in R and the 
first two principle components were plotted. Pol V dependent nucleosomal regions were 
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identified as sites were H3 ChIP signal in Col-0 was at least two fold greater than in 
nrpe1 and reads in ago4 and spt5l on these regions were counted. 
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Figure 5.1 SPT5L binding sites reflect RdDM activity 
A) Profile and heatmap of SPT5L ChIP-seq signal on called SPT5L binding sites. 
Graph shows median SPT5L ChIP-seq signal ratios in Col-0 vs spt5l (black) or ago4 
vs spt5l (green) relative to background around SPT5L peaks. Dashed line indicates 
SPT5L peak summit around which the plot is oriented. Heatmaps display this same 
region ordered from highest to lowest SPT5L peak score with red indicating strong 
Col-0/spt5l or ago4/spt5l SPT5L ChIP-seq signal ratios and white/yellow indicating  
138 
 
  low signal ratios. All signal ratios were taken as reads per million (RPM). 
B) SPT5L is enriched on Promoters and Transposons. Barplot indicating the 
percentage of SPT5L peaks (black) overlapping genes, promoters, and transposons. 
Random permutations matching the size distribution of SPT5L peaks were 
overlapped with genes, promoters, and transposons for comparison. Permutations 
were run 1000 times and the median value was plotted (grey). Error bars indicate 
standard deviation between permutations. * indicates p < .001 as calculated by 
permutation. 
C) Profile and heatmap of Pol V ChIP-seq signal on called SPT5L binding sites. 
Graph shows median Pol V ChIP-seq signal ratios in Col-0 vs nrpe1 (black) relative 
to background around SPT5L peaks. Dashed line indicates SPT5L peak summit 
around which the plot is oriented. Heatmaps display this same region ordered from 
highest to lowest SPT5L peak score with red indicating strong Col-0/nrpe1 Pol V 
ChIP-seq signal ratios and white/yellow indicating low signal ratios.   All signal ratios 
were taken as reads per million (RPM). 
D) Profile and heatmap of AGO4 ChIP-seq signal on called SPT5L binding sites. 
Graph shows median AGO4 ChIP-seq signal ratios in Col-0 vs ago4 (black) or 
nrpe1/ago4 (red) relative to background around SPT5L peaks. Dashed line indicates 
SPT5L peak summit around which the plot is oriented. Heatmaps display this same 
region ordered from highest to lowest SPT5L peak score with red indicating strong 
Col-0/ago4 or nrpe1/ago4 AGO4 ChIP-seq signal ratios and white/yellow indicating 
low signal ratios.   All signal ratios were taken as reads per million (RPM). 
E) De novo DNA methylation enrichment on SPT5L binding sites. meCHH signal on 
SPT5L peaks was counted and normalized by region size (per kb). Random genomic 
regions were taken and plotted for comparison. * indicates p < .001 calculated by t-
test. 
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  Figure 5.2 AGO4 binding sites reflect RdDM activity 
A) Profile and heatmap of AGO4 ChIP-seq signal on called AGO4 binding sites. 
Graph shows median AGO4 ChIP-seq signal ratios in Col-0 vs ago4 (black) or spt5l 
vs ago4 (red) relative to background around AGO4 peaks. Dashed line indicates 
AGO4 peak summit around which the plot is oriented. Heatmaps display this same 
region ordered from highest to lowest AGO4 peak score with red indicating strong 
Col-0/ago4 or spt5l/ago4 AGO4 ChIP-seq signal ratios and white/yellow indicating 
low signal ratios. All signal ratios were taken as reads per million (RPM). 
B) Profile and heatmap of Pol V ChIP-seq signal on called AGO4 binding sites. 
Graph shows median Pol V ChIP-seq signal ratios in Col-0 vs nrpe1 (black) relative 
to background around AGO4 peaks. Dashed line indicates AGO4 peak summit 
around which the plot is oriented. Heatmaps display this same region ordered from 
highest to lowest AGO4 peak score with red indicating strong Col-0/nrpe1 Pol V 
ChIP-seq signal ratios and white/yellow indicating low signal ratios.   All signal ratios 
were taken as reads per million (RPM). 
C) Profile and heatmap of SPT5L ChIP-seq signal on called AGO4 binding sites. 
Graph shows median SPT5L ChIP-seq signal ratios in Col-0 vs spt5l (black) or 
ago4/spt5l (green) relative to background around AGO4 peaks. Dashed line indicates 
AGO4 peak summit around which the plot is oriented. Heatmaps display this same 
region ordered from highest to lowest AGO4 peak score with red indicating strong 
Col-0/spt5l or ago4/spt5l SPT5L ChIP-seq signal ratios and white/yellow indicating 
low signal ratios.   All signal ratios were taken as reads per million (RPM). 
De novo DNA methylation enrichment on AGO4 binding sites. meCHH signal on 
AGO4 peaks was counted and normalized by region size (per kb). Random genomic 
regions were taken and plotted for comparison. * indicates p < .001 calculated by t-
test. 
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  low signal ratios.   All signal ratios were taken as reads per million (RPM). 
D) De novo DNA methylation enrichment on AGO4 binding sites. meCHH signal on 
AGO4 peaks was counted and normalized by region size (per kb). Random genomic 
regions were taken and plotted for comparison. * indicates p < .001 calculated by t-
test. 
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Figure 5.3 Pol V transcript availability determines AGO4 and SPT5L binding to 
chromatin 
A) Categories of SPT5L chromatin binding. SPT5L ChIP-seq signal was grouped into 
those reduced, increased, or unchanged in ago4. Reductions were defined as peaks 
where ago4/Col-0 < 0.5 (21% of called peaks), increases where ago4/Col-0 > 2 (16% 
of called paks), and unchanged where 0.5 < ago4/Col-0 < 2 (63% of called peaks).  
B) Categories of AGO4 chromatin binding. AGO4 ChIP-seq signal was grouped into 
those reduced, increased, or unchanged in spt5l. Reductions were defined as peaks 
where spt5l/Col-0 < 0.5 (9% of called peaks), increases where spt5l/Col-0 > 2 (18% 
of called paks), and unchanged where 0.5 < spt5l/Col-0 < 2 (73% of called peaks). 
C) Relationship between SPT5L binding and Pol V transcript availability. Pol V  
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  transcript changes in ago4 (ago4/Col-0; x-axis) as measured by RT-PCR are plotted 
in relation to SPT5L ChIP-seq signal changes in ago4 (ago4/Col-0; y-axis). A best fit 
linear correlation line is shown (R2=0.6356).  
D) Relationship between AGO4 binding and Pol V transcript availability. Pol V 
transcript changes in spt5l (spt5l/Col-0 RT-PCR; x-axis) as measured by RT-PCR are 
plotted in relation to AGO4 ChIP-seq signal changes in spt5l (spt5l/Col-0 AGO4 
ChIP-seq; y-axis). A best fit linear correlation line is shown (R2=0.5245).  
E) Overlap between categories of SPT5L and AGO4 bound loci. AGO4 peak and 
SPT5L peak lists were combined and categorized as in Figure 5.3A. Loci found in 
different categories are shown with the size of the circle and the amount of overlap 
relative to the number of peaks in each category. 
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  Figure 5.4 SPT5L plays a more limited role than AGO4 in directing DNA 
methylation 
A) Overlap of differentially methylated regions (DMRs). Venn Diagram showing 
overlap between nrpe1, ago4, and spt5l DMRs identified as regions with at least four 
fold decreases in CHH methylation compared to Col-0. The size of the circle and the 
amount of overlap is relative to the number of regions in each category. 
B) spt5l mutant has limited effects on CHH methylation. Histogram of CHH 
methylation on nrpe1 DMRs in the spt5l mutant relative to Col-0 and nrpe1. Dashed 
lines at 0 and 1 indicate spt5l methylation level similarities to nrpe1 and Col-0 
respectively ([spt5l – nrpe1] / [Col-0 - nrpe1]).  
C) ago4 mutant has dramatic effects on CHH methylation. Histogram of CHH  
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  methylation on nrpe1 DMRs in the ago4 mutant relative to Col-0 and nrpe1. Dashed 
lines at 0 and 1 indicate ago4 methylation level similarities to nrpe1 and Col-0 
respectively ([ago4 - nrpe1] / [Col-0 - nrpe1]).  
D) SPT5L binds nrpe1, spt5l DMRs and nrpe1 DMRs unchanged in spt5l. nrpe1 
DMRs were divided into those overlapping spt5l DMRs (spt5l/Col-0 <= .25) and those 
with little change in spt5l (spt5l/Col-0 >= .75) and SPT5L ChIP-seq signal was 
plotted. SPT5L ChIP-seq signal on random genomic regions is plotted as an estimate 
of background signal. Dashed line indicates a ChIP-seq signal ratio expected if no 
enrichment of SPT5L is present.  
E) AGO4 binds nrpe1, ago4 DMRs, but not nrpe1 DMRs unchanged in ago4. nrpe1 
DMRs were divided into those overlapping ago4 DMRs (ago4/Col-0 <= .25) and 
those with little change in ago4 (ago4/Col-0 >= .75) and AGO4 ChIP-seq signal was 
plotted. AGO4 ChIP-seq signal on random genomic regions is plotted as an estimate 
of background signal. Dashed line indicates a ChIP-seq signal ratio expected if no 
enrichment of AGO4 is present.  
F) Dramatic meCHH reductions in spt5l are explained by reductions in AGO4 binding. 
AGO4 and SPT5L peaks were pooled and those overlapping nrpe1 DMRs were kept. 
These were further categorized as in Figure 5.3C into AGO4 sites reduced, 
unchanged, or increased in spt5l. The level of CHH methylation in spt5l relative to 
Col-0 was plotted in each category. 
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  Figure 5.5 Both SPT5L and AGO4 are necessary for RdDM specific nucleosome 
positioning 
A) Principle component analysis of CHH methylation in mutants of RdDM. Ten 
mutants known to be involved in RdDM were chosen and compared to each other 
and to Col-0 (wild-type) and ago1 (not involved in RdDM). The first two principle 
components are plotted against each other. 
B) spt5l mutant affects CHH methylation similar to idn2/idnl1/idnl2 triple mutant. 
nrpe1 DMRs were taken and meCHH levels for spt5l and idn2,idnl1,idnl2 relative to 
Col-0 were calculated and plotted. The gradient from white to dark blue indicates low 
to high density points. Solid diagonal line indicates a slope of 1 (i.e. spt5l =  
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  idn2/idnl1/idnl2).  
C) ago4 mutant affects CHH methylation more than does idn2,idnl1,idnl2 triple 
mutant. nrpe1 DMRs were taken and meCHH levels for ago4 and idn2,idnl1,idnl2 
relative to Col-0 were calculated and plotted. The gradient from white to dark blue 
indicates low to high density points. Solid diagonal line indicates a slope of 1 (i.e. 
ago4 = idn2,idnl1,idnl2).  
D) ago4 mutant affects CHH methylation more than does spt5l. nrpe1 DMRs were 
taken and meCHH levels for ago4 and spt5l relative to Col-0 were calculated and 
plotted. The gradient from white to dark blue indicates low to high density points. 
Solid diagonal line indicates a slope of 1 (i.e. ago4 = spt5l).  
E) Both SPT5L and AGO4 are necessary for RdDM specific nucleosome positioning. 
Nucleosomes showing at least two fold signal reduction in nrpe1 (nrpe1/Col-0  <= 
0.5) were selected. H3 ChIP-seq signal in spt5l and ago4 relative to Col-0 were 
plotted. 
F) DNA methylation and nucleosome positioning are separate functions of RdDM. 
Nucleosomes reduced in nrpe1 with nrpe1 DMRs were taken and CHH methylation 
changes in ago4 (ago4/Col-0) and spt5l (spt5l/Col-0) were plotted. The gradient from 
white to dark blue indicates low to high density points. Solid diagonal line indicates a 
slope of 1 (i.e. ago4 = spt5l). 
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Figure 5.6 Model of SPT5L and AGO4 in RdDM 
Pol V (blue) produces lncRNA scaffolds (red line) to which proteins bind. siRNA 
bound AGO4 (green) and SPT5L (peach) are guided to chromatin by Pol V 
transcripts where they bind independent of each other. AGO4 directs de novo DNA 
methylation placed by DRM2 (light brown). AGO4 and SPT5L interact with each other 
and are both important for nucleosome positioning. AGO4 is important for IDN2 
(yellow) to bind lncRNA. IDN2 dimerizes and helps SWI/SNF (orange) deposit 
nucleosomes (grey) at RdDM targets. Mechanism of SPT5L activity in nucleosome 
positioning is yet to be determined (dashed line). 
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Figure 5.7 SPT5L binding sites reflect RdDM activity (supplementary to Figure 
5.1)  
A) Locus specific validation of SPT5L ChIP-seq peaks. ChIP-qPCR showing 
enrichment of SPT5L in Col-0 (black) compared to nrpe1 (tan) and spt5l (blue). Error 
bars represent standard deviation from three biological replicates. 
B) SPT5L and AGO4 bind promoters of protein coding genes. Profile of SPT5L 
(black) and AGO4 (green) relative to the transcriptional start site (TSS) of protein 
coding genes. Profiles were scaled to the minimum and maximum value. 
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Figure 5.8 AGO4 binding sites reflect RdDM activity (supplementary to Figure 
5.2)  
A) Locus specific validation of AGO4 ChIP-seq peaks. ChIP-qPCR showing 
enrichment of AGO4 in Col-0 (black) compared to nrpe1 (tan) and ago4 (green). 
Error bars represent standard deviation from three biological replicates. 
B) Profile and heatmap of AGO4 ChIP-seq signal on called SPT5L binding sites. 
Graph shows median AGO4 ChIP-seq signal ratios in Col-0 vs ago4 (black) or spt5l 
vs ago4 (red) relative to background around SPT5L peaks. Dashed line indicates 
SPT5L peak summit around which the plot is oriented. Heatmaps display this same 
region ordered from highest to lowest SPT5L peak score with red indicating strong 
Col-0/ago4 or spt5l/ago4 AGO4 ChIP-seq signal ratios and white/yellow indicating 
low signal ratios.   All signal ratios were taken as reads per million (RPM). 
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Figure 5.9 Pol V transcript availability determines AGO4 and SPT5L binding to 
chromatin (supplementary to Figure 5.3) 
A) Histogram of ago4 effects on SPT5L chromatin binding. The log fold change in 
ago4 compared to Col-0 is plotted as a histogram. Vertical dashed lines indicate two-
fold changes. 
B) Histogram of spt5l effects on AGO4 chromatin binding. The log fold change in 
spt5l compared to Col-0 is plotted as a histogram. Vertical dashed lines indicate two-
fold changes. 
C) RT-PCR of Pol V transcripts shown in figure 5.3CD. Q-PCR signal was normalized 
to ACTIN and plotted relative to Col-0. UBQ is a control locus (not transcribed by Pol 
V). Error bars indicate standard deviation from three biological replicates. 
D) Effects of spt5l on AGO4 do not correlate to the effects of ago4 on SPT5L. 
Scatterplot showing changes in SPT5L ChIP-seq signal in ago4 (log[ago4/Col-0], x-
axis) compare to the changes to AGO4 ChIP-seq signal in spt5l (log[spt5l/Col-0], y-
axis). 
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Figure 5.10 SPT5L plays a more limited role than AGO4 in directing DNA 
methylation (supplementary to Figure 5.4) 
A) Methylation reduction in spt5l is limited. Heatmap of nrpe1 DMRs showing CHH 
methylation changes in nrpe1, ago4, spt5l, and drm2 relative to Col-0. 
B) AGO4 is important for DNA methylation at SPT5L binding sites. Scatterplot 
showing CHH methylation changes in ago4 (log[ago4/Col-0], x-axis) compared to 
nrpe1 (log[nrpe1/Col-0], y-axis). Vertical and horizontal lines indicate no change from 
Col-0. Diagonal line indicates a slope of 1 (i.e. ago4 = nrpe1). 
C) SPT5L is semi-important for DNA methylation at SPT5L binding sites. Scatterplot 
showing CHH methylation changes in spt5l (log[spt5l/Col-0], x-axis) compared to 
nrpe1 (log[nrpe1/Col-0], y-axis). Vertical and horizontal lines indicate no change from 
Col-0. Diagonal line indicates a slope of 1 (i.e. spt5l = nrpe1). 
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  Figure 5.11 Both SPT5L and AGO4 are necessary for RdDM specific 
nucleosome positioning (supplementary to Figure 5.5) 
A) ago4 mutant affects CHH methylation similar to the drm1/drm2 double mutant. 
nrpe1 DMRs were taken and meCHH levels for ago4 and drm1,drm2 relative to Col-0 
were calculated and plotted. The gradient from white to dark blue indicates low to 
high density points. Solid diagonal line indicates a slope of 1 (i.e. ago4 = drm1/drm2).  
B) DNA methylation and nucleosome positioning are separate functions of RdDM. 
Nucleosomes reduced in nrpe1 were taken and CHH methylation changes in ago4 
(ago4/Col-0) and spt5l (spt5l/Col-0) were plotted. Solid diagonal line indicates a slope 
of 1 (i.e. ago4 = spt5l). 
C) DNA methylation changes and nucleosome positioning in ago4 are not correlated. 
Nucleosomes reduced in nrpe1 were taken and CHH methylation changes in ago4 
(ago4/Col-0) were plotted against nucleosome changes in ago4 (ago4/Col-0). Vertical  
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and horizontal lines indicate no change from Col-0. 
D) DNA methylation changes and nucleosome positioning in spt5l are not correlated. 
Nucleosomes reduced in nrpe1 were taken and CHH methylation changes in spt5l 
(spt5l/Col-0) were plotted against nucleosome changes in spt5l (spt5l/Col-0). Vertical 
and horizontal lines indicate no change from Col-0. 
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CHAPTER 6 
RNA-directed DNA Methylation Controls Gene Expression via Chromosome 
Looping 
 
The contents of this chapter will be submitted for publication in the near future. Gudrun 
Böhmdorfer prepared RNA-seq samples. I performed all other experiments and data 
analysis shown in this chapter. 
  
Abstract 
RNA-mediated transcriptional silencing, in plants known as RNA-directed DNA 
methylation (RdDM), is a conserved process where small interfering RNA (siRNA) and 
long non-coding RNA (lncRNA) work together to establish repressive chromatin 
modifications 1,2. This process not only represses transposons but also affects 
expression of protein-coding genes 3,4. Mechanisms used by RdDM to control 
transcription remain mostly unknown. In this work we show that RdDM controls 
chromosome looping between distant genomic regions, specifically at RdDM target loci 
in Arabidopsis thaliana. Presence of chromosome loops is correlated with high levels of 
gene expression and the absence of repressive chromatin modifications on 
corresponding distant regulatory regions. Direct RdDM targets have the potential to 
engage in chromosome looping, which is prevented by the presence of repressive 
chromatin modifications. In mutants defective in RdDM, looping at RdDM targets is 
strongly increased. This includes increased looping between genes repressed by RdDM 
and distant regions, which are direct RdDM targets and are enriched in transcription 
factor binding sites. This suggests that RdDM may repress looping between genes and 
potential regulatory regions like enhancers. We propose a model where RdDM 
contributes to the regulation of gene expression by controlling looping between genes 
and their distant enhancers. 
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Significance Statement 
RNA-directed DNA methylation (RdDM) is a process, where small interfering 
RNA (siRNA) and long non-coding RNA (lncRNA) work together to repress 
transposons. In addition to controlling repetitive sequences, it contributes to the 
regulation of gene expression. Molecular mechanisms of transcription regulation by 
RdDM remain mostly unknown. We show that RdDM is involved in repression of long 
range chromosomal interactions. We propose a model where RdDM contributes to the 
regulation of gene expression by controlling looping between genes and their distant 
enhancers.   
 
Introduction 
RNA-mediated transcriptional silencing is a process, which directs repressive 
chromatin modifications to transposons and other repetitive loci. In Arabidopsis thaliana 
it is known as RNA-directed DNA methylation (RdDM) and uses two specialized RNA 
polymerases, RNA polymerase IV (Pol IV) and RNA polymerase V (Pol V) 5. While Pol 
IV is believed to produce siRNA precursors, Pol V produces lncRNA scaffolds which 
help guide proteins to chromatin 5,6. ARGONAUTE 4 (AGO4) interacts with both siRNA 
and lncRNA to target specific loci for silencing 7,8. At these loci AGO4 and other RNA 
binding proteins, such as SPT5L and IDN2, are important for chromatin modifiers to 
bind and/or function 9–12. Components of RdDM are important for de novo DNA 
methylation, nucleosome positioning, and repressive histone modifications 9,10,12–14.  
The RdDM pathway not only represses transposons but also contributes to the 
regulation of gene expression. We used genome-wide chromosome conformation 
capture assay (Hi-C) to test the hypothesis that RdDM affects gene expression by 
controlling long range chromosomal interactions. We found that chromosome looping is 
less likely to occur at silenced genes and at regions with repressive chromatin marks. 
Our data also show that RdDM inhibits chromosome loops specifically at RdDM targets. 
We also show that gene expression may be controlled by RdDM via inhibiting 
interactions with distant transcription factor binding sites. These findings lead us to 
propose a model where RdDM affects gene expression by inhibiting long distance 
chromosomal interactions.  
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Results 
Gene expression is correlated with looping to euchromatin 
Components of the RNA-dependent DNA methylation pathway (AGO4, Pol V) 
have been shown to bind chromatin in putative promoter regions upstream of protein-
coding genes 8,15. To test if AGO4 controls the expression of proximally located genes, 
we performed RNA-seq in the ago4 mutant and compared changes in RNA levels to our 
ChIP-seq data of AGO4 binding to chromatin 8. Only 11% of genes with expression 
levels changed in the ago4 mutant had evidence of AGO4 binding within their proximal 
regulatory regions defined as 2.5kb upstream of the transcription start site. Although this 
overlap is significant, the non-overlapping features suggest that the majority of genes 
differentially expressed in the ago4 mutant do not have evidence of detectable AGO4 
binding within their proximal regulatory regions (Figure 6.1A). One explanation of this 
disparity may be posttranscriptional or indirect effects. Alternatively, AGO4 may affect 
transcription over long distances by controlling chromosome looping.  
To test this possibility, we performed chromosome conformation capture 
experiments followed by high throughput sequencing (Hi-C) 16,17. To facilitate 
comparative analysis of Hi-C and ChIP-seq datasets, we used the same tissue type, 
similar crosslinking conditions, and the DpnII restriction enzyme, which is insensitive to 
DNA methylation and produces a median fragment size of 166 bp in the Arabidopsis 
genome. We first analyzed Hi-C data from Col-0 wild type Arabidopsis seedlings and 
tested if gene expression is correlated with looping. Consistent with reports from other 
organisms 18–20, genes with lower expression (approximated by RNA-seq signal) are 
less likely to engage in chromosome looping than more highly expressing genes (Figure 
6.1B, Figure 6.5D). This is consistent with a model where looping brings regulatory 
elements into close proximity to genes thereby activating transcription. 
To test if chromatin modifications present at distant regions may affect looping 
and thereby gene expression, we identified loops that connect genes to other genomic 
regions and compared the presence of specific histone modifications with gene 
expression levels. High levels of an active/euchromatin mark (H3K4me2) at distant 
interacting regions were associated with higher levels of gene expression (Figure 6.1C). 
Similarly, high levels of an inactive/heterochromatin mark (H3K9me2) at distant 
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interacting sites were associated with lower levels of gene expression (Figure 6.1D). 
Although exceptions to this trend clearly exist (Figure 6.1C, 6.1D), it is consistent with a 
proposed model 21 where chromatin modifications at distant regions affect the formation 
of loops to genes and/or control the expression of genes distally located. Because 
RdDM establishes DNA methylation and other repressive chromatin modifications, it is 
possible that RdDM may also affect chromosome looping.  
We then tested if the frequency of looping corresponds to particular chromatin 
modifications. Presence of activating chromatin modifications (higher H3K4me2 and 
lower H3K9me2 levels) was associated with higher probability of looping (Figure 6.1E). 
Conversely, the presence of repressive chromatin modifications (lower H3K4me2 and 
higher H3K9me2 levels) was associated with lower probability of looping (Figure 6.1E). 
These results were also supported by a second biological repeat of Hi-C, which was 
sequenced at lower coverage (Figure 6.5E-H). This is consistent with chromatin 
modifications being important for chromosome looping 22–24. Together, these results 
indicate a correlation between activating chromatin modifications, gene expression, and 
chromosome looping.  
RdDM inhibits chromosome looping at RdDM sites  
Negative correlation between repressive chromatin modifications and looping 
(Figure 6.1E) indicates that RdDM may prevent the formation of chromosome loops. To 
test this possibility we performed the Hi-C experiment in nrpe1 and ago4 mutants, both 
of which are defective in RdDM (NRPE1 encodes the largest subunit of RNA 
Polymerase V, which produces long non-coding RNA required for RdDM) 25–28. 
Examining the Hi-C data, we identified chromosome looping at RdDM chromatin 
targets, defined as regions where NRPE1 and AGO4 bind to chromatin (ChIP-seq 
peaks) and mediate CHH DNA methylation (loss of methylation in nrpe1 mutant). We 
found that in Col-0 wild type plants, RdDM targets were significantly less likely to 
engage in looping than random genomic regions (Figure 6.2A). In contrast, this 
repression of looping was alleviated in nrpe1 and ago4 mutants (Figure 6.2A). 
Moreover, loops to nrpe1 differentially methylated regions (DMRs) were also supported 
by higher numbers of Hi-C sequencing reads in nrpe1 and ago4 mutants compared to 
Col-0 wild type (Figure 6.2B, Figure 6.6C). Enhanced looping in RdDM mutants was 
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consistently observed in the second low coverage repeat of Hi-C (Figure 6.6AB) and 
validated using a locus-specific 3C assay on a few selected loci (Figure 6.2C). This 
repression of looping can also be seen at non-centromeric transposons, which are 
generally thought to be targets of RdDM 8 (Figure 6.6D). Additionally, these effects were 
specific to RdDM targets and most likely not caused by a widespread disruption of 
chromosome looping since there was no difference in the overall relationship between 
total gene expression levels in Col-0 wild type and looping between Col-0 wild type and 
nrpe1 or ago4 mutants (Figure 6.5D). These results indicate that RdDM prevents 
formation of chromosome loops specifically at RdDM targeted chromatin. 
Gene repression correlates with repression of chromosome looping by RdDM 
Chromatin modifications on distant looping regions are correlated with the 
frequency of looping (Figure 6.1E) and gene expression levels (Figure 6.1CD). 
Moreover, site specific chromosome looping is repressed by RdDM (Figure 6.2A). This 
suggests that RdDM may affect gene expression by repressing gene looping to 
heterochromatin. To test this possibility we analyzed genes repressed by RdDM. For 
this analysis we define genes repressed by RdDM as those increased in both nrpe1 and 
ago4 mutants (Figure 6.3A) since genes increased in a single mutant may be due to 
indirect effects or limitations of RNA-seq; however, overlap of differentially expressed 
genes between the two mutants is significant (Figure 6.3A) and supports the model of 
coordinated action by Pol V and AGO4.  Having obtained high confidence differentially 
expressed genes, we tested what fraction of those genes loop to regions bound by 
AGO4. When we analyzed loops identified in Col-0 wild type, we found that genes 
upregulated in RdDM mutants were less likely to loop to AGO4 binding sites in the wild 
type than expected by chance (Figure 6.3B, Figure 6.7). However, when we analyzed 
loops identified in nrpe1 and ago4 mutants, we found that genes upregulated in both 
RdDM mutants were more likely to loop to AGO4 binding sites in the mutants than 
expected by chance (Figure 6.3B, Figure 6.7). Similar results were obtained for larger 
groups of genes upregulated in nrpe1 or in ago4 (Figure 6.7). This indicates that genes 
repressed by RdDM have the potential to loop to regions bound by AGO4 but in Col-0 
wild type this looping is prevented.  
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Changes in gene expression observed in RdDM mutants may be explained by 
two non-mutually exclusive mechanisms. First, RdDM targets on gene promoters or 
promoter proximal elements may affect transcription without the involvement of looping. 
Second, RdDM targets on distant regulatory regions (potential enhancers) may affect 
gene expression via chromosome looping. For these purposes we define distal 
regulatory regions (enhancers) as located at least three DpnII restriction sites away 
from the gene or its proximal regulatory region and connected by detectable 
chromosome looping from Hi-C. To test if RdDM influences gene expression long-range 
we examined genes with differential expression in nrpe1 for AGO4 binding to chromatin 
on the promoters or distant regulatory regions. AGO4 has evidence of binding in three 
different scenarios: on the distal regulatory region (Figure 6.3C - Q1), on the proximal 
region (Figure 6.3C – Q3), or on both (Figure 6.3C – Q2). We also calculated how many 
genes upregulated in the ago4 mutant show evidence of AGO4 binding to their proximal 
regulatory regions, distant regulatory regions, or both. We found evidence of detectable 
AGO4 binding within only the proximal regulatory regions, within only the distant 
regulatory regions (enhancers), or within both proximal and distant regulatory regions 
(Figure 6.3D). This indicates that long and short distance effects of RdDM are likely to 
coexist. Together these results suggest that RdDM binds regulatory regions either 
proximally or distally from genes where gene expression is controlled through the 
inhibition of chromosome looping. 
RdDM represses looping between genes and their enhancers 
Connecting genes to distant enhancers is thought to be an important function of 
chromosome looping 21. To determine if this is the case in Arabidopsis we tested 
whether genomic regions that loop to protein-coding genes are enriched in transcription 
factor binding. By reanalyzing seven independent genome-wide transcription factor 
binding datasets from seedlings (see Methods), we found that in general, genes are 
more likely to loop to transcription factor binding sites than expected by chance (random 
regions in the genome) (Figure 6.4A). Since the presence of transcription factor binding 
sites is a hallmark of enhancers 29, this suggests that Arabidopsis genes preferentially 
loop to enhancers.  
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To examine whether RdDM inhibits looping to enhancers, we further tested if 
distant regulatory regions which loop to genes upregulated in the nrpe1 mutant are also 
enriched in transcription factor binding sites. We found that these distant regions are 
enriched in the presence of transcription factor binding sites (Figure 6.4B). This 
suggests that distant regions looping to genes upregulated in the nrpe1 mutant are 
possible regulatory elements like enhancers. This is consistent with our hypothesis that 
RdDM affects looping between genes and their distant regulatory regions / enhancers. 
 
Discussion 
Based on presented results we propose a model, where RdDM affects gene 
expression by repressing looping between genes and their enhancers. According to this 
model, at least some genes which are repressed by the RdDM pathway have direct 
RdDM targets on their proximal promoters and/or on their distant enhancers (Figure 
6.4C – wild type). In wild type plants, regions directly targeted by RdDM have high 
levels of DNA methylation and repressive histone modifications. These repressive 
chromatin marks prevent the formation of chromosome loops between genes and 
enhancers (Figure 6.4C – wild type). Lack of gene-enhancer looping contributes to gene 
repression. When RdDM is not active in nrpe1 or ago4 mutants or under specific 
environmental conditions 30, repressive chromatin marks are eliminated. When 
repressive chromatin modifications are removed or lost, chromosome looping is no 
longer repressed. Loops between genes and their distant enhancers may form and 
transcription factors binding to enhancers activate gene expression (Figure 6.4C – No 
RdDM). 
Our model leads to an important question of what feature of RdDM directly 
affects the formation of chromosome loops. One possibility is that chromatin 
modifications directly affect chromosomal interactions. Another possibility is that looping 
is directly mediated by transcription factors, which are unable to bind to chromatin with 
repressive modifications. In both cases the effects on looping are not expected to be 
limited to RdDM. Repressive chromatin modifications established using other 
mechanisms are likely to have similar effects on chromosome looping. 
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Our results are consistent with a recent report studying higher order organization 
of Arabidopsis chromosomes using chromosome conformation capture, where a 
correlation in chromatin modifications between both ends of loops has been shown 31. 
However, the mechanism we observe appears to be different than looping reported on 
the FLC gene, which was shown not to be affected by ncRNA or chromatin 
modifications 32 but may be affected by other factors altering chromatin modifications at 
this locus. 
Looping between specific chromosomal regions is a conserved process found by 
chromosome conformation capture from bacteria to mammals 19,20,33–35 and is believed 
to contribute to regulation of gene expression 36–38. Chromosome looping is often 
mediated by insulator proteins which preferentially bind to open chromatin 19,39. 
Activating histone modifications and gene activity have also been shown to be 
correlated with chromosome looping 19,20. This is consistent with our model where 
RdDM prevents looping by establishing repressive chromatin marks. These similarities 
suggest a conserved mechanism where transcriptional silencing pathways affect gene 
expression by inhibiting chromosome looping. 
Chromosome conformation capture (Hi-C), relies on in vivo crosslinking and 
ligation, in which the effects of biological variability and conditions are not well 
understood. We attempt to mitigate some of the limitations of Hi-C by performing 
biological repeats and locus-specific validation. We also perform comparative analysis 
with ChIP-seq, which involves a similar crosslinking step. Our observations of both 
correlations and anti-correlations between Hi-C and ChIP-seq datasets (Figures 6.1E 
and 6.3B) suggest that crosslinking or sequencing biases have a limited impact on our 
datasets. Also our findings are at least in part based on a comparison of genetic 
backgrounds. Although currently, there is very limited availability of tools allowing 
independent verification of Hi-C data over a broad range of chromosomal distances, 
obtaining such an independent evidence confirming our model is an important goal for 
future research. 
We have recently shown that RdDM mediates nucleosome positioning 12 by the 
SWI/SNF ATP-dependent chromatin remodeling complex. Together with the results 
presented here, this indicates that RNA-mediated transcriptional silencing may affect 
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several aspects of chromatin structure. This further identifies lncRNA as a master 
regulator of chromatin structure. 
 
Materials and Methods 
Plant Material 
Arabidopsis thaliana mutant lines nrpe1 (nrpd1b-11) and ago4 (ago4-1 
introgressed into Col-0) were described previously 25,40,41. Seedling tissue was used in 
all experiments and only datasets from the same tissue type were used in analysis. 
3C/Hi-C sample preparation 
Arabidopsis seedlings were grown for 2 weeks under long day conditions after 
which above ground tissue was harvested and cross-linked in 0.5% formaldehyde as 
previously described 42. Nuclei were extracted using the same protocol as ChIP 42, with 
the exception that the final wash was performed in 1.2x DpnII buffer (NEB). Nuclei were 
then incubated in DpnII reaction buffer supplemented with 0.3% SDS at 65°C for 40 
minutes and 37°C for 20 minutes. Triton-X was added to a final concentration of 1.8% 
and samples were incubated for 1 hour at 37°C after which 600 units of DpnII were 
added and samples were incubated overnight at 37°C with mixing. To stop digestion, 
SDS was added to 1.25% and samples were incubated at 65°C for 25 minutes. They 
were then diluted in 7ml 1x Ligation Buffer (NEB) supplemented with 1% Triton-X and 
incubated for 1 hour at 37°C. Ligation was performed with 600 units T4 DNA Ligase 
(NEB) for 4 hours at 16°C followed by 1 hour at 25°C. 600 µg of Proteinase K 
(Invitrogen) was added and de-crosslinking was performed at 65°C overnight. RNA was 
eliminated by incubation with 300 µg RNAse A (Invitrogen) at 37°C for 30 minutes. DNA 
was purified using phenol:chloroform extraction and ethanol precipitation as 
described42. Library preparation and Illumina Paired-End Sequencing were performed 
by the University of Michigan Sequencing Core. Primers for 3C can be found in 
Appendix F. 
Hi-C data analysis 
Each end of paired-end reads with unique alignment was mapped to the 
Arabidopsis genome (TAIR10) using Bowtie and then paired. The genome was divided 
into 250bp windows and interactions between windows were counted. Interaction 
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events more than three DpnII sites apart were kept (Figure 6.5A) and plotted as a 
function of window distance (Figure 6.5B). A polynomial for each curve was generated 
and multiplied by 0.1 to provide distance to read based cutoffs keeping only the highest 
confidence short range interactions while maintaining long-range interaction events with 
a minimum of two reads supporting independent ligation events (Figure 6.5BC). 
Genome annotations were obtained from the TAIR website (www.arabidopsis.org) and 
gene proximal elements were defined as 2.5kb upstream of the transcription start site. 
H3K9me2 and H3K4me2 datasets were obtained from 43,44 (GSE49090 and GSE37644 
respectively). AGO4 and Pol V ChIP-seq datasets were obtained from 3,28 (GSE35381 
and SRA054962 respectively). Genome-wide bisulfite sequencing datasets were 
obtained from 45 (GSE39901). nrpe1 DMRs were identified using a 3 step process: 1. 
Regions were identified as having more than one methylated base in a CHH context (> 
10% methylation score) within 100bp of each other; 2. Regions less than 50bp in length 
and with less than 10% methylation level per 10 bp were filtered to keep only highly 
methylated regions; 3. DMRs were then called as having less than 25% methylation in 
nrpe1 vs. Col-0. 
RNA-seq 
RNA from ago4 seedlings was prepared in three biological repeats as described 
12 and libraries were prepared by the University of Michigan Sequencing Core. Reads 
were mapped to the TAIR10 genome assembly and differential expression was called 
using the Tophat / Cufflinks suite. Published RNA-seq datasets from seedlings (Col-0 
wild type and the nrpe1 mutant) 12 (GSE38464) were grown, harvested, isolated, and 
sequenced in parallel to the ago4 dataset. Overlaps in differential expression were 
calculated and plotted as a weighted Venn diagram using the Venneuler package in R.  
Transcription factor datasets 
Raw reads for transcription factor ChIP-seq data was downloaded for AL5 
(GSE56706), IBH1 (GSE51120) 46, LFY (GSE24568) 47, PIF4 (GSE35315) 48, PRR7 
(GSE49282) 49, SPL7 (GSE45213), and SVP (GSE33120) 50. Reads were then mapped 
to the TAIR10 genome and immunoprecipitation vs. control were counted in 250bp 
windows for comparison to Hi-C. Transcription factor binding was defined as the 
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presence of at least 10 sequencing reads and signal to background ratio of at least 2 in 
a 250 bp window. 
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Figure 6.1 Gene expression corresponds to looping to euchromatin 
A) Overlap between genes with differential expression in ago4 mutant (green) and 
genes with AGO4 peaks defined using high confidence (brown) or lower confidence 
(light brown) score cutoffs. AGO4 binding to a gene is defined as binding within a 
region from 2.5kb upstream of the TSS to the 3’ end of the transcribed region. 
B) Correlation between RNA accumulation and chromosome looping. Genes were 
divided into inactive (0 RPKM) and a range of categories from low to high expression 
(RPKM) in Col-0. The number of genes in each expression category that had evidence 
of long range chromatin interactions in Col-0 were plotted as a percentage of each 
category. RPKM – reads per kilobase per million.  
C) Correlation between gene expression and the level of H3K4me2 at distant 
regulatory regions. Genes with evidence of looping in Col-0 were divided into 
categories based on the levels of wild type H3K4me2 ChIP-seq signal normalized to 
H3 ChIP-seq at distant regulatory regions, and RNA-seq signal from Col-0 was plotted. 
Dashed horizontal line indicates median gene expression in the genome. 
D) Anti-correlation between gene expression and the level of H3K9me2 at distant 
regulatory regions. Analysis was performed like for (C) except that a H3K9me2 dataset 
was used. 
E) Correlation between histone modifications and the probability of chromosome 
looping. Genomic regions were divided into categories based on H3K4me2 ChIP-seq 
signal or H3K9me2 ChIP-seq signal. The numbers of regions in each category with 
detectable long range chromatin interactions in Col-0 were plotted relative to 
permutated random genomic regions. ChIP-seq signal for each genomic region was 
normalized to H3 ChIP-seq. 
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Figure 6.2 RdDM inhibits chromosome looping at RdDM sites 
A) Comparison of looping from RdDM target loci in Col-0, nrpe1 and ago4. The 
numbers of RdDM targets with detectable chromosome looping in Col-0, nrpe1, or 
ago4 (Actual) relative to the average numbers of permutated random regions 
(Random). Error bars indicate standard deviations between 1000 permutations, * 
indicates p<0.005. 
B) Numbers of sequencing reads supporting chromosome looping to nrpe1 DMRs. 
Numbers in each signal intensity cutoff were normalized to those from total identified 
interactions in each genotype and to Col-0 wild type.  
C) Locus-specific validation of chromosome looping from RdDM targets using 3C. 
Both ends of loops are indicated with the closest annotated features. ACTIN2 locus 
serves as a loading control. A representative result from at least two biological 
replicates is shown. 
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Figure 6.3 Repression of chromosome looping to RdDM targets correlates with 
gene silencing 
A) Overlaps between genes with increases or decreases in RNA accumulation in 
nrpe1 and ago4 mutants. * indicates p <0.05. Overlapping genes are used in Figure 
6.3B. 
B) Fraction of genes, which form chromosome loops with AGO4-bound direct RdDM 
targets. Total genes, genes affected in both ago4 and nrpe1 (Figure 6.3A) and random 
permutations of genes are shown. Only genes with detectable looping were included. 
AGO4 binding is defined by AGO4 ChIP-seq signal (Col-0 > 10 reads and Col-0 / 
ago4> 2) at the distant regulatory region. Error bars indicate standard deviation 
between 1000 permutations.  
C) AGO4 binding intensity to proximal and distant regulatory regions. Genes with 
increased expression in nrpe1 (blue) or total genes (grey) were taken and AGO4 
signal was counted on the proximal regulatory regions and distant regulatory regions 
identified by looping detected in the nrpe1 mutant. Dot sizes represent the intensity of 
change in gene expression in nrpe1. AGO4 binding is presented as log enrichment 
(Col-0/ago4) in 250 bp windows. Lines indicate 2 fold cutoffs. 
D) Fractions of genes with RNA levels increased in the ago4 mutant, which show 
AGO4 binding to proximal regulatory regions, distant regulatory regions identified in 
the ago4 mutant or both. AGO4 binding is defined as Col-0 / ago4 AGO4 ChIP-seq 
signal > 2 with more than 10 reads in Col-0 in a 250 bp window.  
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Figure 6.4 RdDM represses looping between genes and their enhancers 
A) Transcription factor (TF) binding to distant regulatory regions of total genes. Bars 
represent numbers of total genes, which create detectable loops in Col-0 to previously 
published binding sites of transcription factors AL5, IBH1, LFY, PIF4, PRR7, SPL7 and 
SVP. The total number of 250bp windows with evidence of TF binding was used to 
calculate the expected numbers. Black bars indicate enrichment of genes which loop 
to TF binding sites relative to the expected number derived from 1000 permutations of 
random regions (grey). Error bars indicate standard deviations between permutations. 
B) Transcription factor binding to distant regulatory regions of genes upregulated in the 
nrpe1 mutant. Values were calculated like on Figure 6.4A except distant regulatory 
regions were identified based on loops deteted in Col-0, nrpe1 or ago4 and only 
transcription factors with evidence of binding to more than 2000 250bp windows were 
included.  
C) Model of gene regulation by RdDM. In wild type plants (top) Pol V (blue) and AGO4 
(yellow) bind to chromatin and help establish repressive chromatin marks at regulatory 
regions. These chromatin modifications then inhibit looping between genes and distant 
regulatory regions. When RdDM is absent (bottom), chromatin looping is able to occur 
between promoters and distant regulatory regions bound by transcription factors 
(orange and green) and thereby increases gene expression. 
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Figure 6.5 Features of the Hi-C datasets and analysis of a second biological 
repeat (supplementary to Figure 6.1) 
A) Numbers of long range ligation events identified in two biological repeats of Hi-C. 
B) Numbers of identified long range ligation events as a function of the interaction 
distance. The Arabidopsis genome was divided into 250bp bins and numbers of 
interactions supported by at least two separate reads and at least more than 3 bins 
apart were plotted as function of the distance between bins (black). Data was then 
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filtered using polynomial cutoffs and plotted (green). 
C) Distances between identified filtered chromosome loops. 
D) Correlation between RNA accumulation and chromosome looping. Genes were 
divided into inactive (0 RPKM) and a range of categories from low to high expression 
(RPKM) in Col-0 (black), nrpe1 (blue), and ago4 (red). The number of genes in each 
expression category that had evidence of long range chromatin interactions were 
plotted as a percentage of each category. RPKM – reads per kilobase per million.  
E) Correlation between RNA accumulation and chromosome looping in a second 
biological repeat. Genes were divided into inactive (0 RPKM) and a range of 
categories from low to high expression (RPKM) in Col-0 (black), nrpe1 (blue), ago4 
(red), and spt5l (brown). The number of genes in each expression category that had 
evidence of long range chromatin interactions were plotted as a percentage of each 
category. RPKM – reads per kilobase per million. Second biological repeat 
corresponding to Figure 6.1D. 
F) Correlation between gene expression and the level of H3K4me2 at distant 
regulatory regions in a second biological repeat. Genes with evidence of looping in 
Col-0 were divided into categories based on the levels of wild type H3K4me2 ChIP-
seq signal normalized to H3 ChIP-seq at distant regulatory regions, and RNA-seq 
signal from Col-0 was plotted. Dashed horizontal line indicates median gene 
expression in the genome. 
G) Anti-correlation between gene expression and the level of H3K9me2 at distant 
regulatory regions in a second biological repeat. Analysis was performed like for (C) 
except that a H3K9me2 dataset was used. 
H) Correlation between histone modifications and the probability of chromosome 
looping in a second biological repeat. Genomic regions were divided into categories 
based on H3K4me2 ChIP-seq signal or H3K9me2 ChIP-seq signal. The numbers of 
regions in each category with detectable long range chromatin interactions in Col-0 
were plotted relative to permutated random genomic regions. ChIP-seq signal for each 
genomic region was normalized to H3 ChIP-seq. 
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 Figure 6.6 RdDM inhibits chromosome looping at RdDM sites (supplementary to 
Figure 6.2) 
A) Comparison of chromosome looping from RdDM target loci in Col-0, nrpe1 and 
ago4 in biological repeat 1. Bars show numbers of RdDM targets with detectable 
chromosome looping in Col-0, nrpe1, or ago4 relative to the wild type level. 
B) Comparison of chromosome looping from RdDM target loci in Col-0, nrpe1 and 
ago4 in biological repeat 2. Bars show numbers of RdDM targets with detectable 
chromosome looping in Col-0, nrpe1, or ago4 relative to the wild type level.  
C) Numbers of sequencing reads supporting chromosome looping to nrpe1 DMRs. 
Numbers in each signal intensity cutoff were normalized to those from total identified 
interactions in each genotype. Loop signal intensity in Col-0, nrpe1, ago4 and 
permutated genomic regions (Random) were plotted as a ratio to values expected over 
the entire genome. 
D) Depletion in chromosome looping to non-centromeric transposable elements (TEs) 
in Col-0 wild type. Chromatin interactions were counted if one side overlapped non-
centromeric TEs or gene promoters. Each category was normalized by the ability to 
map sequencing reads to those regions and calculated as a ratio to permutated 
random regions. Error bars indicate standard deviation of permutations. 
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Figure 6.7 Repression of genes corresponds to RdDM repressed looping 
(supplementary to Figure 6.3) 
Fraction of genes, which form chromosome loops with AGO4-bound direct RdDM 
targets. Total genes and genes increased or decreased in ago4 or nrpe1 are shown. 
Only genes with detectable looping were included. AGO4 binding is defined by AGO4 
ChIP-seq signal (Col-0 > 10 reads and Col-0 / ago4 > 2) at the distant regulatory 
region.  
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CHAPTER 7 
Conclusion 
 
Introduction 
Long non-coding RNA (lncRNA) is a class of molecules where many significant 
functions are known, but actual mechanisms involving lncRNA are currently poorly 
understood. In recent years, as more functions of lncRNA are found, this topic has 
garnered a lot of attention (Figure 7.1). However, despite the increased attention much 
of the current research focuses on the downstream effects of lncRNA and leaves 
molecular mechanisms relatively unexplored. As research connected to lncRNA 
increases, understanding mechanisms involving these molecules becomes ever more 
pertinent. One important role of lncRNA is to direct chromatin modifications to control 
genomic elements such as potentially harmful transposons1,2. The aim of my research 
has been to understand long non-coding RNA specifically pertaining to its function in 
chromatin modification and transcriptional control. 
One reason that progress in understanding mechanisms of lncRNA may be slow 
is the difficulty of genetic studies on this topic. In many organisms, the protein 
responsible for creating lncRNA is also necessary to create messenger RNA (mRNA); 
thus knockout of this protein results in many deleterious effects. In many cases, 
mutations in this protein are lethal to the organism3. In contrast, in Arabidopsis thaliana 
a specialized RNA polymerase is responsible for creating lncRNA, allowing generation 
of viable knockouts3. These knockouts make this system especially advantageous for 
studying molecular mechanisms involving lncRNA. 
Studies of lncRNA show a function in directing chromatin modification2,4. By 
acting as platforms (i.e. scaffolds) for RNA binding proteins, lncRNA helps direct the 
activity of chromatin modifying enzymes2,4. At the beginning of the work presented in 
this dissertation, only a general framework of this process was known. It was shown that 
AGO4 binds siRNA and lncRNA produced by Pol V and that these components are 
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necessary for directing the de novo methyltransferase DRM2, giving this pathway the 
name RNA-directed DNA Methylation (RdDM)1. SPT5L was also shown to be important 
in RdDM, but the exact role of this protein was unknown5. Another protein, IDN2, was 
known to be involved in RdDM, but again the exact role was unknown6. Additionally, 
although RdDM was shown to be able to silence transposons, only a handful of targets 
was discovered7. The goal of my research was to understand the various roles of 
proteins involved in RdDM and to explore other functions of this pathway.  
 
Findings 
RdDM, also known as Transcripitonal Gene Silencing (TGS), functions in 
transposon silencing1,4; however, most transposons are located near centromeres 
where chromatin modifications are maintained independent of RdDM1,8. To investigate 
this contradiction, we examined AGO4 binding sites genome-wide (Chapter 2)8. AGO4 
binds to chromosome arms rather than centromeric regions suggesting that RdDM 
functions outside of centromeric regions. Interestingly, AGO4 targets chromatin directly 
upstream of protein coding genes at what are thought to be regulatory regions (i.e. 
promoters). Sites bound by AGO4 are enriched for de novo DNA methylation. 
Placement of modifications like DNA methylation may alter the accessibility of chromatin 
for transcription factors and could potentially affect gene expression. Indeed, after 
testing several genes that displayed AGO4 binding signal in the promoter, I found gene 
expression changes in the ago4 mutant. It is a novel finding that RdDM not only targets 
transposons in gene dense regions, but that it is involved in gene expression control. 
Many of these genes are part of stress response signaling pathways which suggests a 
function of RdDM in this process. In fact, components of RdDM are shown to be 
important for responding to stressful conditions9,10. Overall, I propose that control of 
these genes occurs by blockage of transcription factor binding, likely through chromatin 
modification.   
This work also discovered a novel function of RdDM in altering chromatin 
structure. Screening for proteins that interact with components of RdDM identified an 
enzyme known to work in nucleosome positioning11. By looking at genome-wide 
nucleosome occupancy, I found nucleosomes whose occupancy is reduced in the pol V 
178 
 
mutant (nrpe1) (Chapter 3)11. We were then able to show that Pol V transcripts are 
bound by IDN2 which is important for placing or stabilizing nucleosomes at RdDM 
targets. These findings clarified IDN2’s role and represents a novel function of RdDM; 
this pathway not only directs DNA methylation and histone modification, but also 
nucleosome positioning. Increasing nucleosome density could be a way in which the 
cell further enhances silencing so that chromatin accessibility to transcription factors is 
even more limited upon nucleosome placement. 
Somewhat like the discovery of IDN2, another protein, SPT5L, was shown to be 
involved in RdDM, but its place in the pathway was unknown5,6. By examining chromatin 
binding of SPT5L in various mutants I found that SPT5L binding to chromatin is 
dependent on Pol V and that SPT5L and AGO4 binding to chromatin is independent of 
each other (Chapter 4)12. Previously SPT5L was proposed to be an intermediate 
between AGO4 and DRM25, but my findings indicate coordinate action of SPT5L and 
AGO4. I also showed that SPT5L differs from AGO4 in that SPT5L binds chromatin 
independent of siRNA. Additionally, I found that the spt5l mutant was necessary for 
DNA methylation only at some loci, which could indicate that the primary role of SPT5L 
lies elsewhere. 
To further investigate the role of SPT5L in chromatin modification, I examined 
SPT5L binding sites genome-wide (Chapter 5). Like AGO4, SPT5L targets chromatin 
directly upstream of protein coding genes. I confirmed that SPT5L and AGO4 bind 
chromatin independent of each other, but also found exceptions to this rule at several 
sites. These loci correlate with feedback to Pol V transcripts, meaning that when Pol V 
transcription is altered AGO4 and SPT5L chromatin binding is affected. Interestingly, 
while AGO4 is necessary for Pol V dependent DNA methylation, defects in the spt5l 
mutant are much less. This minor role in DNA methylation is not due to limited SPT5L 
binding since SPT5L is found at most methylation sites dependent on Pol V. In other 
words, even though SPT5L is bound, methylation does not depend on this protein. This 
could suggest that SPT5L plays a different role than AGO4 in RdDM. When comparing 
the effects of various mutants on DNA methylation, spt5l is very similar to idn2. 
Correlation in the methylation pattern may indicate that these two proteins work 
together, or similarly in this pathway. Due to the finding that IDN2 is involved in 
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nucleosome positioning, I examined genome-wide nucleosome occupancy in spt5l and 
ago4. I found that Pol V dependent nucleosomes are dependent on both AGO4 and 
SPT5L. This clarifies the role of SPT5L in RdDM; SPT5L is more important for 
nucleosome positioning than for directing de novo DNA methylation. 
It is evident that the RdDM pathway alters chromatin in a variety of ways: DNA 
methylation, histone modification, and nucleosome positioning4. Targeting of these 
modifications to regulatory regions occurs in this pathway which can control gene 
expression. Since regulatory regions often take part in long range enhancer-promoter 
interactions13, I investigated whether RdDM is involved in controlling chromatin looping. 
Using genome wide maps of chromatin interactions (HiC)14, I uncovered features of 
chromatin looping which are conserved between Arabidopsis and other eukaryotes15,16 
(Chapter 6). Simply put, genes with active expression are more likely to participate in 
long-distance interactions than inactive genes. Additionally, sites that have active 
histone modifications are more likely to loop than sites with repressive modifications. 
This is particularly intriguing as RdDM helps direct repressive chromatin modifications. 
Indeed, RdDM sites in wild-type conditions mostly do not engage in chromatin looping; 
however, knockout of pol v or ago4 caused looping at these sites to increase. This 
indicates that RdDM modifies chromatin at regulatory regions so that enhancer-
promoter interactions do not occur. When examining genes whose expression is 
controlled by RdDM I saw inhibition of looping in wild-type and increases in looping in 
the pol v and ago4 mutants. Furthermore, these inhibited sites correspond to AGO4 
binding sites indicating that AGO4 binds repressed chromatin interaction sites. Taken 
together these data indicate that RdDM can control gene expression long-distance by 
inhibiting enhancer-promoter interactions. 
 
Implications 
 The finding that non-coding RNA is abundant in the nucleus in many 
eukaryotes19–21 suggests that these molecules have important functions. One of these 
functions is to prevent transposons from causing mutation in the genome22. In addition, 
this work found that long non-coding RNAs in Transcriptional Gene Silencing (TGS) 
have the ability to control gene expression8. It is interesting that many of those genes 
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are linked to stress response pathways8. Having an overarching mechanism for 
responding to environmental stress as well as controlling harmful mutation may allow 
organisms to try to survive harsh conditions, but could also create advantageous 
mutations which help the species as a whole adapt and survive. Indeed transposons are 
thought to drive evolution by reshuffling genomic sequences22,23. Thus TGS may reign 
in mutation when it is not needed, but could release transposon control upon 
environmentally stressful conditions and thus increase mutagenic potential. 
 In addition to transposon control, investigating transcribed non-coding regions of 
the genome can increase our understanding of the coding regions of the genome. RNA 
Pol V and Pol II recently diverged in Arabidopsis and, though functionally separate,  
share several subunits3. Similarities between these RNA polymerases may allow 
insights from pol v knockouts to be applied to Pol II. Aside from transcription, SPT5L, 
involved in TGS / RdDM, is similar to the Pol II transcription factor, SPT55. Like that of 
Pol V, details of SPT5L’s role in RdDM may provide insights into SPT5.  
 Although investigation of gene expression is important, understanding 
mechanisms of RdDM is important in its own right. This has particular implications in 
early human development when de novo chromatin modifications are established1,24. 
Additionally, chromatin modifications are important features to consider for the 
generation and study of stem cells and investigating components of RdDM may improve 
studies in these fields25. 
 In addition to these wider implications, the finding that SPT5L plays less of a role 
in DNA methylation, but more in nucleosome positioning further resolves the model of 
RdDM. The role of SPT5L in RdDM has been in question for years since its discovery; 
its position and function in the pathway have been mysterious5. By answering these 
questions, this work has filled in missing pieces and led to a greater understanding of 
the RdDM mechanism. 
 Perhaps even more intriguing is the role of RdDM in influencing chromatin 
looping. These findings indicate that chromatin modifications control gene expression 
long-range by altering enhancer-promoter interactions. This could suggest a link 
between lncRNA and insulator proteins. This notion is especially enticing in light of the 
finding in many organisms that even active enhancers often have lncRNA26. The role of 
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lncRNA in chromatin looping is a novel field of study and may provide dramatic insights 
into three dimensional genome organization and gene expression control. 
 
Limitations 
 This research is meant to be applicable to a wide range of fields studying gene 
expression and/or chromatin modification. The Transcriptional Gene Silencing (TGS) 
pathway has many elements conserved across a broad range of species1,27. Certainly, 
transposon silencing is important for nearly all eukaryotic organisms27,28. However, the 
low transposon level in Arabidopsis thaliana is used to argue that this plant has been 
more successful than most at limiting transposition28, which could mean that differences 
in TGS exist between Arabidopsis and other organisms. This is fully acknowledged and 
is seen by the separation of lncRNA production from mRNA production by Pol V and Pol 
II respectively in Arabidopsis3. Although differences may occur, Arabidopsis is a leading 
model organism in this field and knowledge from plants has been essential for insights 
into transposon and chromatin control in humans1,4. Despite the differences, general 
principles discovered in plants have greatly advanced our understanding of non-coding 
RNA in humans1,27. 
 Much of the research presented here utilizes genome-wide studies to explore 
transcriptional silencing mechanisms. While this provides overall pictures of what is 
happening in the genome, locus variability can, and likely does occur. These individual 
loci may be functionally significant and merit further study; however, by generating 
these publicly available genome-wide maps, future studies of individual loci are greatly 
facilitated. These data should be used to illustrate genomic trends, but also to examine 
individual sites of interest. 
 Locus variability should especially be considered due to the finding that SPT5L 
binding and the effects to chromatin can vary significantly. While this variability may be 
explained by feedback between RdDM components, the cause of this feedback at some 
loci and not at others merits further investigation. These locus specific effects of SPT5L 
could explain why some RdDM targets have variations in their downstream effects on 
histone modification and gene expression12,29. 
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 In proposed models of TGS / RdDM, gene expression is controlled by inhibition 
of transcription factors or Pol II binding to chromatin8. It is likely that this occurs because 
of the chromatin modifications placed at RdDM targets, but direct inhibition by 
components of RdDM is possible. Likewise, control of chromatin looping may be 
through chromatin modification or through direct interference by RdDM components. 
Alternately, unknown proteins could be targeted to these loci dependent on RdDM and 
control expression. In essence, this work resolves much of the mechanism and function 
of RdDM in gene expression control, but we are only beginning to understand the 
connection between these two processes.  
 
Future Directions 
 This work represents the first to implicate RdDM in chromatin looping and is one 
of the first to study the three dimensional genome organization of plants. Much more 
about long distance gene expression control is known in other organisms15,16, thus 
studying the role of TGS / RdDM in these organisms may provide further insights into 
long-distance gene expression control. In other systems, lncRNA has been found at 
active enhancers which engage in chromatin looping important for gene expression26,30 
which suggests that lncRNA may have a larger role in genome organization than just 
TGS. Examining the role of these lncRNAs in chromatin looping and their relationship to 
insulator proteins may yield novel insights into gene expression control.  
Identifying enhancer RNAs in Arabidopsis is also interesting and would allow a 
more direct comparison to lncRNAs involved in transcriptional silencing. Comparing 
these two functions could indicate what causes lncRNA to be either activating or 
silencing2,26. Discovery of ncRNAs involved in gene expression control could help 
identify Arabidopsis regulatory regions, which have typically been difficult to define. 
Once markers of regulatory regions are defined, manipulation of gene expression will be 
easier and locus specific studies can be performed in the correct context. 
Although the data indicate involvement of RdDM in controlling chromatin looping 
at enhancers, very little is known of what specifically drives genome organization. In 
many eukaryotes, regions of the genome cluster to form topologically associated 
domains (TADs)15,31; however, TADs are not found in Arabidopsis or yeast. On the other 
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hand, these organisms do engage in long distance enhancer-promoter interactions 
(Chapter 6)32,33. TADs and other chromatin loops are thought to be mediated by 
insulator proteins34, yet insulator proteins in Arabidopsis and yeast have not been 
identified. Identifying these proteins and resolving their relationship to RdDM or lncRNA 
would greatly advance this field. 
Some insulator proteins in other systems have been found to avoid or rearrange 
nucleosomes35. It is suggested that nucleosome positioning is an important feature to 
consider in regards to chromatin looping36. Since two functions of RdDM identified in 
this work are nucleosome positioning and inhibition of chromatin looping, a connection 
between the two may exist. Future work should investigate nucleosome occupancy in 
regards to chromatin looping.  
 
Concluding Remarks 
 From this work several genome-wide data sets have been made publicly 
available, including gene expression data in several mutants, nucleosome occupancy 
maps, chromatin binding locations of SPT5L and AGO4, as well as some of the first 
long distance chromatin interaction maps in Arabidopsis (see Appendix G, Table 7.1). 
While these data have been used to gain insights in TGS / RdDM, the scientific 
community can benefit from them in the future. 
The aim of this work has been to understand the mechanism and functions of 
RdDM in transcriptional control. The main findings support a model where coordinate 
binding of SPT5L and AGO4 direct nucleosome positioning at transposons and 
regulatory regions. This pathway then inhibits regulatory regions from chromatin looping 
in order to control gene expression. These novel functions represent ways in which 
lncRNA can act in the genome and have changed the way we think of Transcriptional 
Gene Silencing. 
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Figure 7.1 Publications about long non-coding RNA by year 
As the abundance of long non-coding RNA in the genome is becoming increasingly 
evident, interest in these molecules is rising. Numbers of publications searchable for 
the term long non-coding RNA or some variation thereof are shown for each year.  
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APPENDIX A 
Supplemental Information for Chapter 1 
 
Table 1.1 Abbreviations 
Abbreviation Full name Notes 
AGO4 ARGONAUTE 4 
Binds siRNA and lncRNA 
and helps direct chromatin 
modifications. 
CMT3 CHROMOMETHYLASE 3 
Maintenance 
Methyltransferase in CHG 
context. 
DMS3 
DEFECTIVE IN MERISTEM 
SILENCING 3 
Part of the DDR complex 
important for Pol V binding to 
chromatin. 
DMS4 
DEFECTIVE IN MERISTEM 
SILENCING 4 
May help Pol V bind to 
chromatin. 
DRD1 
DEFECTIVE IN RNA-DIRECTED 
DNA METHYLATION 1 
Part of the DDR complex 
important for Pol V binding to 
chromatin. 
DCL3 DICER-LIKE 3 
Cleaves dsRNA into 24 nt 
siRNA. 
DNMT1 DNA METHYLTRANSFERASE 1 
Maintenance 
Methyltransferase in 
humans. 
DNMT3B 
DNA METHYLTRANSFERASE 3 
BETA 
de novo Methyltransferase in 
humans. 
DRM2 
DOMAINS REARRANGED 
METHYLTRANSFERASE 2 
Places de novo DNA 
methylation. 
dsRNA double stranded RNA Often cleaved into siRNA. 
H3Ac Histone 3 Acetylation 
Generally a mark of active 
chromatin. 
H3K9me2 Histone 3 Lysine 9 di-methylation 
Generally a mark of inactive 
chromatin. 
HOTAIR HOX ANTISENSE INTERGENIC RNA 
Well studied lncRNA 
involved in guiding chromatin 
modifications. 
HEN1 HUA ENHANCER 1 Methylates small RNA. 
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IDN2 INVOLVED IN DE NOVO 2 
Interacts with SWI3B to help 
position nucleosomes. 
lncRNA long non coding RNA 
Used as structural 
components, diversions, or 
scaffolds for proteins. 
MET1 METHYLTRANSFERASE 1 
Maintenance 
Methyltransferase in CG 
context. 
miRNA micro RNA 
21 nucleotide product 
important for Post 
Transcriptional Gene 
Silencing. 
NRPD1 NUCLEAR RNA POLYMERASE D 1 Largest subunit of Pol IV.  
NRPE1 NUCLEAR RNA POLYMERASE E 1 Largest subunit of Pol V.  
Pol II Polymerase II 
Polymerase important for 
messenger RNA. 
Pol IV Polymerase IV 
Creates lncRNA as 
precursors for siRNA. 
Pol V Polymerase V 
Creates lncRNA as scaffolds 
for protein binding. 
RDR2 
RNA-DEPENDENT RNA 
POLYMERASE 2 
Creates dsRNA from Pol IV 
transcripts. 
RdDM RNA-directed DNA Methylation Another name for TGS. 
RDM1 
RNA-DIRECTED DNA 
METHYLATION 1 
Part of the DDR complex 
important for Pol V binding to 
chromatin. 
SHH1 
SAWADEE HOMEODOMAIN 
HOMOLOG 1 
May help recruit Pol IV to 
chromatin. 
siRNA small interfering RNA 
24 nucleotide product which 
binds AGO4 and can direct 
silencing. 
SUVH2 SU(VAR)3-9 HOMOLOG 2 
May help Pol V bind to 
chromatin. 
SUVH9 SU(VAR)3-9 HOMOLOG 9 
May help Pol V bind to 
chromatin. 
SPT5 SUPRESSOR OF TY INSERTION 5 
Helps guide Pol II through 
nucleosomes. 
SPT5L / 
KTF1 
SUPRESSOR OF TY INSERTION 5 - 
LIKE / KOW DOMAIN CONTAINING 
TRANSCRIPTION FACTOR 1 
Binds chromatin dependent 
on Pol V and helps guide 
chromatin modifications. 
SWI/SNF 
SWITCH/SUCROSE 
NONFERMENTABLE 
Proteins important in 
nucleosome remodeling. 
SWI3B SWITCH3B 
Part of a complex important 
for nucleosome positioning 
TAD Topologically Associated Domain Distinct clusters of looped 
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DNA with similar chromatin 
features. 
TF Transcription Factor 
Proteins which bind DNA 
and influence transcription. 
TGS Transcriptional Gene Silencing 
Important for transposon 
silencing and gene 
expression control. 
TSS Transcriptional Start Site 
The environment near the 
TSS can impact gene 
expression. 
UHRF1 
UBIQUITIN-LIKE CONTAINING PHD 
AND RING FINGER DOMAINS 1 
Recognizes hemimethylated 
DNA. 
Xist X-inactive specific transcript 
lncRNA involved in X-
inactivation. 
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APPENDIX B 
Supplemental Information for Chapter 2 
 
Supplemental Materials and Methods 
Chromatin Immunoprecipitation 
ChIP was performed as described 1 with slight modifications. 3 grams of 2-3 
week old seedling tissue was harvested and crosslinked with 0.5% formaldehyde for 2 
min followed by 8 min vacuum infiltration.  Glycine was added to 80 mM and vacuum 
reapplied for 1 min then 4 min. Crosslinked tissue was rinsed with water and frozen in 
liquid nitrogen. Nuclei were extracted by grinding frozen tissue into powder using a 
mortar and pestle, suspended in 25 ml of Honda Buffer (20 mM HEPES-KOH pH 7.4, 
0.44 M sucrose, 1.25% Ficoll, 2.5% Dextran T40, 10 mM MgCl2, 0.5% Triton X-100, 5 
mM DTT, 1 mM PMSF, 1% plant protease inhibitors (Sigma)), filtered through two 
layers of Miracloth and centrifuged at 2000 x g for 15 min. Nuclear pellets were washed 
three times with 1 ml of Honda buffer, resuspended in Nuclei Lysis Buffer (50 mM Tris-
HCl pH 8.0, 10 mM EDTA, 1% SDS, 1 mM PMSF, 1% Plant Protease Inhibitors from 
Sigma) and DNA was fragmented to the average size of 250 bp by 8 pulses of 
sonication each 10 seconds long with 1 minute pauses in between pulses using Fisher 
Scientific 100 Sonic Dismembrator at power setting 1. After centrifugation at 15,000 x g 
for 10 min, the supernatant was diluted 10-fold with 1.1% Triton X-100, 1.2 mM EDTA, 
16.7 mM Tris-HCl pH 8.0, 167 mM NaCl. 50 µl Dynabeads Protein A (Invitrogen) and 
the appropriate antibody were added and samples were incubated for 8 h at 4 ˚C on a 
rotating mixer. Bead-antibody complexes were washed 5 times, 5 min each, with 
binding/washing buffer (150 mM NaCl, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 1% Triton 
X-100, 0.1% SDS, 1 mM PMSF and twice for 5 min each with TE. Samples for ChIP-
seq were eluted with RIP elution buffer (100 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% 
SDS) for 20 min at 65 ˚C and were digested with 20 μg of proteinase K (Invitrogen) 
overnight at 60 ˚C. An equal volume of phenol/chloroform/isoamyl alcohol pH 6.7 
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25:24:1 was added to extract DNA, followed by addition of an equal volume of 
chloroform/isoamyl alcohol 24:1 and subsequent precipitation by addition of 2 volumes 
100% EtOH, 0.1 volume 3 M Sodium Acetate and 4 µl Glycoblue (Ambion). Precipitated 
samples were washed once with 70% EtOH and resuspended in 30 µl TE. Other ChIP 
samples were eluted using 100 μl of 10% (w/v) Chelex (Bio Rad) resin, in water, added 
to the beads and crosslinking was reversed at 99 ˚C for 10 min. Samples were digested 
with 20 μg of proteinase K (Invitrogen) for 2 h at 60 ˚C followed by heat-inactivation at 
95 ˚C for 10 min. ChIP samples were amplified in triplicate in Applied Biosystems 7500 
real time PCR machine and obtained data were analyzed using comparative Ct relative 
to inputs. All ChIP-real time PCR experiments were replicated in two or three 
independent biological repeats, which yielded very similar results. 
ChIP-seq library construction 
All ChIP-seq libraries (6 total; Col-0, ago4, and nrpe1 ChIP and input samples) 
were prepared according to the Illumina ChIP-seq library preparation protocol. 
High-throughput sequencing 
All ChIP-seq or input libraries were sequenced using an Illumina Genome 
Analyzer IIx at the University of Michigan DNA Sequencing Core as per manufacturer's 
instructions for 80 nt single-end sequencing. 
Pre-processing and mapping of sequencing reads 
In essence, all reads were pre-processed and mapped to the Arabidopsis 
genome using a pipeline as previously described 2 with slight modifications. The 
detailed procedures are described below: 
Trimming of 3'-adaptors.  
All raw reads were aligned to the Illumina Genomic DNA 3'-adaptor sequence 
using cross-match program from Phrap package 
(http://www.phrap.org/phredphrapconsed.html#block_phrap), and those with ≥10 nts of 
alignment at the 3'-end with ≤10% mismaches were subsequently trimmed at the 
insert/adaptor junctions. Reads without detectable 3'-adaptors were also kept un-
changed for subsequent processing. 
Reducing to NR-tags.  
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Both trimmed and untrimmed reads were reduced to non-redundant (NR) tags by 
collapsing reads with identical sequences; the goal of this step is to save processing 
time and space requirements. The clone-number for each NR-tag was also recorded 
and is then used for all subsequent analysis. We will use the term “read” and “NR-tag” 
interchangeably hereafter. 
Mapping to Arabidopsis genome.  
The trimmed and untrimmed reads were mapped to Arabidopsis thaliana genome 
(TAIR9 assembly) independently using the Bowtie program 3, with parameters tuned to 
allow ≤6% of seed mismatches (using 34 nt seeds), ≤8% of total mismatches and all 
valid alignments are reported. A subsequent parsing step was implemented to enforce 
these restraints, as well as to require insert lengths of ≥15 nt or ≥30 nt for the trimmed 
and untrimmed reads, respectively. It is of importance that the actual “insert length” for 
untrimmed reads was determined according to their alignments, by implementing a one-
dimensional dynamic programming algorithm that could identify the most possible 
insert-fragment length based on output from Bowtie. Finally, we filtered only “best-
stratum” alignments that contain ≤4% more mismatches compared to the best-hits for 
any given read. 
Summary of mapping and clone-number information.  
All mapped trimmed and untrimmed reads (NR-tags) were combined and their 
mapping and clone-number information was recorded. All of these data were loaded 
into a local MySQL database for subsequent fast queries. 
Calling AGO4-bound peaks 
To call AGO4-bound peaks (AGO4 binding regions) using our ChIP-seq data, 
input tables were prepared in which genome coordinates and weighted clone-number 
were included for all 6 libraries (ChIP and input for Col-0, ago4, and nrpe1 plants). The 
weighted clone-number is defined as ( / )i i iW round C L , where the Wi, Ci and Li is the 
weighted clone-number, raw clone-number and number of mapped loci for a given NR-
tag i. It is of note that by using weighted clone-numbers, we have the advantages of 
allowing non-uniquely mapping reads and the non-biased estimation of their clone-
abundance. This step is necessary because AGO4 is thought to target heterochromatin 
and repetitive elements in Arabidopsis. 
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We then called different sets of peaks using the CSAR 4 R package, with non-
default parameters set as: w = 250, considerStrand = "Sum", uniquelyMapped = 
FALSE, backg = 0, norm = 2e10. Taken together, these parameters extend all mapped 
reads up-to 250 nt (average size of the ChIP-seq fragments used to construct the 
sequencing libraries), merge them from both strands, normalize, and finally call AGO4-
bound peaks. All calls required significant fold-enrichment between test and control with 
FDR < 0.05; the FDR was achieved by randomly permuting the mapped reads from test 
samples 10 times using the CSAR 4 package. As a result, 5 sets of peaks were called: 
A = Col-0 ChIP vs. Col-0 input 
B = ago4 ChIP vs. ago4 input 
C = nrpe1 ChIP vs. nrpe1 input 
D = Col-0 ChIP vs. ago4 ChIP 
E = nrpe1 ChIP vs. ago4-ChIP 
The A, B, C peak sets are traditional ChIP against input calls and D, E sets are 
“direct-comparison” peaks using the ago4 null mutant sample that were included in this 
study to eliminate effect of non-specific binding of DNA to the AGO4 antibody. We then 
defined Pol V-dependent and Pol V-independent peaks using the following “peak-
arithmetic”. Specifically, Pol V-dependent peaks are defined as F – G and Pol V-
independent peaks are F∩G, where F = (A – B)∩D and G = (C – B)∩E. This peak-
arithmetic was designed to identify high-quality peaks enriched for both ChIP vs. input 
and WT vs. mutant comparisons and minimize the effects of non-specific interactions. 
All the peak-arithmetic was performed using BEDTools 5, with the overlapping 
proportion being no less than half (-f = 0.5) of the peaks being compared. 
Filtering Pol V-dependent and Pol V-independent peaks 
Our ago4 mutant plants were originally identified 6 in the Landsberg (Ler-1) 
ecotype of Arabidopsis, which was subsequently back-crossed to Col-0 plants for 3 
successive times. As a consequence, the ago4 plants could still contain some 
proportion of the genome that originates from Ler-1, and thus the calling procedure of 
Pol V-dependent and Pol V-independent peaks could include ecotype biases. 
Therefore, we further filtered out peaks that could originate specifically from Ler-1. In 
essence, any peak that either 1) cannot be mapped to Ler-1 draft genome (Ler-1 
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unmappable) or 2) can be better mapped to Ler-1 draft genome (Ler-1 better mapped) 
was recognized as potentially originating from Ler-1, and thus discarded from further 
analysis. More specifically, we first pulled out all raw reads as well as their qualities (in 
FASTQ format) in all called Pol V-dependent or Pol V-independent peaks, then re-
mapped them to both the Col-0 genome and Ler-1 draft genome as described above. 
Only the ago4 ChIP library was used as a proxy for this analysis. It is of note that we 
used the “standard” assembly of the 2011-08-25 release of the Ler-1 genome from the 
1001 genomes project (http://1001genomes.org/), which was in draft status and still 
lacked a significant portion of the genome compared to the Col-0 genome sequence 
(TAIR9 assembly). We also re-mapped the reads to Col-0 genome while retaining read 
quality information, so that the mapping quality between the Col-0 and Ler-1 genomes 
for any given read could be better distinguished. All mapping criteria were kept identical 
as described above. By comparing the alignments for the Col-0 and Ler-1 genomes for 
each read, we defined “Ler-1 unmappable peaks” as those that contain <50% reads 
mapping to Ler-1 genome relative to Col-0, and “Ler-1 better mapped peaks” as those 
that contain more reads that can either exclusively or better map to Ler-1 compared to 
the Col-0 genome. A read is deemed as “better mapped” to a genome if the best hit to 
that genome contains fewer mismatches, and if it is a tie (same number of mismatches) 
they are further resolved by comparing the total quality scores over all mismatch sites.  
Sampling of random peaks as negative controls 
To generate negative control peaks (NC-peaks) for our analysis, we randomly 
sampled genomic regions from the Col-0 genome, with the same number and size-
distribution as the filtered Pol V-dependent peaks, and this sampling was repeated 1000 
times. All described analyses were based on these same sets of NC-peaks. 
Partitioning the Pol V-completely dependent and Pol V-partially dependent peaks 
To distinguish the AGO4 peaks that are completely-dependent from those that 
are partially-dependent on Pol V activity, we calculated the total number of reads within 
all Pol V-dependent peaks for all ChIP samples, then plotted the log-odds of enrichment 
for Col-0 ChIP vs. ago4 ChIP against nrpe1 ChIP vs. ago4 ChIP on a scatter-plot (Fig. 
1C). The Pol V-completely dependent peaks were defined as those with less than 2 fold 
enrichment when comparing nrpe1 ChIP vs. ago4 ChIP (|abs(log-odds)| < 1), whereas 
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Pol V-partially dependent peaks were defined as all of the remaining peaks. This 
partitioning of peaks is based on the assumption that Pol V-completely dependent 
peaks should show no significant difference in clone-abundance between nrpe1 and 
ago4 samples. As expected, most Pol V-dependent peaks are completely dependent, 
and we didn’t separate these peaks in further analyses for convenience, since partially 
dependent peaks are an insignificant fraction of the total AGO4 peaks. 
Classification and annotation of AGO4 peaks 
All AGO4-peaks were classified according to their genomic coordinates 
compared to known genetic elements on the Arabidopsis genome using the GFF 
annotation file downloaded from TAIR9 FTP repository for varies kinds of elements, 
including protein-coding genes (exons and introns), rRNAs, tRNAs, miRNAs, snoRNAs, 
snRNAs, ncRNAs, pseudogenes, and transposable elements (TEs). We also defined 
gene promoters as the upstream 1 kb regions of the transcription-start sites (TSS) of 
protein-coding genes. Additionally, we also searched the Arabidopsis genome (TAIR9 
assembly) for more repetitive elements using the RepeatMasker program 
(RepeatMasker-open-3.2.8) (http://www.repeatmasker.org) with the repeat libraries from 
RepBase (release14.06) 7. We used the RepeatMasker annotated repeats because the 
TEs annotated by TAIR don't have detailed class or family information. Other than the 
TEs, the RepeatMasker (RMSK) program could also identify repeat-rRNAs (RMSK-
rRNAs) and tandem-repeats (RMSK-TRs). 
To fast classify AGO4 peaks, we implemented a Java program that indexes 
various kinds of elements of the whole genome with bits. To produce a detailed 
annotation of the identified AGO4 peaks, all above genetic elements were loaded into 
the MySQL database and searched for overlapping ones for every AGO4 peak. As a 
control, all the NC-peaks were also classified and annotated as described for the AGO4 
peaks, and the p-values of enrichment or depletion of specific categories were 
estimated using a bootstrapping method based on the 1000 sets of NC-peaks. 
Characterizing smRNA profiles near AGO4 peaks 
We downloaded published smRNA-IP and total smRNA datasets 8 for both AGO4 
and AGO1 from Arabidopsis seedlings (accession: GSE28591) for our analysis. Raw 
reads were dumped from the NCBI SRA, processed, and mapped to the Arabidopsis 
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genome as described for our ChIP-seq libraries. Then smRNA-IP or total smRNA reads 
were searched within the AGO4 peaks as well as their flanking regions (2 kb of both 
upstream and downstream), and the base-wise coverage for every peak was 
determined for 24 nt and 21 nt reads, respectively. Finally, the coverage values were 
normalized by the total mapped reads of each specific sized library, and averaged 
across all AGO4 peaks. 
Characterizing cytosine methylation in AGO4 peaks 
To characterize the cytosine methylation (mC) in AGO4 peaks, we used the 
published single-nucleotide mC datasets 9 provided by Dr. Ryan Lister. The original mC 
site coordinates were based on the TAIR8 assembly, so we transformed them into 
TAIR9 coordinates using the Perl script provided by TAIR. The mC sites were searched 
within all AGO4 peaks as well as NC-peaks, and the mC density was calculated and 
compared between AGO4 peaks and NC-peaks for CG, CHG and CHH methylation 
types or altogether. We also used the recently published single-nucleotide mC datasets 
10 to directly compare the mC density between Col-0 and nrpe1 mutant plants. It is of 
note that in this comparison a corresponding Col-0 wild type dataset was used. 
Characterizing the class and family of transposable elements in AGO4 peaks 
To get the class and family summaries for the TEs in AGO4 peaks, we extracted 
all unique overlapping TEs and grouped them into different classes or families based on 
the RepeatMasker annotation information (described above). TEs annotated by TAIR 
were not included in this analysis.  
Displaying the chromosome-distribution of AGO4 peaks 
All AGO4-peak coordinates were plotted against their sizes for all 5 
chromosomes; the reference gene-density and TE-density were calculated by dividing 
the chromosome into 100 kb bins. Only protein-coding genes were used for calculating 
the gene-density; both the TAIR annotated and RepeatMasker annotated TEs were 
used for calculating the TE-density. 
Characterizing AGO4 binding profiles around TSS 
The log fold-change profile of ChIP-seq reads between Col-0 and ago4 samples 
was generated using the CEAS program 11 with relative positions to the TSS of all 
protein-coding genes. 
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Characterizing nucleosome profiles around AGO4 peaks 
To characterize the nucleosome profiles, we used published MNase-seq 
datasets 12 from NCBI GEO (accessions GSE21673, GSM543296), and merged raw 
reads from all 6 replicate runs. The MNase-seq reads were mapped to the Arabidopsis 
genome using Bowtie using the same parameters as described for our ChIP-seq 
libraries, with the exception that we only kept uniquely mapping reads. The log fold-
change profile of MNase-seq reads between Col-0 and ago4 samples were generated 
using the CEAS program 11 with relative positions to the TSS of all protein-coding 
genes. Well-positioned nucleosomes were then called as previously described 13, and 
the nucleosome-density profiles were determined near all AGO4-peaks or for only 
promoter overlapping peaks, respectively. It is of note that all mapped MNase-seq reads 
were extended to 147 nt before calling the well-positioned nucleosomes, which is the 
known average nucleosome size for eukaryotic genomes. 
Identification of enriched biological processes in the genes whose promoters are 
bound by AGO4 
To identify significantly enriched biological processes for AGO4-bound 
promoters, the corresponding gene IDs (TAIR AGI) of these promoters were extracted 
and subjected to the GOEAST online Batch-Genes analysis tool 14 with an FDR < 0.05, 
and other parameters set as default. 
Identification of overlaps between AGO4 binding and regions of differential DNA 
methylation 
DMRs identified by Dowen et al. (2012) were overlapped with AGO4 peaks using 
PeakAnalyzer 15. p-values were derived from 1000 random permutations. 
Detection of Pol V-dependent transcripts 
Total RNA was isolated from 100 mg 2.5 weeks old seedlings (Col0, nrpe1, ago4) 
using the Plant RNeasy Mini kit (Qiagen) including on-column DNase treatment. To 
remove any potential residual DNA, 1 unit of Turbo DNase (Ambion) was added to 1 µg 
of total RNA and heat-inactivated after incubation at 25°C for 15 minutes. For cDNA 
synthesis, 500 ng of the DNase-treated RNA were converted to cDNA using the 
Random Primer Mix (NEB) and Superscript III Reverse Transcriptase (Invitrogen) 
following manufacturers' instructions. To detect potential contaminations by genomic 
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DNA, we also prepared control samples lacking reverse transcriptase. Subsequent real 
time PCR reactions were performed using Platinum Taq (Invitrogen) on a Bio-Rad CFX 
Connect Real-Time System. 
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Table 2.1 Oligonucleotides used in chapter 2 
Locus Application Primer 1 Primer 2 
ACTIN 
ChIP-qPCR, 
qRT-PCR 
GAGAGATTCAGATGCCCAGAAGTC TGGATTCCAGCAGCTTCCA 
AT1G12700 
ChIP-qPCR CTTCCCCACCAAATGAATGTT GAAACCAATACTACTGATGGAGATGC 
PCR CTACAAACATCCATGGAGACG AAATATGACATGTGACACGAGGA 
AT1G12730 
ChIP-
qPCR,qRT-
PCR 
GGATTTAACGACATTTTTCCCTTCA GGCTTAGGGCCCGTAACTAATAAAT 
PCR GACTTAACGACGCGTATAATGTGG TGTGTGAATTAGCGAAACTTGTCA 
AT1G19400 PCR CCTCGGATCTTTGGAGCATT TTTCTTGGAGCTTTCACATCTGTT 
AT1G27770 ChIP-qPCR GAAATTTTTACAAAAGTAGACGAAAAA TTTGACAAACAATGAGAGCAAATC 
AT1G35160 PCR TTGCTCAATCAACAGAAATTACAAAA TGAAAAAGGTGGAGAAAGAAAGAGA 
AT1G49490 PCR TGAGGCTAAAATGATGATAAAATCCA AACCATGTCTCTGCATATTCAATC 
AT1G51805 PCR CTTGGAGCAATCATTTTATGGTTTT TAAACCAATGATTGAATGACAACTGTG 
AT1G54120 
ChIP-qPCR GGTTCGATTCCTGACCACCA TAAGGGTCCCCTGGAACTGG 
PCR AAACCCAGGCATCGTGGTCT TTTATAATTTAGTGTCCTGACCACACA 
AT1G55535 PCR TCCAAGATTGAGGCCAAATTA AAAAGGAGTGGCCAAGTTGGAA 
AT1G56090 
ChIP-qPCR CGCCCGTGTATTTGTTTTCG TGCCTAAACGTGTCACATTCC 
qRT-PCR TCCAGTGAAGAAGAAGACGATGAA GAGGTGGCGACTCATCACTG 
AT1G66580 
ChIP-qPCR, 
qRT-PCR 
ATGTGGATGGATTTGTTAACCCTCT GAAGAACGAAGAACAATGTGTTGAC 
AT1G67120 
ChIP-qPCR TTTTAAAAAGTTCGGTTTCCTTC TCTCTGAAAGATGAAAGAGAGAGAAG
A 
AT1G79120 ChIP-qPCR TAGATAGTTTTCTTCTCGTCGAACTCA GAAGCAACAATGAGTCCCCTGT 
AT1TE36560 
ChIP-qPCR TCGATGACAGTCGATAACTCATTTT AAATCTCTATCCATTGCACATGCTC 
PCR CATTTTAGAGCATGTGCAATGGA CCAATAACCAAACGGTTAACCAAA 
AT1TE73075 ChIP-qPCR GAACCTCTCTCTATCTCCTTCATTTTT TCAATGAGATACTCTCCCACTAGAA 
AT2G01735 PCR CAAATCTGAAGTCGAACCCAAAA GTCGGATTCGGGTAAAATTCG 
AT2G21840 
ChIP-qPCR CGAGCTTCACTTTTGGGAGTTC CGATATCCAAACCCATAATTGACC 
qRT-PCR TTCGAGGGTGACTCGAGCTT TCCGTAGAACGACACACCACA 
AT2G30740 ChIP-qPCR AATCGTCTTCCCCGCGGTTT TGCTTGATGATGAAGACGGAGA 
AT2G36490 
ChIP-qPCR, 
qRT-PCR 
CGTTTGTTTATGTAGGGCGAAAG TAAAACTTTTCCCGCCAACCA 
qRT-PCR GGAAACATGTCCAGCGCTTT TGGAAGAGAAGCAGTTTCAGCA 
AT2G46130 ChIP-qPCR AGGAGAGAAGGAGAGTTAAATTTCTCG GTGATTACACCTGTCCAATCATCC 
AT3G06410 PCR ACGAACCAGAGGGCTCATTG TGGATCTTGTGCTATGCTCCAA 
AT3G27690 
ChIP-qPCR TTGGTCTTTGTTTCAAAGTACACATGA GCGCTAACATTTGGGGTACG 
PCR TTGATGATGCTTACCCATATAAATGTT TGGATGAGGTGTTATTCCAAAAATG 
AT3G28100 
ChIP-qPCR TGGTCCGTTTAACGTCCAAT GACCGTTCATTAAACCCCAAAA 
PCR ACTAATAAGGTGTCAAGTGGTCCGTTT TGGCTTTACGAGTTTCATGACTCC 
AT3G30380 PCR GAGGGAAAGATGATCCGTCAA TGCACAAAATGACTATGAATTGTAAA 
AT3G46700 ChIP-qPCR CCGGTAATTCCGCTAAAAACAA TTGTCTCCTTTGAAAGATTATGGAA 
AT3G48131 
ChIP-qPCR TCAGTTGCAAGAAGACGACGA TGGGCTATAAAGAGGCCCAAT 
qRT-PCR TGCGATCATGTGTTTTCTCTTTTC GCAAATCGATCTTCACAACGAA 
PCR GGCAACAAGAAGTAGAGCAAATCG AAAAAGGAATGTGGAGAGATGAAA 
AT4G08310 PCR GGGTCGGGTTCGGTTAAAA CAAACCCGAACCCAAAACTAAA 
AT4G10570 ChIP-qPCR CGTTTTCTTAATATTTGTATTTTTCC TGCTTCTGTTCCTTTTTGTTTGA 
AT4G11330 ChIP-qPCR TCTGGAAATTCAAACTCAAAGACC GTGGATCCCGCCTCTAGAAAA 
AT4G31770 PCR ATGCCAACGTTGACTCACGA TCATGAGTTTGGGAATGGTTTT 
AT4TE23930 ChIP-qPCR GGCTGGTGCAACGTGATATG CTGGCTAGGTCGACCGGGTA 
AT4TE36990 PCR GAACATGAGATGTAATCAAGGGCATA TTGAATATTTGTGGCATAACATGGA 
AT5G01225 PCR TTCTCATTCAAATTTTCTTGTTTGACA GGAGCATAGCACAAGGTCCAA 
AT5G07250 PCR CCGGTTTTTGTGGTACGTGTT GGGTATCAAGTCCAGAAGTTTAGACA 
AT5G18640 ChIP-qPCR TCGAGTTTTGATTATTGTAAGGGTTT GAGGGTCCCAATTTGTTTGTC 
AT5G19257 ChIP-qPCR TCCATATAAAGAGAAACCGAGTAGGG AACCACGGTTTTGTAGGGTTTTT 
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PCR TTCAAAGATGGAGTTTCACGTGTC CGACTTCCGTAACACCCATT 
AT5G27860 PCR TGGAAAAGAATTGAGAGAATGATCTTG TTCAACCTTTGTTGTTTATTTGTCCA 
AT5G28620 PCR TTGACCAATTATATTTCACCACA TGCCATATGTTCTTTTCTTCTGA 
AT5G52070 
ChIP-qPCR CATCTGATTCTTAACACCACCTACTCA ATGTCCTGAGCTGCCACGTT 
qRT-PCR TTGAAGCTGCTGTGTTGGACA CCAATCAATTCGAACGATAAGCTC 
PCR GACTTAACGACGCGTATAATGTGG TGTGTGAATTAGCGAAACTTGTCA 
AT5G58510 PCR AGAGATCCGCTTCGGGAAAG AGAAACCATTGATAGAGATGGTCTTAG 
AT5TE60680 PCR CAACGAATCAGCCAACTCAGAA GAGAAGCCTTCAAACCCTAAA 
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APPENDIX C 
Supplemental Information for Chapter 3 
 
Supplemental Materials and Methods 
Yeast two hybrid 
The full length cDNA of IDN2 was generated by PCR and cloned into pAS2 
vector (Clontech). Yeast Y190 cells containing pAS2-IDN2 plasmid were transformed 
with Arabidopsis yeast two hybrid cDNA library, (ABRC stock #CD4-22 1), and screened 
on dropout medium lacking leucine, tryptophan, and histidine but containing 50mM 3-
aminotriazol. To test the interaction between two proteins in yeast, the full length cDNAs 
were cloned into pENTR/D-Topo vector (Invitrogen) to produce entry clones according 
to manufacturer’s instructions. All the entry constructs were subsequently transferred to 
destination vector pGADT7-GW or pGBKT7-GW 2, and the pGADT7/pGBKT7 empty 
vectors served as negative controls. All the pGBKT7-based constructs were 
transformed into yeast strain Y187, and all the pGADT7-based constructs were 
transformed into yeast strain Y190. Yeast mating of Y187 and Y190 was performed 
according to Clontech Yeast Protocols Handbook (1999).  
Generation of transgenic plants 
The full length cDNA or genomic DNA including promoter regions of SWI3B and 
IDN2 were cloned into pENTR/D-Topo vector (Invitrogen) to produce entry clones 
according to manufacturer’s instructions. The resulting entry plasmids were incubated 
with the destination vectors: pMDC107 3, pEarleyGate103 4, pEarleyGate302 4,  or 
pZY35S302 with the Gateway LR Clonase™ II Enzyme Mix (Invitrogen) to obtain 
IDN2p:IDN2-GFP (pMDC107-IDN2), IDN2p:IDN2-M8-GFP (pMDC107-IDN2-M8), 
SWI3Bp:SWI3B-FLAG (pEarleyGate-SWI3B), 35S:SWI3B-GFP (pEarleyGate103-
SWI3B), 35S:IDN2-FLAG (pZY35S302-IDN2), 35S:IDN2-GFP (pEarleyGate103-IDN2),  
35S:SWI3B-FLAG (pZY35S302-SWI3B), and 35S:IDN2-M8-FLAG (pZY35S302-IDN2-
M8). To generate a binary vector pZY35S302 for 35S-driven expression of C-terminally 
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FLAG-tagged proteins, the Gateway cassette, FLAG nucleotide sequence and OCS 3’ 
were amplified from pEarleyGate302 4 using Pfu DNA Polymerase (Agilent 
Technologies). Primers used for this and other PCR amplifications are shown in Table 
S1. After KpnI and HindIII double digestion, the Gateway cassette was inserted into 
KpnI and HindIII digested pCHF1 vector 5. All constructed plasmids were introduced into 
the GV3101 strain of Agrobacterium tumefaciens and transformed into Arabidopsis 
plants by the floral dip method 6 or infiltrated into tobacco leaves 7.  
Protein co-immunoprecipitation 
Infiltrated tobacco leaves or 3-week-old Arabidopsis rosette leaves were ground 
into fine powder in liquid nitrogen, extracted using lysis buffer (50mM Tris-HCl pH8.0, 
150mM NaCl, 10mM EDTA, 10% glycerol, 1mM PMSF, 1% Plant Protease Inhibitor 
(Sigma), 0.5% Triton-X100 and centrifuged at 8000 rpm at 4˚C for 10 min. Resulting 
protein extracts were incubated with anti-GFP antibody (MBL 598, 1:1000 dilution) and 
50μl of 50% slurry of Protein A agarose beads (Invitrogen). Beads were washed 3 times 
with the lysis buffer, and the bound proteins were eluted with 2x SDS buffer. Gel blots 
were analyzed using monoclonal anti-GFP antibody (Covance, MMS-118P), or 
monoclonal anti-FLAG antibody (Stratagene, 200472). 
Chromatin-immunoprecipitation (ChIP) 
ChIP was performed as described  8 with the following modifications: proceeding 
washes with Honda buffer, nuclei were washed once in 1 ml MNase reaction buffer (10 
mM Tris-Cl pH 8, 15 mM NaCl, 60 mM KCl, 1 mM CaCl2; centrifugation at 1900 g, 5 
minutes at 4°C) and resuspended in 1 ml MNase reaction buffer. 250 µl aliquots of 
nuclei were incubated with 600 Kunitz units of Micrococcal Nuclease (NEB) at 37°C for 
10 min, then sonicated with two 10 second long pulses (1 minute intervals) with a Fisher 
Scientific Sonic Dismembrator Model 100 (power setting 1). Immunoprecipitation was 
performed using 50 µl Dynabeads protein A (Invitrogen) and 2.5 µl histone H3 antibody 
(ab1791, Abcam) or affinity purified anti-SWI3B antibody at 4°C over-night. After 
reversion of crosslinking, samples were incubated with 20 µg proteinase K (Invitrogen) 
at 65°C for 2 hours. Rabbit polyclonal anti-SWI3B antibody was raised against a C-
terminal portion of the SWI3B protein (aa 248-469) expressed in bacteria and affinity 
purified. H3 ChIP-seq samples were treated similarly, but without MNase treatment and 
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were sonicated eight times with 10 second long pulses. Library generation and Illumina 
sequencing were performed by the University of Michigan Sequencing Core. 
RNA analysis 
For RT-PCR total RNA from inflorescences was extracted using RNeasy Plant 
Mini kit (Qiagen), and treated with DNase I (Invitrogen). Real time RT-PCR was 
performed using One-Step qRT-PCR kit (Invitrogen) according to the manufacturer’s 
instructions. Pol V-dependent transcripts were assayed in RNA digested with 1 unit of 
Turbo DNase (Ambion) and reverse transcribed with Superscript III reverse 
transcriptase (Invitrogen) using random primers (Invitrogen) followed by real time PCR. 
For RNA-seq total RNA was extracted from 2.5 weeks old seedlings using RNeasy 
Plant Mini kit (Qiagen). rRNA was depleted from 8µg total RNA using RiboMinus Plant 
Kit for RNA-seq (Invitrogen). Library generation and Illumina sequencing was performed 
by the University of Michigan Sequencing Core. 
DNA methylation analysis 
DNA methylation tests using methylation sensitive restriction endonucleases 
were performed as described 9 and analyzed by PCR or real-time PCR.  
MNase-seq 
2g of 2.5-weeks old seedlings were ground to a fine powder in liquid nitrogen and 
resuspended in 15 ml Honda buffer (0.44 M Sucrose, 1.25 % Ficoll, 2.5 % Dextran T40, 
20 mM HEPES-KOH pH7.4, 10 mM MgCl2, 0.5% Triton X-100, 5 mM DTT, 1 mM 
PMSF, 1 % plant protease inhibitors (Sigma)). After filtering through two layers of 
Miracloth, the filter was washed in 10 ml Honda buffer. This washing buffer was then 
filtered through two fresh layers of Miracloth and the combined filtrates were centrifuged 
(2500 g, 15 minutes at 4°C). The pellet was washed four times in 1 ml Honda buffer 
(centrifugation at 2500 g, 15 minutes at 4°C) and 1 ml MNase reaction buffer (10 mM 
Tris-Cl pH 8, 15 mM NaCl, 60 mM KCl, 1 mM CaCl2; centrifugation at 3000 g, 5 minutes 
at 4°C) and finally resuspended in 660 µl MNase reaction buffer. 100 µl aliquots of 
nuclei were incubated with Micrococcal Nuclease (NEB) at 20°C for 10 minutes. To 
terminate the reaction, 10 µl STOP buffer (100 mM EDTA, 100 mM EGTA), 10 µl 10 % 
SDS and 40 µg proteinase K (Invitrogen) were added followed by an incubation at 60°C 
for one hour. DNA was extracted with phenol-chloroform-isoamyl alcohol and 
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chloroform-isoamyl alcohol and precipitated with ethanol. The pellet was washed in 70% 
ethanol, resuspended in 30 µl TE and incubated with 1 U RNase cocktail (Ambion) at 
37°C for one hour and then at 4°C over-night. DNA corresponding to the 
mononucleosomal fraction was purified (QIAEX II gel extraction kit, Qiagen) after 
separation on a 2% agarose gel and 20 ng of DNA was used for library generation. 
Library generation and Illumina sequencing was performed by the University of 
Michigan Sequencing Core. 
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Table 3.1 Oligonucleotides used in chapter 3 
Target Name Sequence (5'-3') Application 
Primers for plasmid constructs 
IDN2 proIDN2-F CACCTGTTGTAGTCGCTGTGATAC amplify 
genomic 
IDN2 
IDN2-R AGCCATTCCACGCTTGCGTTTCGC 
IDN2 IDN2-cacc-F CACCATGGGAAGCACTGTGATTTTA amplify IDN2 
cDNA IDN2-R AGCCATTCCACGCTTGCGTTTCGC 
IDN2 IDN2-pAS2-EcoRI-F TGGAGGCCGAATTCATGGGAAGCACTGTGATT generate 
pAS2-IDN2 
construct 
IDN2-pAS2-PstI-R TAGCTTGGCTGCAGCTAAGCCATTCCACGCTTG 
SWI3B SWI3b-cacc-F CACCATGGCCATGAAAGCTCCCGA amplify 
SWI3B 
cDNA 
SWI3b-R ACACTCTATTCTATCTTCAGTTTTCC 
SWI3A SWI3a-cacc-F CACCATGGAAGCCACTGATCCAAG amplify 
SWI3A 
cDNA 
SWI3a-R TTTCACGTACGTATGATCCCAACG 
SWI3D SWI3d-cacc-F CACCATGGAGGAAAAACGACGCGA amplify 
SWI3D 
cDNA 
SWI3d-R CGAAGAAACATTGTCTGAACCTG 
SWI3C SWI3C-cacc-F2 CACCATGCCAGCTTCTGAAGATAGAAGAGG amplify 
SWI3C 
cDNA 
SWI3C-R2 TAAGCCTAAGCCGGACCCTGAGCCTGAAC 
SWI3B SWI3B-Pro-CACC-F CACCTTAAGGCATGCGTTGAAGCAAAAGTT amplify 
genomic 
SWI3B 
SWI3b-R ACACTCTATTCTATCTTCAGTTTTCC 
Gateway pEG300F CGTCACGTCTTGCGCACTGATTTG generate 
pZY35S302 
vector 
pEG300R GAACCCTGTGGTTGGCATGCAC 
    
TRUNCATIONS AND SITE-DIRECTED MUTAGENESIS 
IDN2 IDN2-274F CACCATGAAATACCTTCAACAAGATCTTGCTG generate 
IDN2-ΔE 
deletion 
IDN2-StopR CTAAGCCATTCCACGCTTGCGTTTCGC 
IDN2 IDN2-721F CACCATGGGAGAAAACTTGAGGAAGACGGG generate 
IDN2-ΔF 
deletion 
IDN2-StopR CTAAGCCATTCCACGCTTGCGTTTCGC 
IDN2 IDN2-964F CACCATGAGTCACATTCAAAAGATAGTTG generate 
IDN2-ΔG 
deletion 
IDN2-StopR CTAAGCCATTCCACGCTTGCGTTTCGC 
IDN2 IDN2-cacc-F CACCATGGGAAGCACTGTGATTTTA generate 
IDN2-ΔH 
deletion 
IDN2-1521StopR CTAATTTGTGTTCCATTCTTTCATAATGT 
IDN2 IDN2-cacc-F CACCATGGGAAGCACTGTGATTTTA generate 
IDN2-ΔI 
deletion 
IDN2-759StopR CTATATAGTTTTCAGATCACCCGTCTTCC 
IDN2 IDN2-cacc-F CACCATGGGAAGCACTGTGATTTTA generate 
IDN2-ΔJ 
deletion 
IDN2-369StopR CTAATGATCACAATCTTGAATAGGGTTTC 
IDN2 IDN2-del760-897(250-
299)F 
CTTGAGGAAGACGGGTGATCTGAAAACTATAATGG
AAGAGAAGGAGAAGAATCAGCAAAAGC 
generate 
IDN2-ΔA 
deletion IDN2-del760-897(250-
299)R 
GCTTTTGCTGATTCTTCTCCTTCTCTTCCATTATAGT
TTTCAGATCACCCGTCTTCCTCAAG 
IDN2 IDN2-del964-
1059(322-353)F 
CGTGAGCTGAATGCTATACAAGAAAGAACAGCAAA
GCGCGAAGTGCACAATGGAACCGAG 
generate 
IDN2-ΔB 
deletion IDN2-del964-
1059(322-353)R 
CTCGGTTCCATTGTGCACTTCGCGCTTTGCTGTTCT
TTCTTGTATAGCATTCAGCTCACG 
IDN2 IDN2-del1153-
1320(385-440)F 
GCATCTAAGAATAGCTCTCTTGAACTAGCTAAGCAC
ATGGCATCAGATGGCGATGCTGAAG 
generate 
IDN2-ΔC 
206 
 
IDN2-del1153-
1320(385-440)R 
CTTCAGCATCGCCATCTGATGCCATGTGCTTAGCTA
GTTCAAGAGAGCTATTCTTAGATGC 
deletion 
IDN2 IDN2-del1405-
1512(469-504)F 
CTTCAAAGATTTAGGTGAGAAGGAAGCACAAAACA
CAAATATCGGTGTTAAGAGAATGGGAG 
generate 
IDN2-ΔD 
deletion IDN2-del1405-
1512(469-504)R 
CTCCCATTCTCTTAACACCGATATTTGTGTTTTGTG
CTTCCTTCTCACCTAAATCTTTGAAG 
IDN2 IDN2-
I325R/V329G/H332R-
F 
AGAACAATGAGTCACAGACAAAAGATAGGTGATGA
TCGTGAGAAATTGAAGAGG 
generate 
IDN2 triple 
mutant 
IDN2-
I325R/V329G/H332R-
R 
CCTCTTCAATTTCTCACGATCATCACCTATCTTTTGT
CTGTGACTCATTGTTCT 
IDN2 IDN2-MM5on3-F GATGATCGTGAGAAATTGGGGAGGCTGAGGGAGT
CAGAGGGGAAGAAACGCGAAATCAAAGGTAATGAG
TTGGCAAAGC 
generate 
IDN2 octuple 
mutant (M8) 
IDN2-MM5on3-R GCTTTGCCAACTCATTACCTTTGATTTCGCGTTTCTT
CCCCTCTGACTCCCTCAGCCTCCCCAATTTCTCAC
GATCATC 
 
RNA DETECTION 
SWI3B Swi3b-qRT-F2 CGGCGAAGTTGCGTTAGTTAAACA real time RT-
PCR Swi3b-qRT-R2 CCTCCAGACGTAGTTTCGGAAAGA 
ACTIN2 Actin2-A118 GAGAGATTCAGATGCCCAGAAGTC real time RT-
PCR 
RNA IP-
qPCR 
Actin2-A119 TGGATTCCAGCAGCTTCCA 
soloLTR 
(At5TE35950) 
soloLTR-F4 TCATGTTAAAACCGATTGCACCATTT real time RT-
PCR soloLTR-R4 CAAAAATTAGGATCTTGTTTGCCAGCTA 
soloLTR 
(At5G27845) 
IG-up-F8 CGGAATGGGGAAATTTCAAGGACGC real time RT-
PCR IG-up-R8 CAGTGACGCTGTCACCCTCGAA 
At1TE51360 LTRCO1-F3 GCCGAATGGCTCATTAAGTACCTG real time RT-
PCR LTRCO1-R3 AAGTGGGTATTCGTGCGAAAAAGA 
At3TE51910 LTRCO3-F2 ATAACCTTCCCACGCTGCATTAGA real time RT-
PCR LTRCO3-R2 TGTGAGCCTGAAGGAGATGTTGAC 
At2TE78930 78930F1  TTGATTAATGATCGCGAAAAAGTA real time RT-
PCR 78930FR1 TAATGAGTGTTGATCGGAAAGAGA 
At1TE58825 58825F1  ACTTACGCATCTCATTGTGTTGTT real time RT-
PCR 58825R1  ATCCTCTCTTCCTTGTCATGATTC 
At4TE27915 27915F1 ATTCAATCGCTCCGGTAAAATCCT real time RT-
PCR 27915R1 AGATCGTGGTCTCGTCTGTTTTCC 
At3TE47400 IG12F1 CGAAGCTTCCCACAAAATATCGTC real time RT-
PCR IG12R1 GAGGGAAGGAGAAGGAGCAGAATC 
TUBULIN8 JR147 GCTTACTAATCAAAGATGCGAGA real time RT-
PCR JR148 CTTGGTATCTTCCCGTCGAA 
UBQ10 GB473_UBQ10
s_fw 
CCATCACCCTTGAAGTGGAA real time RT-
PCR 
GB474_UBQ10
s_rv 
GATCTTGGCCTTGACGTTGT 
ROC3 GB469_ROC3s
_fw 
AAGGTTGGATCTGACTCTGGAA real time RT-
PCR 
GB470_ROC3s
_rv 
TCTGACCACAATCAGCAATGA 
25S rRNA JR41 TGTTCACCCACCAATAGGGAA RNA IP-
qPCR JR42 TCAGTAGGGTAAAACTAACCTGTCTC 
IGN5 GB268_IGN5-A ACATGAAGAAAGCCCAAACC real time RT-
PCR GB269_IGN5-A GCCGAATAACAGCAAGTCCT 
IGN20 GB280_IGN20 AAGAACCGGACCAATACGG real time RT-
PCR GB281_IGN20 CCACCGCCTCTATTGAAATG 
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IGN22 GB282_IGN22 TGGTCCATAGGTTCGGAATTT real time RT-
PCR GB283_IGN22 GGCATGGTTTGATATCAGGAG 
IGN25 GB288_IGN25 AAACCCACCTCTTTAGGTCCA real time RT-
PCR GB289_IGN25 GGCTTGGAGAGTCCAACAAT 
IGN26 GB290_IGN26 CGTTGTTCCGCCTAATTCTG real time RT-
PCR GB291_IGN26 GCCAGGAAACCCTAACTTCC 
IGN27 JA13 GGATTTAACGACATTTTTCCCTTCA real time RT-
PCR JA14 GGCTTAGGGCCCGTAACTAATAAAT 
IGN28 JA17 ATGTGGATGGATTTGTTAACCCTCT real time RT-
PCR JA18 GAAGAACGAAGAACAATGTGTTGAC 
IGN29 JA227 CGTTTGTTTATGTAGGGCGAAAG real time RT-
PCR 
RNA IP-
qPCR 
JA228 TAAAACTTTTCCCGCCAACCA 
IGN30 GB402_PV-3 GTGTGATGATGTATCATTTATATGGAG real time RT-
PCR 
RNA IP-
qPCR 
GB403_PV-3 ATATATGAAAATTGGCCTACACTCTC 
IGN31 GB416 CAATCTGGCACACACGAAAC real time RT-
PCR 
RNA IP-
qPCR 
GB417 CAGGTTGGATCTGTTGACGA 
IGN32 GB424 CCGAAACCACAGCATGTAAT real time RT-
PCR 
RNA IP-
qPCR 
GB425 TGAAATTTTCGCATCACAACA 
IGN33 GB418 TCTCTTAGGTTCCACCGGATT real time RT-
PCR 
RNA IP-
qPCR 
GB419 CGGGTTTCATTCGTCTTCAT 
    
 
DNA METHYLATION ASSAYS 
soloLTR 
(At5TE35950
) 
soloLTR-C-
F(A211)(AluI ) 
ATAAAACTCGAAACAAGAGTTTTCTTATTGCTTTC Chop qPCR, 
AluI 
soloLTR-C-
R(A212)(AluI ) 
TAATGGTATTATTTTGATCAGTGTTATAAACCGGA 
siR02 siR02chop-qPCR-
F(AluI) 
ATAGTGCAGTTCCGAAACAGTAAACCAT Chop qPCR, 
AluI 
siR02chop-qPCR-
R(AluI) 
TCAAAGTGAAAGTGGTTCTTGGGTTTAT 
At2TE78930 78930M1-F(AvaII) ATCAATACAAGGTCCATCAACAAA Chop qPCR, 
AvaII 78930M1-R(AvaII) GGGATTGAGGGTTTGAGTTTAGGG 
JA35/JA36 JA35 GGCGACCTTCTCGAGTTTCC Chop qPCR 
JA36 CAAGAACCCCACCCCATACA 
IGN6 IGN6-A30(AluI ) GGGACATCTATTGGGTTTAGGCTGGATG Chop qPCR, 
AluI,  IGN6-A31(AluI ) TTTGTAATTCTCAGTTCGGGTATCTGCTTG 
IGN22 IGN22-A413(AvaII) CAAAAATATTCACCCGCTACAAACAAAAA Chop-qPCR, 
AvaII IGN22-A414(AvaII) TCTTCCATTTGTGGGGCATGGT 
At3TE51910 51910M-F1(NlaIII) TATTACATTGTCCCCCGCTATCA Chop qPCR, 
NlaIII 51910M-R1(NlaIII) GGTGGAAGCATAAAGGATTAGGG 
AtSN1 AtSN1-A32(HaeIII) ACCAACGTGCTGTTGGCCCAGTGGTAAATC Chop PCR, 
HaeIII,  AtSN1-A33(HaeIII) AAAATAAGTGGTGGTTGTACAAGC 
IGN5 IGN5-A28(HaeIII) TCCCGAGAAGAGTAGAACAAATGCTAAAA Chop PCR, 
HaeIII,  IGN5-A29(HaeIII) CTGAGGTATTCCATAGCCCCTGATCC 
MEA-ISR MEA-ISR-F(Sau3AI) AAAAAGCTCTTTAAAATCCGAAAGTAAC Chop PCR, 
Sau3AI  MEA-ISR-R(Sau3AI)  ACATTGTGAAATCTAACCGGATTTTGGA 
PAR5 methpar5L GGCGACCTTCTCGAGTTTCC Chop PCR, 
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methpar5R CAAGAACCCCACCCCATACA non cutting 
control for 
Sau3AI  
ACTIN2 Actin2g-qPCR-F; TTTATTTGCTGGATCTCGATCTTGTTTT Chop qPCR,  
non cutting 
control for 
AluI, AvaII, 
NlaIII 
Actin2g-qPCR-R; AAACCAAAAGATTTAGTGGAGGTTCACA 
ACTIN2 Actin2g-qPCR-F2; AGTGTCGTACGTTGAACAGAAAGC Chop  
qPCR, non 
cutting 
control for 
Sau3AI 
Actin2g-qPCR-R2; GAGCTGCAAACACACAAAAAGAGT 
ACTIN2 ACTIN2-A65 CGAGCAGGAGATGGAAACCTCAAA Chop PCR, 
non cutting 
control for 
HaeIII,  
ACTIN2-A66 AAGAATGGAACCACCGATCCAGACA 
    
NUCLEOSOME VALIDATION 
PVS1 JR339 GAAAATTAGAGAGTGAAACGAGAGCA ChIP-qPCR 
JR340 TTTATTGGCCTGCCCTATTTG 
PVS2 JR377 CCTTCAAGGGGTGTGAAAAGA ChIP-qPCR 
JR378 TCTCCTTCTTCGCTGCCAAA 
PVS3 JR379 CCCACAAAAATGGTTTTCCATC ChIP-qPCR 
JR380 CAAGCCCAACATCTCGGAAA 
PVS4 JR381 CCCATTGGTCCATTTGGTGT ChIP-qPCR 
JR382 GGGCCTGTAGTGGCCTTGTA 
PVS5 JR555 AGTTGGATGGAGTCCACGAC    ChIP-qPCR 
JR556 CGCTCTCTGCAATTTTGCTT                     
PVS6 JR575 AAGGAGAAGAGACGAGTTGATGA ChIP-qPCR 
JR576 TGCCTCTTGCGAAAACAACA         
ACTIN2 Actin2-A118 GAGAGATTCAGATGCCCAGAAGTC  ChIP-qPCR 
Actin2-A119 TGGATTCCAGCAGCTTCCA  
HSP70 A512 CTCTTCCTCACACAATCATAAACA ChIP-qPCR  
A513 CAGAATTGTTCGCCGGAAAG 
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APPENDIX D 
Supplemental Information for Chapter 4 
 
Supplemental Materials and Methods 
Chromatin immunoprecipitation protocol 
Three grams of above-ground tissue of 2-week old plants was crosslinked with 
0.5% formaldehyde for 10 min by vacuum infiltration, followed by addition of glycine to 
80 mM. Plants were rinsed with water, frozen in liquid nitrogen, ground into powder 
using a mortar and pestle, suspended in 25 ml of Honda Buffer (20 mM HEPES-KOH 
pH 7.4, 0.44 M sucrose, 1.25% ficoll, 2.5% Dextran T40, 10 mM MgCl2, 0.5% Triton X-
100, 5 mM DTT, 1 mM PMSF, 1% plant protease inhibitors (Sigma)), filtered through 
two layers of Miracloth and centrifuged at 2000 x g for 15 min. Nuclear pellets were 
washed three times with 1ml of Honda buffer, resuspended in Nuclei Lysis Buffer (50 
mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS, 1 mM PMSF, 1% Plant Protease 
Inhibitors) and DNA was fragmented to the average size of 350-500 bp by 8 to 10 
pulses of sonication each 10 seconds long with 1 minute pauses in between pulses 
using Fisher Scientific 100 Sonic Dismembrator at power setting 1. After centrifugation 
at 16000 x g for 10 min., the supernatant was diluted 10-fold with 1.1% Triton X-100, 1.2 
mM EDTA, 16.7 mM Tris-HCl pH 8.0, 167 mM NaCl. 25 µl of Protein A Agarose/Salmon 
Sperm DNA (Millipore) or Dynabeads Protein A (Invitrogen) and the appropriate 
antibody was added. Samples were then incubated for 8h or overnight at 4ºC on a 
rotating mixer. Bead-antibody complexes were washed 5 times, 5 min each, with 
binding/washing buffer (150 mM NaCl, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 1% Triton 
X-100, 0.1% SDS, 1 mM PMSF) and twice for 5 min each with 10 mM Tris-HCl pH 8.0, 
1 mM EDTA. 100µl of 10% (w/v) Chelex (Bio Rad) resin, in water, was then added to 
the beads and crosslinking was reversed at 99 ºC for 10 min. Samples were digested 
with 20 µg of proteinase K (Invitrogen) for 1-2 h at 43-60 ºC followed by heat-
inactivation at 95 ºC for 10 min. Alternatively, elution was performed twice with 50 µl 
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RIP elution buffer (100 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS) for 20 min at 65 
ºC. Samples were digested with 20 µg of proteinase K (Invitrogen) for 6h - overnight at 
60 ºC. An equal volume of phenol/chloroform/isoamyl alcohol pH 6.7 25:24:1 was added 
to extract DNA, followed by addition of an equal volume of chloroform/isoamyl alcohol 
24:1 and subsequent precipitation by addition of 2 volumes 100% EtOH, 0.1 volume 3 
M Sodium Acetate and 4ul Glycoblue (Ambion). Precipitated samples were washed 
once with 70% EtOH and resuspended in 100ul water or TE.  
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Table 4.1 Oligonucleotides used in chapter 4 
Locus 
TAIR 
Annotation Primer Sequence Method Reference in Chapter 4 
Actin AT3G18780 GAGAGATTCAGATGCCCAGAAGTC 
real-time PCR Wierzbicki et al. 2008  
TGGATTCCAGCAGCTTCCA 
CGAGCAGGAGATGGAAACCTCAAA 
PCR Wierzbicki et al. 2008  
AAGAATGGAACCACCGATCCAGACA 
TUB8 AT5G23860 GCTTACTAATCAAAGATGCGAGA 
real-time PCR Numa et al. 2010  
CTTGGTATCTTCCCGTCGAA 
AtSN1 AT3TE63860 CCAGAAATTCATCTTCTTTGGAAAAG 
real-time PCR Wierzbicki et al. 2008 
GCCCAGTGGTAAATCTCTCAGATAGA 
ACCAACGTGCTGTTGGCCCAGTGGTAAATC 
PCR Wierzbicki et al. 2008 
AAAATAAGTGGTGGTTGTACAAGC 
solo 
LTR 
AT5TE35950 GGATAGAGATGAATGATGGATAATGACA 
real-time PCR Wierzbicki et al. 2008 
TTATTTTGATCAGTGTTATAAACCGGATA 
ATAAAACTCGAAACAAGAGTTTTCTTATTGCTTTC 
PCR Wierzbicki et al. 2008 
TAATGGTATTATTTTGATCAGTGTTATAAACCGGA 
IGN5 Between 
AT4TE10770 
& 
AT4TE10775 
AAGCCCAAACCATACACTAATAATCTAAT 
real-time PCR Wierzbicki et al. 2008 
CCGAATAACAGCAAGTCCTTTTAATA 
TCCCGAGAAGAGTAGAACAAATGCTAAAA 
PCR Wierzbicki et al. 2008 
CTGAGGTATTCCATAGCCCCTGATCC 
IGN20 Between 
AT4G00400 
& 
AT4G00413 
GCGGTGGCTCGAGTCAAAA 
real-time PCR - 
CCTTCCTTTGTGTCGAATTAGTCCTA 
TGTTAGCCAAAACCGACAAGAACC 
PCR - 
TTTGTCCTCGATTTTGTTCCTTCCT 
IGN22 AT4G01530 CGGGTCCTTGGACTCCTGAT 
real-time PCR - 
TCGTGACCGGAATAATTAAATGG 
CAAAAATATTCACCCGCTACAAACAAAAA 
PCR - 
TCTTCCATTTGTGGGGCATGGT 
IGN23 AT4TE12070 GCCATTAGTTTTAGATGGACTGCAA 
real-time PCR - 
GGGCGAACCTGGAGAAAGTT 
ACTGAAAATTGTAAACAAAGAAACGGCACTACA 
PCR - 
GATCGGTCCATAAACTTGTTGGGTTT 
IGN25 AT4TE22865 TCAAACCAAACCCCGAACTT 
real-time PCR - 
ATGCCAGAGCCTGGTGCTA 
CTTCTTATCGTGTTACATTGAGAACTCTTTCC 
PCR - 
ATTCGTGTGGGCTTGGCCTCTT 
IGN26 Between 
AT4G11485 
& 
AT4G11490 
TTCCTGGCCGTTGATTGGT 
real-time PCR - 
CGTGACATTAGAAGCTCTACGAGAA 
CTCTTTCAGTGCGACAGCCTCAT 
PCR - 
CGGCCAGGAAACCCTAACTTCC 
SPT5L 
mRNA 
AT5G04290 TTCGTCTGCTGGTGGTTGTGCT 
real-time PCR - 
CCCGGTTTGTCATTGGTTTCTTTCT 
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APPENDIX E 
Supplemental Information for Chapter 5 
 
Table 5.1 Oligonucleotides used in chapter 5 
Locus ID Primer 1 Primer 2 
ACTIN GGATAGAGATGAATGATGGATAATGACA TTATTTTGATCAGTGTTATAAACCGGATA 
IGN22 CGGGTCCTTGGACTCCTGAT TCGTGACCGGAATAATTAAATGG 
IGN25 TCAAACCAAACCCCGAACTT ATGCCAGAGCCTGGTGCTA 
IGN28 ATGTGGATGGATTTGTTAACCCTCT GAAGAACGAAGAACAATGTGTTGAC 
IGN29 CGTTTGTTTATGTAGGGCGAAAG TAAAACTTTTCCCGCCAACCA 
IGN34 ATGAATAACAAATTTGGAGTCGTC CCCTTTCATCGACACTGACA 
IGN35 GACGGACCAAACGATTTCAT TTCCTCTTTGAGCTTGACCA 
IGN36 CAGTTTTGGGTGCGGTTTAT GACAAAAATTGCTTTAGACCATGA 
IGN5A CGTTTCTAGAAGAACTGATTGG TTTGTTTAATAAAATTCTATCAGCTG 
JA19 GTGGACTTTCCTTTTAGGCTGTTTT CTTGATGATGAAGACGGAGACAGAT 
JA213 CATCTGATTCTTAACACCACCTACTCA ATGTCCTGAGCTGCCACGTT 
JR1031 CGGTGGATAAAGTATACGCCACAT TCACTGCCTTGTTTTGTCTGTGTC 
JR1033 AGATGGTTGTGACAAAAAGGAAAA TGCAATGGACATGCTCTAAGTGTT 
JR1035 GGGTCTCAAAACCGTCATATTTTG ACCTTTTGGTTATCGTTTGTGACG 
JR1039 ACCATCTAATCAGGCCCGACTCTT GTGCACTAGCACACTCAGCACCT 
JR1041 ACCGGTTTTTGTGGTACGTGTTAC TAGCTCCGTTACGATACAGTGTGC 
JR341 CTTACTAGGCCTATCAAATTAAAGCA CTATCAAGCGGGGCCATCAG 
JR587 TGATTTGAAAACAAAAACAAGTAACGA TCCCCAGTAAAGTCCTCACACC 
JR687 GATATCCGGTTTTTCGGATCG ATCCGCGGGTATCCGTATCT 
JR693 CGGTCATGAGCATAACCAGATG GAGTTTCTGGCCCAAAATATGC 
soloLTR GGATAGAGATGAATGATGGATAATGACA TTATTTTGATCAGTGTTATAAACCGGATA 
UBQ CCATCACCCTTGAAGTGGAA GATCTTGGCCTTGACGTTGT 
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APPENDIX F 
Supplemental Information for Chapter 6 
 
Table 6.1 Oligonucleotides used in chapter 6 
Chromatin Loop Primer 1 Primer 2 
AT2TE22565 - 
AT3G03855 
CGTTATCATCATCACCATTACTACCG AGGAGAGAGAGAGGGAGAGAGATAGG 
AT5TE93845 - 
AT4G10920 
TAACCACAAATCCGCGTTTACTGT TTTATGGTGAAAAATTAAGAGCCAAA 
AT3TE70710 - 
AT4G17000 
CACGTTATCAGCACGCTCTAAAAG TCTAGATGATGGGCTTAGATGATAAGT 
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APPENDIX G 
Supplemental Information for Chapter 7 
 
Table 7.1 Publicly available datasets generated by this work 
GEO ID 
Chapter Data was 
Analyzed 
Description Method 
GSE35381 Chapter 2 and 5 AGO4 binding sites AGO4 ChIP-seq 
GSE41143, 
GSE38401 
Chapter 3 
Nucleosome occupancy in Col-0 and 
nrpe1 
MNase-seq, H3 ChIP-seq 
GSE38400 Chapter 3 
mRNA levels in Col-0, nrpe1, ago4, idn2, 
swi3b 
RNA-seq 
To be 
uploaded 
Chapter 5 
Nucleosome occupancy in Col-0, spt5l, 
ago4, and idn2 
MNase/H3 ChIP-seq 
To be 
uploaded 
Chapter 5 SPT5L binding sites SPT5L ChIP-seq 
To be 
uploaded 
Chapter 6 
Long distance chromatin-interaction sites 
in Col-0, nrpe1, ago4, and spt5l 
HI-C 
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APPENDIX H 
Analysis of Long Non-coding RNAs Produced by a Specialized RNA Polymerase 
in Arabidopsis thaliana 
 
The contents of this appendix are methods by which to study long non-coding RNAs in 
Arabidopsis and were published in the journal Methods in 2013. Gudrun Böhmdorfer 
contributed to sections on RIP and RT-PCR. 
 
Abstract 
Long non-coding RNAs (lncRNAs) play important roles in several processes 
including control of gene expression. In Arabidopsis thaliana, a class of lncRNAs is 
produced by a specialized RNA Polymerase V (Pol V), which is involved in controlling 
genome activity by transcriptional gene silencing. lncRNAs produced by Pol V have 
been proposed to serve as scaffolds for binding of several silencing factors which 
further mediate the establishment of repressive chromatin modifications. We present 
methods for discovery and characterization of lncRNAs produced by Pol V. Chromatin 
Immunoprecipitation coupled with deep sequencing (ChIP-seq) allows discovery of 
genomic regions bound by proteins in a manner dependent on either Pol V or 
transcripts produced by Pol V. RNA Immunoprecipitation (RIP) allows testing lncRNA-
protein interactions at identified loci. Finally, real-time RT-PCR allows detection of low 
abundance Pol V transcripts from total RNA. These methods may be more broadly 
applied to discovery and characterization of RNAs produced by distinct RNA 
Polymerases. 
 
Introduction 
Long non-coding RNA (lncRNA), among other functions, is involved in directing 
chromatin modifications in order to control genes and transposons 1. These 
modifications include de novo DNA methylation, histone modifications, and nucleosome 
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positioning in a pathway known as RNA-mediated transcriptional gene silencing or 
RNA-dependent DNA methylation (RdDM) 2,3,4.  Mutations in components of the RdDM 
pathway can cause increased transposon activity, faulty DNA repair, or misregulation of 
genes 4,5,6. 
In Arabidopsis thaliana, a class of lncRNAs involved in RdDM is produced by 
RNA Polymerase V, a specialized DNA dependent RNA polymerase 7. Pol V transcripts 
are thought to create scaffolds on which several factors bind in order to control 
chromatin states 3,8.  One of these factors is ARGONAUTE4 (AGO4), which binds to the 
Pol V C-terminal domain as well as to RNA and DNA 9,10. AGO4 is guided to chromatin 
by not only Pol V and its transcripts, but also by 24 nucleotide small interfering RNA 
(siRNA) 4,8. These siRNAs are generated from cleavage of double stranded transcripts 
produced by the coordinated activity of RNA Polymerase IV and RNA-dependent RNA 
Polymerase 2 4,11. AGO4 associates with siRNA and is guided to chromatin based on 
the sequence specificity of the siRNA and the localization of Pol V 3,5. 
Another protein that binds to chromatin dependent on Pol V-produced lncRNA is SPT5-
like (SPT5L) 12,13,14. SPT5L works with AGO4 in a locus specific manner to direct the 
activity of the de novo DNA methyltransferase, DRM2 2,13.  
Although DNA methylation is a major repressive chromatin modification 
established in RdDM, it is not the only one. Our recent work implicated Pol V-produced 
lncRNA in nucleosome positioning by indirectly recruiting a SWI/SNF chromatin 
remodeling complex via the IDN2 protein 15. Being involved in the establishment of DNA 
methylation and repressive histone modifications as well as changes in nucleosome 
positioning, Pol V-produced lncRNA has broad effects on chromatin status and has 
been proposed to control genome activity 3.   
Discovery of loci under control of Pol V-produced lncRNAs relies on finding 
genomic regions bound by Pol V 16,17. An additional approach is identifying binding sites 
of proteins recruited by Pol V transcripts 5. Further investigation of the functional 
significance of those lncRNAs requires the ability to directly detect their presence and 
study their interactions with proteins 7,9,15,16,17. We present methods, which allow the 
study of Pol V produced lncRNA as well as transcripts produced by other RNA 
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polymerases. Although methods we show have only been tested with plant tissue, they 
should be applicable to the wide array of eukaryotic organisms. 
 
Chromatin Immunoprecipitation (ChIP) 
One of the main mechanisms used by lncRNA to control genome activity is by 
guiding proteins to specific genomic loci 3. Detecting where these proteins are bound 
can give insights into the function of lncRNA 9,13. This approach may also be used in 
conjunction with high-throughput sequencing in order to discover new loci that are 
impacted by lncRNA 5,16,17. Moreover, when performed in different mutant backgrounds, 
protein-DNA interaction assays may be used to further study molecular mechanisms 
involving these proteins.  
Binding of specific proteins to DNA may be detected using Chromatin 
Immunoprecipitation (ChIP) 18. In this method proteins and associated nucleic acids are 
precipitated using an antibody specific towards the protein of interest. DNA is further 
quantified and recovery of DNA above the background level is evidence of protein-DNA 
interaction.  
An important step in ChIP is crosslinking with formaldehyde, which covalently 
fixes protein-DNA interactions but also makes it difficult to differentiate between direct 
and indirect interactions. The specificity of particular antibodies may cause variability 
between experiments studying different proteins; it is advisable to optimize the amount 
of antibody used for each protein studied. Additionally, other key points, such as 
formaldehyde concentration or DNA fragmentation intensity, may be optimized 
depending on the protein studied. This method outlines basic procedures for 
crosslinking, chromatin isolation, immunoprecipitation, and DNA isolation (Figure 8.1), 
and has been successfully used for several proteins that bind chromatin in a way 
dependent on lncRNA 5,7,9,13,15,16. 
Crosslinking 
Successful ChIP usually requires a relatively large amount of starting material, 
thus 3g of approximately 2.5 weeks old Arabidopsis thaliana seedlings are used for 
each sample. Crosslinking is performed with formaldehyde 19. In order to limit 
spontaneous decrosslinking, samples are kept on ice as much as possible. Samples are 
218 
 
first washed once with ultrapure water to remove contaminants.  Enough formaldehyde 
is added to completely cover the tissue and a vacuum is applied to infiltrate plants. To 
neutralize formaldehyde, glycine is added, mixed, and the plants are exposed to 
vacuum again. Samples are placed on ice and washed twice in ultrapure water. To 
make grinding easier, samples are lightly squeezed between paper towels in order to 
remove excess water and then frozen in liquid nitrogen. Samples may be stored at -
80°C. 
Chromatin Isolation 
Frozen crosslinked plant material can now be directly used to isolate chromatin. 
Each step should be performed on ice. Samples are ground in liquid nitrogen to a fine 
powder and resuspended gently in ice cold Honda buffer (supplemented with DTT, 
PMSF, and Plant Protease Inhibitors). The resuspended powder is filtered through two 
layers of Miracloth, and the flow-through is collected in an empty tube. To increase 
yield, the used Miracloth is washed in Honda buffer and the resulting solution is filtered 
through a clean Miracloth and the two filtrates combined. Nuclei are collected by 
centrifugation and washed several times with cold Honda buffer to remove cellular 
debris.  After washes, the nuclei are resuspended in Nuclei Lysis Buffer. 
Nuclei are lysed and chromatin is fragmented by sonication on ice to an 
approximate average DNA length of between 250 and 500 bp. The fragmentation 
intensity should be experimentally optimized for a specific sonicator instrument prior to 
performing ChIP experiments (See Fig. 8.2A). Sonication optimization may be 
performed by skipping immunoprecipitation (steps 23-33) in our ChIP protocol and by 
checking the DNA fragment sizes by gel electrophoresis. Average fragment length of 
sonicated DNA is an important variable since it limits resolution of the entire ChIP 
assay. 
After fragmentation, nuclear debris is pelleted by centrifugation and the 
supernatant containing fragmented chromatin is kept. The large amount of starting 
material means that aliquots can be taken and kept at -80°C after flash freezing in liquid 
nitrogen, providing several ChIP experiments from one chromatin isolation step. A 
smaller aliquot from each sample should also be made and stored for input controls.  
 Immunoprecipitation and Elution of DNA 
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Immunoprecipitation is done with magnetic beads conjugated to protein A 
(Dynabeads Protein A). In preparation for immunoprecipitation, the magnetic beads are 
washed and resuspended in B/W buffer supplemented with PMSF. All steps are 
performed on ice or at 4°C. Chromatin aliquots are thawed on ice and diluted with ChIP 
Dilution Buffer to reduce the concentration of SDS. The prepared magnetic beads are 
added, as is the antibody directed against the protein of interest. Immunoprecipitation is 
performed at 4°C rotating overnight. In addition to samples with antibody, samples 
without antibody can be included to determine the nonspecific background pulled-down 
directly by the beads. 
The next day, the inputs are thawed on ice. Meanwhile, the beads are washed in 
B/W Buffer to remove non-precipitated chromatin. Another wash with TE is performed 
during which the beads are transferred to new tubes in order to reduce background by 
DNA bound nonspecifically to the tubes. After the washes, crosslinked protein-DNA 
complexes are eluted in Elution Buffer at 65°C. Inputs are also prepared by adding a 
small amount of chromatin to Elution Buffer. After transferring the eluate to a new tube, 
a second elution step is done to increase the yield of recovered DNA, and the eluates 
are combined. Inputs and ChIP samples are digested with Proteinase K at 60°C 
overnight. Extended heat treatment also reverses formaldehyde-induced crosslinks, 
which allows subsequent purification of DNA. 
DNA Isolation 
DNA is purified by phenol extraction. After centrifugation the aqueous phase (top 
layer) is transferred to a new 1.5ml tube. Subsequent extraction with chloroform-isoamyl 
alcohol helps to remove traces of phenol in the sample, which is essential if samples 
are used for library preparation. DNA is precipitated with 96% Ethanol in the presence 
of GlycoBlue (or a different carrier compatible with downstream applications) and 
washed with 70% Ethanol. The supernatant is carefully removed and, after air drying, 
the pellet is resuspended in water. 
Alternately, if samples are to be used solely for real-time PCR analysis, 10% 
Chelex may be added directly to the magnetic beads after the final wash with TE 20. 
Chelex should be added using a pipette tip cut at the 100µl mark while mixing the 
Chelex in between the addition to each sample. The tip is cut to ensure equal amounts 
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of beads are added to each sample. Samples can then be incubated at 99°C for ten 
minutes. Proteinase K is then added and samples are incubated at 65°C for 2 hours 
followed by 95°C for ten minutes. Samples should be centrifuged at maximum speed for 
1 minute and the supernatant taken to avoid carryover of Chelex before PCR analysis.   
Analysis and Interpretation 
Purified immunoprecipitated DNA may be analyzed by real-time PCR. Signal 
levels are usually calculated relative to input for every specific locus using a relative 
delta-cT method 21,22. Several controls are required to conclusively demonstrate protein 
binding to DNA.  
1. Background level control shows signal that does not originate from specific 
antibody-epitope interactions. If a protein-specific antibody is used, a knock-out mutant 
line entirely lacking the protein of interest should be used as a background level control 
(Figure 8.2A – nrpe1). Alternatively, when an epitope tag-specific antibody is used to 
detect a tagged protein, a line which does not express the epitope-tagged protein also 
provides reliable background level information. 
2. Loading control shows if technical issues arise during sample preparation. This 
has to be a locus where signal levels should be identical between samples. It can be 
beneficial to use more than one loading control locus. This control can either be loci 
where the protein does not bind (Figure 8.2B – ACTIN2) or loci where the protein is 
known to bind in all samples. Signal levels from the loading control may sometimes be 
used for further normalization of ChIP results. 
3. No antibody control, in which ChIP is performed without an antibody or by 
using non-specific antibodies. It shows signal that does not originate from antibody 
interactions but is non-specifically carried over on the beads. Because most antibodies 
show non-specific interactions, this control often underestimates background levels and 
should not be used as a replacement to a background level control described above.  
4. Positive control, which is a locus tested in all biological samples and based on 
pre-existing information is known to be bound by the protein of interest. This control is 
necessary if samples will be tested using high-throughput sequencing. 
Protein binding to DNA is conclusively demonstrated if specific signal is detected 
above the background level signal and loading controls show no significant differences 
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between biological samples (Figure 8.2B). Additionally, specific signal should be 
significantly higher than no antibody controls and a positive control should also 
demonstrate signal above the background level. Every ChIP experiment should be 
performed in at least three independent biological repeats. 
High-throughput sequencing 
Purified immunoprecipitated DNA, which has been successfully tested on specific 
loci using real-time PCR, may be used to discover new loci bound by the protein of 
interest by high-throughput sequencing. Samples used for high-throughput sequencing 
should have high signal to background proportion on known binding sites, ideally higher 
than 8x. If this proportion is lower, data analysis may be difficult and therefore the ChIP 
protocol should be optimized to increase signal to background ratio. Sequencing 
libraries can be generated using the Illumina ChIP-seq Library Preparation protocol. 
Detailed description of library generation is beyond the scope of this paper and usually 
is performed by specialized facilities.   
 
RNA-Immunoprecipitation (RIP) of Pol V Transcripts 
Using a similar strategy as ChIP, protein-RNA interactions can be detected. 
When applied to studying interactions between proteins and Pol V-produced non-coding 
transcripts they provide a link between a protein’s effect on chromatin and the ability to 
bind lncRNA. As for ChIP, binding is manifested as enrichment between 
conditions/genotypes when analyzed by real-time RT-PCR. Protein-RNA interactions 
are covalently fixed using reversible chemical crosslinking. RIP follows the same steps 
as ChIP: crosslinking, chromatin preparation and fragmentation, immunoprecipitation, 
and nucleic acid isolation (Figure 8.1). Differences include enzymatic elimination of DNA 
and precautions against loss of RNA. 
This approach shares all the limitations of ChIP, including limited resolution and 
inability to conclusively distinguish direct from indirect interactions. It is however much 
more straightforward than CLIP 23 and may successfully be applied for specific 
questions, especially if proper controls are available. The protocol described below has 
been applied to study interactions of Pol V-produced lncRNAs with several proteins 
9,12,15. 
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Procedure 
Crosslinking is performed exactly as described for ChIP and crosslinked tissue 
can be used interchangeably between these methods. Chromatin isolation is also 
performed as described for ChIP with the addition of an RNase inhibitor to most buffers 
to prevent RNA degradation. Immunoprecipitation is also performed as in ChIP, with a 
few minor modifications. Inputs are prepared by adding undiluted chromatin to Elution 
Buffer, and the following steps are performed with both inputs and precipitated samples. 
Two elution steps are performed to retrieve RNA, the first is performed at room 
temperature for ten minutes, while the second is performed at 65°C for ten minutes. 
Proteinase K digestion is done at 55°C for one hour 15 minutes. RNA is isolated by 
extraction with acidic phenol:chloroform:isoamyl alcohol (pH 4.3) followed by 
centrifugation and ethanol precipitation as in ChIP. After final wash in 70% ethanol it is 
critical to remove as much of the supernatant as possible and air dry the pellet for as 
short as possible (preferably 2 min.).  
Analysis and Interpretation 
Using the reverse transcription method, precipitated RNA should immediately be 
converted to cDNA (after DNase I digestion) and then analyzed by real-time RT-PCR. 
Evidence of binding to RNA can be established based on controls as described for 
ChIP. If applied to studying a specific class of RNA, it is important to include an 
additional control, which allows determining background interaction of non-specific 
RNAs. In the case of Pol V-produced lncRNA this control may be a knock-out mutant in 
a Pol V subunit, which lacks Pol V transcripts and any detected signal may be attributed 
to RNAs produced by other RNA polymerases. A critical control is RT-PCR without 
reverse transcriptase (no RT) to detect DNA contaminations, which are the most 
common technical problem in RIP. An additional consideration is that in contrast to 
ChIP, signal levels in RIP may vary dramatically between tested loci due to differences 
in transcription levels. It is therefore possible that background signal levels detected at 
an unrelated locus may be much higher than specific signal. Input levels can provide 
additional information on RNA levels, however RNA obtained from input samples is 
often difficult to amplify. Normalization to inputs may be applied during analysis as 
shown in Figure 8.3A. Due to potential quality issues and variations in total RNA levels 
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between samples, inputs should be examined before deciding to normalize. For 
example, Pol V produced lncRNAs are eliminated in the Pol V mutant (nrpe1) making 
normalization to inputs in nrpe1 impossible. For comparing independent biological 
replicates it is often necessary to normalize to wild type controls. 
 
Real-Time RT-PCR of low abundance lncRNA  
Following RIP, RNA is converted to cDNA and amplified by real-time PCR. In 
addition to analyzing RIP, this method may be used for detection of lncRNAs in total 
RNA samples. Long non-coding RNAs, including Pol V transcripts, are generally 
transcribed at low levels (some approximately 10,000 fold lower than ACTIN2), causing 
them to be difficult to detect. This method is sensitive enough to reliably and 
quantitatively detect Pol V transcripts and other low abundance RNAs. The protocol 
involves a DNase digestion to eliminate DNA, reverse transcription and real-time PCR. 
We recommend using random oligonucleotides as primers, however if strand-specificity 
is required, locus-specific primers should be used. The method we describe has been 
used to detect and quantify several Pol V-produced lncRNAs 5,15. 
RNA Isolation and cDNA Synthesis 
For detection of Pol V transcripts from total RNA, RNA isolation is performed with 
the RNeasy Plant Mini Kit from Qiagen. The optional on-column DNase I digestion step 
is followed to eliminate contaminating DNA. Alternately, RIP samples are used. Quality 
of total RNA should be tested using denaturing agarose electrophoresis (Fig. 8.3B) or 
using a Bioanalyzer. Quality of immunoprecipitated RNA is very difficult to assay directly 
at this step, since expected amounts of RNA recovered from RIP are below detection 
thresholds of currently available methods. 
One microgram of total RNA is sufficient for each reverse-transcription reaction 
to reliably detect Pol V transcripts. To further eliminate any DNA contamination, RNA is 
treated with Turbo DNase in the presence of Ribolock RNase Inhibitor. RNA is then 
separated into two reactions per genotype: half of the RNA is transferred to a new tube 
to be used as a no-reverse-transcriptase control (no RT), while the other half of the 
sample is transferred to a separate tube for the RT reaction. To denature and anneal 
primers, the RNA is mixed with random primers and dNTPs and incubated at 65°C 
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followed by at least one minute on ice.  For reverse-transcription, DTT, 5 x First Strand 
buffer, Ribolock, and Superscript III Reverse-Transcriptase are added. In case of the 
no-RT controls, water is added in place of Superscript III. Reverse transcription is 
performed at 50°C. 
A critical technical issue is avoiding DNA contaminations, especially originating 
from previously handled PCR products. We recommend using filtered tips, disposable 
gloves and working in clean workspace to avoid possible contaminations. 
Real-Time PCR of Long Non-Coding RNA 
For real-time PCR, a small volume of the cDNA is added to a PCR reaction mix, 
which in addition to a Hot Start Taq Polymerase, corresponding buffer, magnesium, and 
dNTPs, also contains SYBR Green – a dye specific towards double-stranded DNA 
which allows real-time quantification of the PCR product. Depending on the real-time 
PCR instrument being used, it may be also necessary to add an internal reference dye. 
The reaction is run with one step at 95°C, followed by 40 cycles of 95°C, 55°C, and 
72°C. It is recommended to finish each reaction with a melting curve to determine 
primer specificity and detect possible contaminations contributing to the signal.  
Analysis and Interpretation 
Obtained results should be analyzed using relative delta-cT method between 
samples 21,22, which is sufficient for comparing signal levels generated with a primer pair 
in various biological samples but does not allow quantitative comparison between 
different primer pairs. If different primer pairs have to be compared, data should be 
analyzed using a standard curve.  
If detecting Pol V transcripts in total RNA, enrichment between wild-type and a mutant 
in a Pol V subunit (nrpe1) indicates presence of lncRNA (Figure 8.3C). This assay may 
be used to show lncRNA production or quantitatively compare lncRNA levels between 
genotypes. If RIP samples are used, protein-RNA interactions can be seen.  
For proper data interpretation, the possibility of DNA contaminations should be 
excluded by performing controls without reverse transcriptase. We recommend 
performing every experiment in three biological repeats and testing every biological 
repeat with three PCR amplifications. In ChIP and RIP experiments it is common that 
overall signal levels are variable between independent experiments. If it is the case, 
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every repeat should be normalized to wild type prior to calculating averages and 
standard deviations for all available biological repeats. 
 
ChIP-Sequence Analysis 
ChIP-seq is performed to identify protein binding sites throughout the genome. In 
order to generate a list of binding locations, the raw sequencing reads must first be 
processed in a way that accurately maps to the Arabidopsis genome while controlling 
for quality. After reads have been mapped, enrichment scores can be generated and 
utilized to obtain genomic coordinates of binding sites (Figure 8.4). Several different 
algorithms exist for each step and decisions on the use of each algorithm can be 
difficult; each has advantages and individual decisions must be made specific to the 
type of protein studied and the question being asked. Presented here is a simple data 
analysis pipeline based on published work 5, presented in a way which should provide a 
starting point to biologists and allow further refinement for a specific dataset. We use 
the peak-calling algorithm, CSAR 24, because it was built specifically around the 
Arabidopsis genome and from our experience has a high rate of discovery with a low 
number of false positives. Several aligners can be used and our experiences with each 
have been excellent. For simplicity sake we use SOAP2 25 because the output format 
can directly be read into CSAR. 
Read Trimming and Alignment 
Although sequencing generally produces quality reads, it may be useful to trim 
any low quality bases from either end. There are several ways to do this, but ConDeTri 
26 provides a simple method of trimming N’s from the 5’ end and low quality bases from 
the 3’ end of reads. 
In order to align reads to the genome efficiently, alignment algorithms generally require 
an index of the reference genome sequence. Alignment packages usually include a 
separate algorithm for index creation. The Arabidopsis genome sequence can be 
downloaded from the TAIR website 
(ftp://ftp.arabidopsis.org/home/tair/Genes/TAIR10_genome_release/TAIR10_chromoso
me_files/TAIR10_chr_all.fas) and indexed using 2bwt-builder in the SOAP2 package 25. 
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Index files will be given the suffix “.index”. Alignments can now be performed using the 
SOAP2 aligner. 
Peak Detection 
Once mapping is complete, binding sites are called based on regional read 
enrichment in wild-type compared to mutant. Although a knockout mutant represents 
the true background signal obtained during the ChIP experiment, inputs may also be 
used to control for sequence or amplification bias during library generation.  Peak 
calling through enrichment scores can be done using CSAR which was built and tested 
around the Arabidopsis genome. First the mapped reads are loaded in R in a format 
that CSAR is able to recognize. Reads are then artificially extended to the fragmentation 
length obtained from sonication, and the number of reads at each base is counted for 
both strands. To remove PCR amplification errors, only unique reads are kept. Scores 
are calculated by comparing two samples (i.e. wild-type versus mutant) and regions with 
enrichment are kept. Significant binding sites are determined by establishing an 
arbitrary cutoff score at a specified false discovery rate (FDR). Generally an FDR of 
0.001 provides high quality peaks, but peak lists at various FDR values can be 
generated. The final list will have chromosomal coordinates, the enrichment scores, and 
the length of peaks included in the file. 
 
Conclusions  
The activity of lncRNA can be studied through a combination of techniques 
focused on indentifying loci controlled by RdDM. New targets of transcriptional gene 
silencing can be detected by ChIP-seq for proteins that bind chromatin in a way 
dependent on lncRNA. These loci can then be directly tested for lncRNA production and 
protein-RNA interactions. Additionally, by using a combination of these methods in 
various mutant backgrounds and with antibodies for different proteins, molecular 
mechanisms of RNA-mediated silencing pathways can be deciphered. As knowledge of 
lncRNA expands, methods such as these will become increasingly important to study its 
role in the regulation of genome activity. 
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Step-by-Step protocols 
ChIP and RIP 
 
Note: Use filter tips when working with RNA. 
Note: Keep samples on ice as much as possible. 
 
1. Harvest 3g of above ground tissues from 2.5 week old seedlings and place in 50ml 
tubes on ice with a hole punched in lids with scissors. 
2. Rinse once with H2O. 
3. Add 0.5% formaldehyde so that tissue is immersed (up to 35ml). 
4. Apply vacuum at 85 kPa (~25in. Hg) below standard atmospheric pressure for 2 
minutes. Release and reapply for 8 minutes. 
 
Note: Ensure a hole is placed in each lid or tubes may break from the pressure. 
 
5. Add 1.25ml 2M glycine. Mix and apply vacuum at 85 kPa (~25in.Hg) for 1 minute. 
Release and reapply for 4 minutes. 
6. Rinse twice in H2O, squeeze dry between paper towels, wrap in aluminum foil, and 
freeze in liquid nitrogen. 
7. Store at -80°C. 
 
Note: Crosslinked tissue can be used for either ChIP or RIP. 
 
8. Prepare 30ml Honda Buffer per sample. For every 30ml Honda Buffer, add 150µl 1M 
DTT, 300µl 100mM PMSF, and 300µl Plant Protease Inhibitor. For RIP, also add 240u 
Ribolock RNase Inhibitor. 
 
Note: For all RNA work solutions should be prepared with RNase-free water. We 
recommend using fresh miliQ water without any additional treatments. 
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9. Place 15ml and 10ml prepared Honda Buffer in 50ml tubes on ice. Keep leftover 
buffer on ice as well. 
10. Grind frozen crosslinked tissue in liquid nitrogen into a fine powder and resuspend 
gently in 15ml prepared Honda Buffer. Keep on ice. 
 
Note: Ensure that all large chunks are dissolved and that a fine powder is present in the 
buffer. 
 
11. Cut two 6cm wide strips of Miracloth and form one into a funnel with two layers 
between outside and inside of the funnel. 
12. Filter the resuspended tissue through funnel into empty 50ml tube. 
13. Invert filter and place in prepared 10ml Honda Buffer. Resuspend as much tissue as 
possible by swirling Miracloth in buffer. 
 
Note: Washing the Miracloth increases chromatin yield. 
 
14. Using the second strip of Miracloth from step 11, form another funnel like the first 
and filter washed sample from step 13, combining the flow through with the previous 
one.  
15. Centrifuge at 3000 g for 7.5 minutes at 4°C and discard supernatant. 
16. Resuspend pellet with 1ml prepared Honda Buffer and transfer to a 1.5ml tube. 
17. Centrifuge at 1900 g for 5 minutes at 4°C. Discard supernatant.  
18. Wash twice with 1ml prepared Honda Buffer by centrifugation at 1900 g for 5 
minutes at 4°C. If the pellet is still green perform one additional washing step. 
 
Note: Use leftover Honda Buffer from step 9 for steps 16 and 18. 
 
19. Resuspend nuclei gently in 550µl freshly prepared cold NLB (with 88U Ribolock for 
RIP).  
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20. Sonicate on ice 8 times for 10 seconds with 1 minute pauses at power setting 1. 
(Fisher Scientific Dismembrator - Adapt number of times based on the instrument used 
until chromatin is fragmented to approximately 250bp to 500bp on average). 
 
Note: It is important to keep samples on ice during sonication to avoid overheating and 
possible protein degradation or loss of crosslinks. 
 
21. Centrifuge samples in a microcentrifuge at maximum speed for 10 minutes at 4°C. 
Transfer supernatant to a new 1.5ml tube. 
22. Take 100µl aliquots and flash freeze in liquid nitrogen. Also freeze one 10µl aliquot 
for inputs. Store at -80°C. 
 
Note. While the preceding steps are specific for plant material, the remainder of the 
protocol may be applicable to chromatin samples obtained from other organisms. 
 
23.  Prepare 5ml B/W buffer by adding 50µl PMSF (and 200U Ribolock for RIP). 
24. Using magnetic rack, wash 40µl per sample Dynabeads Protein A three times with 
1ml B/W buffer from step 23. Resuspend in 110µl B/W from step 23 per sample. 
25. Combine one 100µl aliquot of chromatin, 900µl ChIP Dilution Buffer (with Ribolock 
for RIP), 100µl washed magnetic beads, and 2.5µg - 5µg antibody.  
26. Rotate at 4°C over-night. 
 
Note: Amount of antibody and incubation time can be adjusted depending on the protein 
studied or the antibody used. In our experience, 2.5µg - 5µg antibody works well for 
most applications. Magnetic beads may be replaced with Protein A Agarose beads 
blocked with salmon sperm DNA, which give lower background levels for some 
antibodies; however, due to the presence of blocking DNA, samples obtained using 
those beads cannot be used for sequencing. 
 
27. Prepare 5ml per sample B/W buffer by adding 50µl PMSF (and 200U Ribolock for 
RIP). 
230 
 
28. For ChIP wash the samples three times with 1ml B/W with rotation at 4°C for 5 
minutes between washes. Follow with one wash in TE. 
For RIP wash twice with 1ml B/W by inverting, magnetic separation, and removal of 
supernatant, followed by twice with 1ml B/W and rotating at 4°C for 5 minutes between 
washes.  
 
Note: Use a magnetic separator buried in ice during washes to keep samples cold. 
 
29. After the last wash transfer samples to new 1.5ml tubes, remove supernatant, and 
add 55µl Elution Buffer (with 22U Ribolock for RIP). 
30. Prepare 1% input samples by adding 1µl chromatin extract to 110µl Elution Buffer 
(with 44U Ribolock for RIP). 
31. Vortex all samples briefly and incubate them at 65°C for 20 minutes for ChIP (room 
temperature for 10 minutes for RIP). 
 
Note: Vortexing vigorously helps elute the sample from the beads. 
 
32. Place on magnetic separator, transfer supernatant to a new 1.5ml tube and add 55µl 
Elution Buffer to beads (with 22U Ribolock for RIP).  
 
Note: Input samples do not need to be transferred. 
 
33. Incubate at 65°C for 20 minutes (10 minutes for RIP), vortex, place on magnetic 
separator, and transfer supernatant to previous eluate. 
34. Add 20µg RNA-grade Proteinase K and incubate at 60°C overnight for ChIP (55°C 
for 1 hour 15 minutes for RIP). 
35. Add 110µl room temperature phenol:chloroform:isoamyl-alcohol 25:24:1 (pH 7.5 for 
ChIP, pH 4.3 for RIP). 
36. Vortex well and centrifuge at maximum speed for 5 minutes. 
37. Transfer 100µl aqueous phase to new 1.5ml tube. 
38. For ChIP repeat steps 35-37 with 24:1 chloroform:isoamyl-alcohol. 
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39. Add 60µg GlycoBlue (or an equivalent amount of a different carrier compatible with 
downstream applications), 10µl 3M sodium acetate pH 5.3, and 250µl 96% ethanol.  
40. Incubate at -80°C for 2 hours (overnight for RIP). 
41. Centrifuge at maximum speed for at least 30 minutes at 4°C. Discard supernatant. 
42. Add 300µl 70% ethanol and centrifuge at maximum speed for 10 minutes at 4°C. 
Discard supernatant. If traces of supernatant are left on tube walls, centrifuge again 
briefly and remove leftovers of the supernatant. 
43. Air dry pellet for 2 minutes and resuspend in 30µl H2O for ChIP (12µl RNase-free 
H2O for RIP). ChIP samples may be stored for up to a year at -20°C, RIP samples may 
be stored at -80°C for a couple of days, however due to low stability of RNA should be 
processed as soon as possible. 
44. ChIP DNA can be checked for enrichment of DNA levels between samples by real-
time PCR or used for library generation and sequencing. RIP RNA can be reverse 
transcribed and used in quantitative PCR as in A.2.  
 
Note: Alternately, if ChIP DNA will not be used for sequencing, steps 29-43 can be 
replaced with the following protocol using Chelex. Cut a pipette tip at 100µl and add 
100µl 10% Chelex-100 to the beads. Prepare 1% inputs by adding 1µl of chromatin to 
100µl 10% Chelex-100. Vortex well and incubate at 99°C for ten minutes. Cool samples 
to 65°C and add 20µg Proteinase K, incubating at 65°C for two hours. Deactivate 
Proteinase K at 95°C for ten minutes and spin samples at max speed for 1 minute. 
Supernatant can be diluted and analyzed by real-time PCR as in step 44. 
 
Real-Time RT-PCR of low abundance lncRNA 
 
Note: Use filtered tips, disposable gloves and clean workspace when working with RNA. 
 
1. Isolate RNA using the Qiagen RNeasy Plant Mini Kit following instructions with the 
optional on-column DNase digestion. RIP samples from A.1 can also be used.  
 
Note: Total RNA may be stored at -80°C up to 2 weeks. 
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2. To 1-5µg total RNA or the entire RIP sample from A.1 step 43, add 3units Turbo 
DNase, 24 units Ribolock, and H2O up to 12µl. 
3. Incubate at 25°C 30 minutes. 
4. Add 3µl 25mM EDTA. 
5. Incubate at 65°C 10 minutes. 
6. Transfer 1/2 RNA to a new tube for no-RT control and transfer 1/2 RNA to a new tube 
for the RT reaction. 
7. Add 0.4µl 500ng/µl random primers (Invitrogen) and 1µl 10mM dNTPs. 
8. Incubate at 65°C 5 minutes. Keep on ice for at least 1 minute. 
9. Add 1µl 0.1M DTT, 4µl 5x First Strand Buffer, 1µl 40U/µl Ribolock, and 1µl 
Superscript III Reverse Transcriptase (substitute water for Superscript III in no-RT 
controls). Add H2O to a total volume of 20µl. 
10. Incubate 25°C for 5 minutes, followed by 50°C for 1 hour, then 70°C for 15 minutes. 
 
Note: cDNA may be stored at -20°C. 
 
11. To 1µl cDNA add 2.5µl 10x Platinum Taq PCR buffer, 1.2µl 50mM MgCl2, 0.5µl 
10mM dNTPs, 0.25µl 25x SYBR Green, 0.2µl 25µM forward and reverse primer mix,  
0.1µl Platinum Taq, and H2O to a total volume of 25µl.  
 
Note: 25X SYBR Green is prepared before hand by diluting 1:400 with H2O and stored 
at 4°C in the dark. 
 
12. Run PCR plate at 95°C for 2 minutes, followed by 40 cycles of 95°C for 15 seconds, 
55°C for 20 seconds, 72°C for 45 seconds. 
 
Simple ChIP-seq Data Analysis Pipeline 
 
Note: Commands for each step are italicized. Ensure all software has been successfully 
downloaded and installed including Condetri, SOAP2, and CSAR. 
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Note: Perform steps 1 and 3 as well as 7 and 8 for each genotype/sample. 
Note: Each command contains file names that will change depending on user 
preference. This example uses the name “wt.fastq” for the file obtained from sequencing 
and “TAIR10_chr_all.fas” for the genome reference file downloaded from the TAIR 
website. 
 
1. Trim reads:  perl condetri_v2.2.pl -fastq1=wt.fastq -prefix=wt -rmN 
 
Note: wt.fastq contains the reads and quality scores from sequencing. The prefix 
parameter “-prefix=” is used to name the output file and should be changed with each 
sample. In step1 the output file will be named wt_trim.fastq. The parameter “-rmN” 
removes N base calls from the beginning of reads. 
 
2. Build Genome Index (only needs to be done once):  ./2bwt-builder 
TAIR10_chr_all.fas 
3. Align Reads to Genome:  ./soap -a wt_trim.fastq -D TAIR10_chr_all.fas.index -o 
wt.soap 
 
Note: wt_trim.fastq is the file containing the trimmed reads from step 1. wt.soap is the 
name of the output file for this step. 
 
4. Repeat Steps 1 and 3 for each sample changing the names of the appropriate files. 
5. Start R:  R 
6. Load CSAR package: > library(CSAR) 
 
Note: The symbols > or + denotes a new line and are displayed by R. 
 
7. Load Mapped Reads for each genotype: > wt <- loadMappedReads(“wt.soap”, format 
= "SOAP", header = FALSE) 
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Note: In R results from each command are saved into temporary variables using the “<-“ 
symbols. The results from step seven are saved into “wt” and these results are called 
upon in step eight. 
 
8. Extend reads to fragmentation length, eliminate PCR amplification errors, and count 
reads: > wt.nhits <- mappedReads2Nhits(wt, file = “wt.nhits” , chr = c("1", "2", "3", "4", 
"5"), chrL = c(30427671, 19698289, 23459830, 18585056, 26975502), w = 250L, 
considerStrand = "Sum", uniquelyMapped = TRUE) 
 
Note: Parameter w is the fragmentation length after sonication and artificially extends 
the reads to this length. considerStrand = “Sum” is used to count all the reads 
regardless of the strand they map to, but can be changed to “Minimum” if only reads 
with equal numbers on both strands are desired. uniquelyMapped is used to remove 
duplicate reads due to PCR amplification errors during library preparation. Each 
chromosome’s length is specified by the chrL parameter. 
 
9. Repeat steps 7 and 8 with each sample changing the names “wt”, “wt.soap”, and 
“wt.nhits” to “mutant”, “mutant.soap”, and “mutant.nhits” respectively. 
10. Compare genotypes and calculate enrichment scores: > score <- 
ChIPseqScore(mutant.nhits, wt.nhits) 
11. Create windows of enrichment between genotypes (these windows will later be 
filtered based on false discovery rate (FDR)): > TotalPeaks <- sigWin(score) 
12. Run each of the following to perform permutations in order to calculate score cutoff 
based on FDR. 
 
 
>dir.create(“permutations”) 
>setwd(“permutations”) 
> for (j in 1:20) { 
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+ permutatedWinScores(nn = j, mutant, wt, fileOutput = "perm", chr = 
c("1","2","3","4","5"), chrL = c(30427671, 19698289, 23459830, 18585056, 26975502), 
w = 250L, considerStrand = "Sum", uniquelyMapped = TRUE) 
+ } 
>permscores <- getPermutatedWinScores(file = "perm", nn=1:20) 
>cutoff <- getThreshold(winscores=TotalPeaks$score, permutatedScores=permscores, 
FDR=.001) 
>setwd(“../”) 
13. Use cutoff value to create list of significant enrichment windows: >FilteredPeaks <- 
TotalPeaks[TotalPeaks$score > cutoff$threshold,] 
 
Note: Step 12 uses a cutoff FDR of 0.001which is somewhat strict. Changing the FDR 
value in step 12 will change the sensitivity and specificity of peaks in the final list. 
  
14. Write file with list of peaks: >write.table(FilteredPeaks, sep="\t", 
file="wtvsmutant.txt", row.names=FALSE) 
 
Note: Exit R and examine the file using a word processor. The list of peaks is saved as 
“wtvsmutant.txt” and includes peaks where the FDR is less than 0.001. This list includes 
the coordinates of binding sites along with the position of the peak summit, the peak 
enrichment score, and the length of the binding region. 
 
Equipment, Reagents and Buffers 
Equipment 
Vacuum chamber (ChIP and RIP), Isotemp Vacuum Oven Model 280A (Fisher 
Scientific), self-cleaning dry vacuum system (Welch) 
Refrigerated centrifuge (ChIP and RIP), Thermo Scientific Sorvall Legend X1 
Centrifuge, Eppendorf centrifuge 5424 
Sonicator (ChIP and RIP), Fisher Scientific, Sonic Dismembrator Model 100 
Rotator (ChIP and RIP), Thermo Scientific Labquake Tube Rotator 
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Magnetic separator (ChIP and RIP), Promega MagneSphere Technology Magnetic 
Separation Stand  
Real-Time Thermal Cycler (ChIP, RIP, and RT-PCR), Biorad CFX Connect Real-time 
System 
Reagents 
DTT (ChIP, RIP, and RT-PCR), Fisher Scientific, BP172-5  
Formaldehyde 0.5% (ChIP and RIP), Sigma-Aldrich, F1635-500ML  
Glycine 2M (ChIP and RIP), Fisher Scientific, G46-1 
PMSF 100mM (ChIP and RIP), Sigma-Aldrich, P7626-25G 
Plant Protease Inhibitor [Sigma] (ChIP and RIP), Sigma-Aldrich, P9599-5ML 
Miracloth (ChIP and RIP), VWR, 80058-394  
Dynabeads Protein A Magnetic Beads [Invitrogen] (ChIP and RIP), Invitrogen, 100-01D 
Protein/Tag specific antibody (ChIP and RIP) 
RNA-grade Proteinase K 20mg/ml [Invitrogen] (ChIP and RIP), Invitrogen, 25530-049  
25:24:1 Phenol-chloroform-isoamyl alcohol pH 7.5 (ChIP), Fisher Scientific, BP1752I-
100 
25:24:1 Phenol-chloroform-isoamyl alcohol pH 4.3 (RIP), Fisher Scientific, BP1754I-100 
24:1 Chloroform-isoamyl alcohol (ChIP), Fisher Scientific (chloroform: C298500, 
isoamyl alcohol: BP1150-500; mix 24:1)  
GlycoBlue 15mg/ml [Ambion] (ChIP and RIP), Fisher Scientific, NC9567599 
3M NaOAc pH 5.2 (ChIP and RIP), Fisher Scientific (NaOAc: BP333-500, acetic acid: 
AC14893-0025) 
96% EtOH (ChIP and RIP), Decon Labs Inc., 2701 
Turbo DNase 2U/µl [Ambion] (RIP and RT-PCR), Fisher Scientific, NC9075048  
Ribolock RNase Inhibitor 40U/µl [Fermentas] (RIP and RT-PCR), Fisher Scientific, 
FEREO0384 
RNeasy Plant Mini Kit [Qiagen] (RT-PCR), Qiagen, 74904 
25mM EDTA pH8 (RT-PCR), Fisher Scientific (EDTA: BP120500, NaOH: BP359-500) 
Random Primer 500ng/µl [Invitrogen] (RT-PCR), life technologies, 48190-011 
dNTPs 10mM [Promega] (RT-PCR), Fisher Scientific, PRU1515  
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Superscript III Reverse Transcriptase 200U/µl, 5 x FS buffer, 0.1M DTT [Invitrogen] 
(RT-PCR), life technologies, 18080-044 
Platinum Taq 5U/µl, 10x Platinum Taq PCR Buffer, 50mM MgCl2 [Invitrogen] (RT-PCR), 
life technologies, 10966-034 
SYBR Green I Nucleic Acid Gel Stain - 10,000X concentrate in DMSO  [Invitrogen] (RT-
PCR), life technologies, S-7563  
Chelex-100 (ChIP), Bio-Rad 142-1253 
Nalgene Rapid Flow Sterile Disposable Filter Unit with PES Membrane [Thermo 
Scientific] (ChIP/RIP), Fisher Scientific, 09-741-02 
Ultra-pure water (miliQ) 
Buffers 
Honda Buffer 
0.44M Sucrose, Fisher Scientific, BP220-212 
1.25% Ficoll 400, Sigma-Aldrich, F2637-100G  
2.5% Dextran T40, Sigma-Aldrich, D1662-100G 
20mM HEPES, KOH pH7.4, Fisher Scientific (HEPES: BP310-100, KOH: P250-1)  
10mM MgCl2, Fisher Scientific, M33-500 
0.5% Triton X-100, Fisher Scientific, BP151-500 
Prepare HEPES first in 350ml and set pH, then add other components. 
Make 500ml and filter through 0.2 micron filter. 
Store at 4°C. 
 
Add the day of experiment: 
5mM DTT, Fisher Scientific, BP1725 
1mM PMSF, Sigma-Aldrich, P7626-25G 
1% Plant Protease Inhibitors, Sigma-Aldrich, P9599-5ML 
8U/ml Ribolock RNase Inhibitor (RIP only), Fermentas, FEREO0384 
 
Binding/Washing Buffer (B/W) 
150mM NaCl, Fisher Scientific, BP358-212 
20mM Tris HCl pH8, Fisher Scientific (Tris: BP152-5, HCl: A144-500) 
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2mM EDTA pH8, Fisher Scientific (EDTA: BP120500, NaOH: BP359-500) 
1% Triton X-100, Fisher Scientific, BP151-500 
0.1% SDS, Fisher Scientific, BP166-500 
Add water to 500ml and filter through 0.2 micron filter. 
Store at 4°C. 
 
Add the day of experiment: 
1mM PMSF, Sigma-Aldrich, P7626-25G 
40U/ml Ribolock RNase Inhibitor (RIP only), Fermentas, FEREO0384 
 
Nuclei Lysis Buffer (NLB)  
50mM Tris-HCl pH8, Fisher Scientific (Tris: BP152-5, HCl: A144-500)  
10mM EDTA, Fisher Scientific (EDTA: BP120500, NaOH: BP359-500) 
1% SDS, Fisher Scientific, BP166-500 
 
Add the day of the experiment: 
1mM PMSF, Sigma-Aldrich, P7626-25G 
1% Plant Protease Inhibitors, Sigma-Aldrich, P9599-5ML 
160U/ml Ribolock RNase Inhibitor (RIP only), Fermentas, FEREO0384 
 
ChIP-Dilution Buffer 
Note: Tris-HCl and EDTA are added from filtered stock solutions. 
1.1% Triton X-100, Fisher Scientific, BP151-500 
1.2mM EDTA pH8, Fisher Scientific (EDTA: BP120500, NaOH: BP359-500)  
16.7mM Tris-HCl pH8, Fisher Scientific (Tris: BP152-5, HCl: A144-500)  
167mM NaCl, Fisher Scientific, BP358-212 
350U/ml Ribolock RNase Inhibitor (RIP only), Fermentas, FERE00384 
Store at 4°C for ease of use. 
 
Elution Buffer 
Note: Tris-HCl and EDTA are added from filtered stock solutions. 
239 
 
100mM Tris HCl pH8, Fisher Scientific (Tris: BP152-5, HCl: A144-500) 
10mM EDTA, Fisher Scientific (EDTA: BP120500, NaOH: BP359-500) 
1% SDS, Fisher Scientific, BP166-500 
Add the day of the experiment: 
400U/ml Ribolock RNase Inhibitor (RIP only) Fermentas, FERE00384 
 
TE Buffer 
10mM Tris-HCl pH8, Fisher Scientific (Tris: BP152-5, HCl: A144-500) 
1mM EDTA, Fisher Scientific (EDTA: BP120500, NaOH: BP359-500) 
 
List of Primers 
IGN29: CGTTTGTTTATGTAGGGCGAAAG and TAAAACTTTTCCCGCCAACCA. 
ACTIN2: GAGAGATTCAGATGCCCAGAAGTC and TGGATTCCAGCAGCTTCCA. 
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Figure 8.1 Overview of Chromatin-Immunoprecipitation (ChIP) and RNA-
Immunoprecipitation (RIP) 
DNA or RNA (black lines) is crosslinked to proteins (circles).  Chromatin is extracted 
and fragmented (straight lines with circles). Fragments bound by the protein of 
interest are precipitated by an antibody (y-shaped) and magnetic beads (diamonds). 
RNA or DNA (straight lines) is purified from proteins (circles) and tested by real-time 
PCR. 
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Figure 8.2 ChIP 
(A) DNA fragmentation after sonication. Fragmentation can be checked by gel 
electrophoresis after decrosslinking. Optimal fragmentation can be determined by 
varying the sonication time as shown.  
(B) ChIP-based detection of DNA bound by NRPE1, the largest subunit of Pol V. 
DNA binding is seen as enrichment in Col-0 wild-type compared to nrpe1 mutant 
(which serves as a background level control) at the IGN29 locus. ACTIN2 serves as 
an unbound loading control to check specificity of immunoprecipitation. Bars 
represent average real time PCR signal normalized to inputs in Col-0 wild-type 
(black) and nrpe1 (gray). Error bars represent standard deviations from three PCR 
amplifications. 
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Figure 8.3 RIP and total RNA RT-PCR 
(A) RIP-based detection of RNA bound by Pol V. RNA binding is seen by 
enrichment between FLAG tagged Pol V subunit (nrpe1 NRPE1-FLAG) compared to 
Col-0 wild-type (which serves as a background control) at IGN29 15. ACTIN2 serves 
as an unbound loading control to check efficiency of immunoprecipitation. Samples 
without reverse transcriptase (-RT) are used to check for signal resulting from DNA 
contamination. Bars represent average real time RT-PCR signal normalized to 
inputs. Error bars represent standard deviations from three PCR amplifications. 
(B) Quality of RNA used in RT-PCR. RNA quality may be seen by gel 
electrophoresis as shown. 
(C) Non-coding transcripts are seen by enrichment between Col-0 wild-type and the 
Pol V mutant (nrpe1) at IGN29 15. ACTIN2 serves as a loading control. Samples 
without reverse transcriptase (-RT) are used to check for signal resulting from DNA 
contamination. Bars represent average RNA signal as a ratio of mutant (nrpe1 – 
gray) to Col-0 wild-type (black). Error bars represent standard deviations from three 
PCR amplifications. 
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Figure 8.4 ChIP-sequencing analysis 
Analysis of sequencing reads from ChIP involves quality control, mapping, and peak 
calling. Low quality reads and bases (dashed lines) are removed from analysis to 
improve alignment. Remaining reads are aligned to the genome. Reads are 
extended to the fragmentation size obtained in sonication to more precisely map 
binding sites (arrows). Enrichment scores and permutations are used to obtain 
statistical significance for enriched genomic regions.  
 
